mefloquine has been researched along with Malaria, Falciparum in 610 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 224 (36.72) | 18.2507 |
| 2000's | 216 (35.41) | 29.6817 |
| 2010's | 144 (23.61) | 24.3611 |
| 2020's | 26 (4.26) | 2.80 |
| Authors | Studies |
|---|---|
| Fidock, DA; Flannery, EL; Winzeler, EA | 1 |
| Alcorn, J; Das, U; Dimmock, JR; Hickman, MR; Lee, PJ; Leed, SE; Roncal, N; Sciotti, RJ; Singh, RS | 1 |
| Azam, A; Inam, A; Leite, AC; Macedo, TS; Moreira, DR; Siddiqui, SM; Soares, MB | 1 |
| Avery, VM; Charman, SA; Chibale, K; Douelle, F; Duffy, S; Gonzàlez Cabrera, D; Le Manach, C; March, C; Nchinda, AT; Ryan, E; Street, LJ; Taylor, D; Waterson, D; White, KL; Wiesner, L; Wittlin, S; Witty, MJ; Younis, Y | 1 |
| Angulo-Barturen, I; Bashyam, S; Birkholtz, LM; Botha, M; Brunschwig, C; Chibale, K; Churchyard, A; Coetzer, TL; Dhinakaran, R; Ferrer, S; Gonzàlez Cabrera, D; Han, Z; Jiménez-Díaz, MB; Lauterbach, S; Le Manach, C; Meister, S; Njoroge, M; Paquet, T; Reader, J; Santos Martínez, M; Street, LJ; Taylor, D; Waterson, D; Winzeler, EA; Wittlin, S; Witty, MJ | 1 |
| Augereau, JM; Benoit-Vical, F; Deraeve, C; Jimenez, T; Mustière, R; Nguyen, M; Ouji, M | 1 |
| Avery, VM; Challis, MP; Creek, DJ; De Paoli, A; Devine, SM; Kigotho, JK; MacRaild, CA; Norton, RS; Scammells, PJ; Siddiqui, G | 1 |
| Arimondo, PB; Bon, C; Cadet-Daniel, V; Claes, A; Dobrescu, I; Erdmann, D; Halby, L; Hammam, E; Mairet-Khedim, M; Mecheri, S; Nardella, F; Peronet, R; Roesch, C; Scherf, A; Tafit, A; Viluma, J; Witkowski, B | 1 |
| Boechat, N; Campos Aguiar, AC; da Silva Araújo, M; Krettli, AU; Medeiros, JF; Penna-Coutinho, J; Pereira, DB; Rios, CT; Sá, PM | 1 |
| Corry, B; Martin, RE; Richards, SN; Shafik, SH | 1 |
| Chaoratanakawee, S; Chin, G; Harrison, D; Lek, D; Menard, D; Rachmat, A; Rogers, WO; Saunders, D | 1 |
| Iwanaga, S; Kamchonwongpaisan, S; Kubota, R; Nishi, T; Shinzawa, N; Srichairatanakool, S; Syafruddin, D; Uthaipibull, C; Yuda, M | 1 |
| Barale, JC; Bouillon, A; Chy, S; Eam, R; Kauy, C; Ke, S; Khean, C; Khim, N; Kim, S; Kloeung, N; Kul, C; Leang, R; Mairet-Khedim, M; Ringwald, P; Roesch, C; Srun, S; Witkowski, B | 1 |
| Na-Bangchang, K; Saeheng, T | 1 |
| Bajpai, S; Banerjee, S; Kushwaha, R; Mandal, A; Mandal, AA; Yadav, AK | 1 |
| Aponte, JJ; Cisteró, P; Cot, M; Desai, M; González, R; Gupta, H; Huijben, S; Kariuki, S; Macete, E; Massougbodji, A; Mayor, A; Menéndez, C; Mombo-Ngoma, G; Mwangoka, G; Ndam, NT; Ramharter, M; Shi, YP; Uberegui, E | 1 |
| Adisa, BA; Oludele, OJ; Olufunso, OO | 1 |
| de Sena, LWP; Ferreira, MVD; Rivera, JGB; Vieira, JLF | 1 |
| Hastings, IM; Hodel, EM; Jones, S; Kay, K; Plucinski, M | 1 |
| Amaratunga, C; Amato, R; Anvikar, AR; Ashley, E; Baidya, S; Behera, PK; Callery, JJ; Chau, NH; Cheah, PY; Chotivanich, K; Chutasmit, K; Day, NPJ; Dhorda, M; Dondorp, AM; Fairhurst, RM; Faiz, A; Fanello, C; Gantait, K; Ghosh, T; Gonçalves, S; Grobusch, MP; Hanboonkunupakarn, B; Heaton, J; Hien, TT; Hlaing, TM; Hoa, NT; Hoglund, RM; Huy, R; Imwong, M; Jacob, CG; Jittamala, P; Kaewmok, W; Kwiatkowski, DP; Lek, D; Lin, K; Mao, S; Maude, RJ; Mayxay, M; Miotto, O; Mohanty, AK; Mukaka, M; Newton, PN; Onyamboko, M; Oun, S; Pearson, RD; Peto, TJ; Pukrittayakamee, S; Pyae Phyo, A; Runcharern, R; Saelow, C; Satpathi, P; Satpathi, S; Smithuis, F; Sovann, Y; Sreng, S; Suon, S; Tarning, J; Thanh, NV; Thant, M; Thuy-Nhien, NT; Tripura, A; Tripura, R; Ul Islam, A; Valecha, N; van der Pluijm, RW; van Vugt, M; von Seidlein, L; Waithira, N; White, NJ; Winterberg, M; Woodrow, CJ; Yen, S | 1 |
| Anvikar, AR; Ashley, EA; Chandramohan, D; Cohee, LM; D'Alessandro, U; Genton, B; Gilder, ME; Guérin, PJ; Juma, E; Kalilani-Phiri, L; Kennon, K; Kuepfer, I; Laufer, MK; Lwin, KM; Mansoor, R; McGready, R; Meshnick, SR; Mosha, D; Mwapasa, V; Mwebaza, N; Nambozi, M; Ndiaye, JA; Nosten, F; Nyunt, M; Ogutu, B; Parikh, S; Paw, MK; Phyo, AP; Pimanpanarak, M; Piola, P; Rijken, MJ; Saito, M; Sriprawat, K; Stepniewska, K; Tagbor, HK; Tarning, J; Tinto, H; Valéa, I; Valecha, N; White, NJ; Wiladphaingern, J | 1 |
| Bah, S; Dabitao, D; Dama, S; Diakité, M; Diakité, SAS; Doumbia, S; Doumbouya, M; Guindo, MA; Keita, B; Konaté, DS; Sangaré, M; Sanogo, I; Traoré, K | 1 |
| Andreani, J; Boxberger, M; Delandre, O; Duflot, I; Fonta, I; Gendrot, M; Hutter, S; Jardot, P; La Scola, B; Le Bideau, M; Mosnier, J; Pradines, B; Rolland, C | 1 |
| Caleon, RL; Gadalla, NB; Lane, KD; Liu, A; Mu, J; Rahman, RS; Sá, JM; Wellems, TE; Windle, ST | 1 |
| Blanshard, A; Hine, P | 1 |
| Adams, M; Boonyalai, N; Chaisatit, C; Chann, S; Chaorattanakawee, S; Deutsch-Feldman, M; Gosi, P; Lanteri, CA; Lek, D; Lertsethtakarn, P; Lin, JT; Lon, C; Morgan, AP; Praditpol, C; Rekol, H; Saingam, P; Satharath, P; Saunders, DL; Sea, D; Shah, Z; Shrestha, B; Smith, PL; Sok, S; Spring, MD; Takala-Harrison, S; Tyner, SD; Vesely, BA; Waters, NC; Wojnarski, M | 1 |
| Chenet, SM; Fernandez, J; Jercic, MI; Lucchi, NW; Oyarce, A; Tapia-Limonchi, R; Tejedo, JR; Udhayakumar, V; Weitzel, T | 1 |
| Boonprasert, K; Cheoymang, A; Kosa, N; Muhamad, P; Na-Bangchang, K | 1 |
| Bancone, G; Carrara, VI; Chu, C; Duanguppama, J; Gilder, ME; Haohankhunnatham, W; Imwong, M; Konghahong, K; Lee, SJ; McGready, R; Min, AM; Nosten, F; Paw, MK; Phyo, AP; Pimanpanarak, M; Proux, S; Saito, M; Singhasivanon, P; Tun, NW; Turner, C; Viladpai-Nguen, J; White, NJ | 1 |
| Bassat, Q; Varo, R | 1 |
| Bejon, P; Boga, M; Day, NPJ; Dhorda, M; Dondorp, AM; Gonçalves, S; Hamaluba, M; Hoglund, RM; Imwong, M; Kalume, P; Khuroo, A; Lal, AA; Miotto, O; Mturi, N; Mukaka, M; Mutinda, B; Mwambingu, G; Ngama, M; Ngetsa, C; Njuguna, P; Tarning, J; Taylor, WRJ; van der Pluijm, RW; Waithira, N; Wambua, J; Weya, J; White, NJ | 1 |
| Ataide, R; Beeson, JG; Boel, M; Drew, D; Fowkes, FJI; McGready, R; McLean, ARD; Nosten, F; Simpson, JA; Tsuboi, T | 1 |
| Bailey, JA; Barnett, EJ; Brazeau, NF; Chaorattanakawee, S; Gosi, P; Juliano, JJ; Lanteri, CA; Lin, JT; Lon, C; Meshnick, SR; Norris, LD; Parobek, CM; Parr, JB; Saunders, DL; Spring, MD | 1 |
| Byaruhanga, O; Ceja, FG; Conrad, MD; Cooper, RA; Katairo, T; Nsobya, SL; Rasmussen, SA; Rosenthal, PJ; Tumwebaze, PK | 1 |
| Maayan, N; Pace, C; Saunders, R; Sinclair, D; Tickell-Painter, M | 1 |
| Chaijaroenkul, W; Na-Bangchang, K; Phompradit, P | 1 |
| Annan, K; Ansah, C; Forkuo, AD; Gyan, B; Mancama, D; Mensah, KB; Theron, A; Wright, CW | 1 |
| Choi, L; Garner, P; Gelband, H; Graves, PM | 1 |
| Agarwal, P; Anvikar, AR; Pillai, CR; Srivastava, K | 1 |
| Anvikar, AR; Arya, T; Bruce, J; Chandramohan, D; Greenwood, B; Kuepfer, I; Mishra, DR; Mishra, N; Mishra, V; Mohanty, R; Mohanty, S; Sharma, S; Srivastava, B; Valecha, N | 1 |
| Cao, P; Dini, S; Fowkes, FJI; McCaw, JM; Price, RN; Simpson, JA; van der Pluijm, RW; Zaloumis, S | 1 |
| Hoglund, RM; Na-Bangchang, K; Ruengweerayut, R | 1 |
| Buathong, N; Chann, S; Chaorattanakawee, S; Fukuda, M; Gosi, P; Huy, R; Levitz, L; Lin, JT; Lon, C; Patel, JC; Samon, N; Saunders, D; Sea, D; Smith, P; Spring, M; Takala-Harrison, S; Thay, K; Wojnarski, M | 1 |
| Cao, P; Cromer, D; Davenport, MP; Dini, S; Fowkes, FJI; Khoury, DS; McCaw, JM; Simpson, JA; Zaloumis, SG | 1 |
| Aydin-Schmidt, B; Björkman, A; Di Santi, S; Inoue, J; Islam, A; Jovel, I; Mårtensson, A; Morris, U; Segurado, AC | 1 |
| Ahyong, V; DeRisi, JL; Garcia, VE; Sheridan, CM | 1 |
| Hine, P; Pryce, J | 1 |
| Horii, T; Tougan, T; Toya, Y; Uchihashi, K | 1 |
| Buffet, P; Chambrion, C; Chartrel, N; Mouri, O; Ndour, PA; Roussel, C; Smith, B; Smith, P; Thellier, M; Wojnarski, M | 1 |
| Aouri, M; Carn, G; Csajka, C; Decosterd, LA; Guidi, M; Kiechel, JR; Mercier, T; Ogutu, B | 1 |
| Ashley, EA; Dahal, P; Guerin, P; Humphreys, GS; Mansoor, R; Stepniewska, K | 1 |
| Chy, S; Felger, I; Hastings, I; Hodel, EM; Jones, S; Kay, K; Mbituyumuremyi, A; Menard, D; Uwimana, A | 1 |
| Amaratunga, C; Amato, R; Ashley, EA; Chau, NH; Cheah, PY; Chotivanich, K; Chutasmit, K; Day, NP; Dhorda, M; Dondorp, AM; Fairhurst, RM; Gonçalves, S; Hamilton, WL; Hanboonkunupakarn, B; Hien, TT; Hoa, NT; Huy, R; Imwong, M; Jacob, CG; Jittamala, P; Kaewmok, W; Kwiatkowski, DP; Lek, D; Mao, S; Maude, RJ; Miotto, O; Mukaka, M; Oun, S; Pearson, RD; Peto, TJ; Pukrittayakamee, S; Runjarern, R; Saelow, C; Sreng, S; Suon, S; Tarning, J; Thanh, NV; Thuy-Nhien, NT; Tripura, R; van der Pluijm, RW; Waithira, N; White, NJ; Winterberg, M; Yen, S; Yok, S | 1 |
| Cowman, AF; Healer, J; Uboldi, AD; Van Tyne, D; Wirth, DF | 1 |
| Cooksey, R; Dahlström, S; Fairhurst, RM; Flegg, JA; Guerin, PJ; Johnson, JD; Le Bras, J; Le Nagard, H; Lim, P; Ménard, D; Mentré, F; Murillo, C; Musset, L; Noedl, H; Nosten, F; Nsobya, SL; Pradines, B; Quashie, NB; Sibley, CH; Sinou, V; Sriprawat, K; Woodrow, CJ | 1 |
| Akala, HM; Andagalu, B; Bulimo, W; Cheruiyot, A; Eyase, FL; Ingasia, L; Johnson, JD; Juma, D; Kamau, E; Okudo, C; Omondi, A; Schnabel, D; Walsh, DS; Wanja, E; Waters, NC; Yeda, R | 1 |
| Chaijaroenkul, W; Karbwang, J; Muhamad, P; Na-Bangchang, K; Ruaengweerayut, R | 1 |
| Dondorp, AM; Faiz, MA; Hien, TT; Mokuolu, OA; Pukrittayakamee, S; White, NJ | 1 |
| Ariey, F; Duong, S; Kiechel, JR; Leang, R; Lim, P; Ménard, D; Navaratnam, V; Ros, S; Taylor, WR | 1 |
| Cremers, S; Fidock, DA; Henrich, PP; Kyle, DE; O'Brien, C; Sáenz, FE | 1 |
| Burkholder, B; Bustos, MD; Delacollette, C; Wongsrichanalai, C | 1 |
| Krudsood, S; Tangpukdee, N; Wilairatana, P | 1 |
| Donegan, S; Gathu, M; Olliaro, PL; Sinclair, D; Zani, B | 1 |
| Anvikar, AR; Dash, AP; Dubhashi, NG; Ghosh, SK; Jullien, V; Kiechel, JR; Kumar, A; Rao, BH; Sharma, B; Singh, JP; Srivastava, B; Taylor, WR; Valecha, N | 1 |
| Dow, GS; McCarthy, WF; Reid, M; Shanks, GD; Smith, B; Tang, D | 1 |
| Bukirwa, H; Kramer, CV; Nair, S; Sinclair, D; Tharyan, P; Unnikrishnan, B | 1 |
| David, K; Møller, CH | 1 |
| Cui, L; Gupta, B; Miao, J; Sun, L; Wang, Z; Xu, S; Yang, Z | 1 |
| Abdali, N; Malik, AM; Rizvi, SW; Shamim, MD | 1 |
| Jullien, V; Kiechel, JR; Sharma, B; Srivastava, B; Valecha, N | 1 |
| D'Alessandro, U; Davies, GR; Lindegardh, N; Tarning, J; Tinto, H; Toe, LC; Traore-Coulibaly, M; Valea, I; Van Geertruyden, JP; Ward, SA | 1 |
| Cheoymang, A; Muhamad, P; Na-Bangchang, K; Phompradit, P | 1 |
| Garner, P; Gelband, H; Graves, PM | 3 |
| Chaijaroenkul, W; Muhamad, P; Na-Bangchang, K; Phompradit, P | 1 |
| Albrecht, L; Angerami, RN; Castiñeiras, CM; Costa, FT; Dos-Santos, JC; Garcia, MT; Lacerda, MV; Levy, CE; Lopes, SC; Moretti, ML | 1 |
| Baret, E; Bercion, R; Camara, C; Diatta, B; Diémé, Y; Fall, B; Fall, KB; Fall, M; Mbaye, PS; Nakoulima, A; Pascual, A; Pradines, B; Wade, B; Wurtz, N | 1 |
| Dahlstrom, S; Ferreira, PE; Franzén, O; Gil, JP; Lum, JK; Nosten, F; Osório, NS; Veiga, MI | 1 |
| Andrianaranjaka, V; Barnadas, C; Benedet, C; Bouchier, C; Durand, R; Khim, N; Kim, S; Legrand, E; Ménard, D; Menegon, M; Mercereau-Puijalon, O; Musset, L; Nour, BY; Popovici, J; Ratsimbasoa, A; Severini, C; Thellier, M; Tichit, M | 1 |
| Evans, AM; Navaratnam, V; Olliaro, PL; Reuter, SE; Upton, RN | 1 |
| Bastiaens, GJ; Behet, MC; Bijker, EM; Graumans, W; Hermsen, CC; Obiero, JM; Sauerwein, RW; Schats, R; Scholzen, A; Teelen, K; van de Vegte-Bolmer, M; van Gemert, GJ; van Lieshout, L; Visser, LG | 1 |
| Chandra, R; Dieng, Y; Djimdé, AA; Dunne, MW; Kain, KC; Mugyenyi, P; Mulenga, M; Oduro, AR; Ogutu, B; Robbins, J; Sagara, I; Sarkar, S; Sie, A; Tiono, AB; Wasunna, M | 1 |
| Buathong, N; Chanarat, N; Chann, S; Chaorattanakawee, S; Chuor, CM; Gosi, P; Heng, TK; Jacob, C; Kong, N; Kuntawunginn, W; Lanteri, CA; Lin, JT; Lon, C; Plowe, C; Prom, S; Saingam, P; Saunders, DL; Se, Y; Sea, D; Sriwichai, S; Sundrakes, S; Takala-Harrison, S; Tangthongchaiwiriya, K; Teja-Isavadharm, P; Tyner, SD; Yingyuen, K; Yom, Y | 1 |
| Bouth, DM; Char, MC; Domergue, A; Duru, V; Khim, N; Kim, S; Leang, R; Menard, D; Ringwald, P; Song, L; Tarning, J; Taylor, WR; Witkowski, B | 1 |
| Hastings, IM; Hodel, EM; Kay, K | 1 |
| Barnwell, JW; Goldman, I; Juma, E; Kariuki, S; Komino, F; Lucchi, NW; Okoth, SA; Onyona, P; Shi, YP; Udhayakumar, V; Wiegand, RE | 1 |
| Croft, AM; Jacquerioz, FA | 2 |
| Ferner, RE; Gogtay, NJ | 2 |
| Bannister-Tyrrell, M; Coosemans, M; d'Alessandro, U; Dierickx, S; Durnez, L; Erhart, A; Gerrets, R; Gryseels, C; Hausmann-Muela, S; Hoibak, S; Muela Ribera, J; Peeters Grietens, K; Phoeuk, P; Set, S; Sluydts, V; Suon, S; Tho, S; Trienekens, S; Uk, S | 1 |
| Dow, GS; Hetzell, B; Lin, G; Liu, J; McCarthy, WF; Smith, B; Tang, D; Thieling, S | 1 |
| Connor, P; Green, AD; Hodgetts, TJ; Ross, DA | 1 |
| Akala, HM; Auschwitz, JM; Cheruiyot, AC; Gaona, HW; Hickman, MR; Johnson, JD; Kamau, E; Lee, PJ; Leed, SE; Murthy, T; Okello, CO; Talwar, M; Yeda, RA | 1 |
| Ager, AL; Birrell, GW; Chavchich, M; Edstein, MD; Heffernan, GD; Jacobus, DP; Jacobus, LR; MacKenzie, DO; Schiehser, GA; Shanks, GD | 1 |
| Almela, MJ; Boechat, N; Herreros, E; Krettli, AU; Miguel-Blanco, C; Penna-Coutinho, J; Sá, PM | 1 |
| Maxmen, A | 1 |
| Baird, JK; Boni, MF; White, NJ | 1 |
| Angulo-Barturen, I; Baker, M; Duparc, S; Elliott, S; Ferrer, S; Griffin, P; Hooft van Huijsduijnen, R; Jiménez-Díaz, MB; Leroy, D; Marquart, L; Martínez, MS; McCarthy, JS; Möhrle, JJ; O'Rourke, P; Rockett, R; Sekuloski, S; Sloots, T; Trenholme, K; Wells, TN | 1 |
| Bastos, MS; de Melo, GN; de Souza-Lima, Rde C; Ferreira, MU; Ladeia-Andrade, S; Luz, Fd; Rodrigues, PT; Salla, LC | 1 |
| Roberts, L | 1 |
| White, C | 2 |
| Cabral, L; Cristiano, ML; Lobo, L; Nogueira, F; Sousa, Bd | 1 |
| Anderson, TJC; Ashley, EA; Bozdech, Z; Carrara, VI; Day, NPJ; Dziekan, J; Imwong, M; Jeeyapant, A; Konghahong, K; Ling, C; Lwin, KM; McGready, R; Nair, S; Nosten, F; Phyo, AP; Proux, S; Sriprawat, K; White, MM; White, NJ; Woodrow, CJ | 1 |
| Eziefula, AC | 1 |
| Ackermann, I; Aubin, F; Carn, G; Gesase, S; Lusingu, JPA; Mnkande, E; Mrango, Z; Mtoro, A; Ngocho, JS; Ogutu, B; Onyango, KO; Ouedraogo, A; Sirima, SB; Strub, N; Vanraes, J; Yaro, JB | 1 |
| Amato, R; Auburn, S; Drury, E; Handayuni, I; Kwiatkowski, DP; Miotto, O; Nosten, F; Pearson, RD; Price, RN; Russell, B; Serre, D; Sriprawat, K; Stalker, J; Suwanarusk, R; To, S | 1 |
| Muhamad, P; Na-Bangchang, K; Phompradit, P; Thiengsusuk, A | 1 |
| Liu, XJ; Peng, HJ; Wei, HX; Xia, J; Zhou, LJ | 1 |
| Amalvict, R; Benoit, N; Briolant, S; Diatta, B; Diawara, S; Diémé, Y; Fall, B; Fall, M; Gendrot, M; Kounta, MB; Madamet, M; Nakoulima, A; Pradines, B; Wade, B; Wade, KA | 1 |
| Chonsawat, P; Kano, S; Krudsood, S; Phophak, N; Srivilairit, S; Tangpukdee, N; Wilairatana, P; Yanpanich, W | 1 |
| Brittenham, GM; Kano, S; Krudsood, S; Li, G; Looareesuwan, S; Pengruksa, C; Phophak, N; Tangpukdee, N; Thanachartwet, V; Wilairatana, P | 1 |
| Beck, HP; Borrmann, S; Genton, B; Hodel, EM; Marfurt, J; Müller, D; Müller, I; Reeder, JC; Rippert, A; Siba, P | 1 |
| Andrade, AA; Boechat, N; Botelho, AC; de Paula, RC; de Pilla Varotti, F; de Souza, MV; Fagundes, EM; Krettli, AU; Mayer, LM; Mendonça, JS; Valverde, A | 1 |
| Alker, AP; Ariey, F; Duong, S; Maguire, JD; Meshnick, SR; Muth, S; Sem, R; Shah, NK; Susanti, AI; Wongsrichanalai, C | 1 |
| Coulibaly, M; Diallo, A; Diawara, SI; Dicko, A; Djimde, A; Doumbo, OK; Guindo, O; Kone, M; Maiga, H; Niambele, MB; Sagara, I; Sissoko, M | 1 |
| Arunkamomkiri, J; Carrara, VI; Htoo, H; Nosten, F; Nwee, P; Phyo, AP; Singhasivanon, P; Soe, M | 1 |
| Benoit-Vical, F; Berry, A; Garcia-Alvarez, MC; Nicolau, ML; Olagnier, D; Soh, PN; Witkowski, B | 1 |
| Ariey, F; Chim, P; Lim, P; Muth, S; Rogers, WO; Sem, R; Socheat, D; Tero, T; Wongsrichanalai, C | 1 |
| Alker, AP; Ariey, F; Bouchier, C; Bouth, DM; Doung, S; Fandeur, T; Incardona, S; Khim, N; Le Bras, J; Lim, P; Meshnick, SR; Puijalon, OM; Ringwald, P; Shah, NK; Wongsrichanalai, C; Yi, P | 1 |
| Chotivanich, K; Day, NP; Dondorp, AM; Imwong, M; Pongtavornpinyo, W; Preechapornkul, P; Pukrittayakamee, S; White, NJ | 1 |
| Anderson, T; Ashley, EA; Barends, M; Brockman, A; Carrara, VI; Hutagalung, R; Imwong, M; Lwin, KM; McGready, R; Nosten, F; Phaiphun, L; Phyo, AP; Preechapornkul, P; Price, RN; Proux, S; Pukrittayakamee, S; Singhasivanon, P; Stepniewska, K; van Vugt, M; White, NJ; Zwang, J | 1 |
| Biswas, B; Thapa, R | 1 |
| Bacon, DJ; Durand, S; Ganguly, B; Green, M; Gutman, J; Quezada, WM; Rojas, OV; Ruebush, TK; Slutsker, L; Utz, GC | 1 |
| Edstein, MD; Fugmann, B; Haynes, RK; Kotecka, BM; Kyle, DE; Obaldia, N; Rieckmann, KH | 1 |
| Donegan, S; Garner, P; Olliaro, P; Sinclair, D; Zani, B | 1 |
| Chandra, A; Dutta, V; Naidu, S; Puri, P; Saha, A; Seth, AK | 1 |
| An, SS; Ariey, F; Chotivanich, K; Das, D; Day, NP; Dondorp, AM; Hanpithakpong, W; Herdman, T; Imwong, M; Lee, SJ; Lim, P; Lindegardh, N; Lwin, KM; Nosten, F; Phyo, AP; Ringwald, P; Silamut, K; Singhasivanon, P; Socheat, D; Tarning, J; White, NJ; Yeung, S; Yi, P | 1 |
| Ambler, MT; Arunjerdja, R; Dubowitz, LM; Hla, EP; Luxemburger, C; McGready, R; Nosten, F; Singhasivanon, P; Thwai, KL; Viladpainguen, J | 1 |
| Carneiro, I; Chandramohan, D; Gesase, S; Gosling, RD; Greenwood, B; Hashim, R; Lemnge, M; Mosha, FW; Mosha, JF | 1 |
| Eaton, L | 1 |
| Chaijaroenkul, W; Na-Bangchang, K; Wisedpanichkij, R | 1 |
| Batty, AJ; Jones, ME; Zuckerman, JN | 1 |
| Balogun, S; Folarin, O; Gbotosho, GO; Happi, C; Michael, O; Okuboyejo, T; Sowunmi, A | 1 |
| Adewoye, EO; Gbotosho, GO; Happi, CT; Nkogho, OO; Okuboyejo, TM; Sowunmi, A | 1 |
| Akkoçlu, G; Cevikel, N; Kirakli, C; Köse, S; Kuzucu, L; Ozensoy Töz, S | 1 |
| Alvarez, LG; Blair, S; Ríos, A; Sanín, F; Tobón, A; Vásquez, AM | 1 |
| Banmairuroi, V; Bualombai, P; Congpuong, K; Na-Bangchang, K | 1 |
| Ariey, F; Beck, HP; Bouth, DM; Chim, P; Chy, S; Coppee, JY; Duong, S; Fandeur, T; Genton, B; Gobert, JG; Khim, N; Kim, S; Le Bras, J; Lim, P; Mercereau-Puijalon, O; Nhem, S; Ringwald, P; Rogers, WO; Sem, R; Wongsrichanalai, C; Yi, P | 1 |
| Adoubryn, KD; Hatz, C; Keiser, J; N'Goran, EK; N'Guessan, NA; Silué, KD; Utzinger, J; Vounatsou, P | 1 |
| Chavchich, M; Chen, N; Cheng, Q; Gerena, L; Kyle, DE; Peters, J | 1 |
| Gadaleta, A; Ingrassia, F; Maggi, P; Pastore, G | 1 |
| Agnandji, ST; Bélard, S; Bouyou-Akotet, MK; Heidecker, JL; Issifou, S; Kombila, M; Kremsner, PG; Kurth, F; Mamfoumbi, MM; Mihindou, MP; Missinou, MA; Ngoungou, EB; Ramharter, M; Trapp, S | 1 |
| Alam, MT; Ariey, F; Barnwell, JW; Escalante, AA; Fandeur, T; Lim, P; Maguire, JD; Meshnick, SR; Muth, S; Rogers, WO; Sem, R; Shah, NK; Susanti, AI; Udhayakumar, V; Vinayak, S; Wongsrichanalai, C | 1 |
| Biswas, B; Ghosh, A; Mallick, D; Thapa, R | 1 |
| Gracia-Marco, R; Henry, M; Morera-Fumero, AL; Renshaw, A; Yelmo, S | 1 |
| Chelo, D; Djoukoue, FM; Frentzel, A; Frey, S; Hatz, C; Mina Ntoto, NK; Mueller, EA; Tietche, F; Trapp, S; Zielonka, R | 1 |
| Kano, S | 1 |
| Schofield, S; Tepper, M | 1 |
| Chalermrut, K; Kiechel, JR; Krudsood, S; Leowattana, W; Looareesuwan, S; Navaratnam, V; Olliaro, P; Phumratanaprapin, W; Ramanathan, S; Tangpukdee, N; Taylor, WR; Vaillant, M; Wilairatana, P | 1 |
| Han, SC; Heger, T; Husums, H; Larsen, S; Sundet, M; Van Heng, Y | 1 |
| Duangdee, C; Krudsood, S; Looareesuwan, S; Pothipak, N; Tangpukdee, N; Warrell, DA; Wilairatana, P | 1 |
| Alvarez, G; Blair, S; Piñeros, JG; Ríos, A; Tobón, A | 1 |
| Alvarez, M; Benoit-Vical, F; Berry, A; Iriart, X; Magnaval, JF; Marchou, B; Menard, S; Naneix-Laroche, V; Soh, PN; Witkowski, B | 1 |
| Azar, RG; Blazes, DL; Burgess, TH; Clagett, CD; Coyne, PE; Deye, GA; Endy, TP; Freilich, D; Green, MD; Magill, AJ; Martin, GJ; Milhous, WK; Shanks, GD; Tasker, SA; Whitman, TJ | 1 |
| Fatunmbi, B; Folarin, O; Gbotosho, GO; Happi, CT; Michael, O; Okuboyejo, T; Sowunmi, A | 1 |
| Bacchieri, A; Bhattacharya, PC; Corsi, M; Dev, V; Dubhashi, N; Duparc, S; Ghosh, SK; Keomany, S; Khanthavong, M; Krudsood, S; Kumar, A; Mayxay, M; Newton, PN; Phyo, AP; Pongvongsa, T; Pukittayakamee, S; Pukrittayakamee, S; Rao, BH; Ruangveerayuth, R; Ubben, D; Uthaisil, C; Valecha, N | 1 |
| Ariey, F; Beck, HP; Decosterd, LA; Duong, S; Genton, B; Hodel, EM; Mercier, T; Olliaro, P; Zanolari, B | 1 |
| Ashley, E; Aung, PP; Imwong, M; Kyaw, MK; Lee, SJ; Myint, NZ; Naing, AL; Nyo, MY; Oo, AP; Phe, O; Smithuis, F; White, NJ; Win, T | 1 |
| Chaijaroenkul, W; Mahamad, P; Na-Bangchang, K; Ruengweerayut, K; Ruengweerayut, R | 1 |
| Chelo, D; Djoukoue, F; Frey, SG; Hatz, C; Kinkela, MN; Tietche, F; Weber, P | 1 |
| Basselin, C; De Monbrison, F; Descloux, E; Peyron, F; Vial, T | 1 |
| Keola, S; Keomany, S; Khanthavong, M; Khomthilath, T; Mayxay, M; Newton, PN; Phompida, S; Pongvongsa, T; Souvannasing, P; Stepniewska, K; Ubben, D; Valecha, N; White, NJ | 1 |
| Berenger, AA; Didier, YJ; Djerea, K; Genevieve, GO; Kouame, MG; Penali, LK; Toure, OA | 1 |
| Chalermrut, K; Kiechel, JR; Krudsood, S; Leowattana, W; Looareesuwan, S; Navaratnam, V; Olliaro, P; Ramanathan, S; Tangpukdee, N; Taylor, WR; Vaillant, M; Wilairatama, P | 1 |
| Bisvigou, U; Dinzouna Boutamba, SD; Ekomy, H; Lekana-Douki, JB; Toure-Ndouo, FS; Zang Edou, SE; Zatra, R | 1 |
| Assi, SB; Basco, LK; Bla, KB; Djaman, AJ; Koné, M; Mazabraud, A; Yavo, W | 1 |
| Terlouw, DJ; van Eijk, AM | 1 |
| Angelino, E; Barnes, KG; Becker, JS; Birren, BW; Cortese, JF; Daniels, RF; Eskin, E; Furlotte, NA; Grossman, SR; Happi, C; Hartl, DL; Johnson, CA; Kang, HM; Karlsson, EK; Lander, ES; Lukens, AK; Mboup, S; Milner, DA; Ndiaye, D; Neafsey, DE; Park, DJ; Rosen, DM; Sabeti, PC; Sarr, O; Schaffner, SF; Shlyakhter, I; Van Tyne, D; Volkman, SK; Wiegand, RC; Wirth, DF; Yamins, D | 1 |
| Cummings, JF; Deye, GA; Fracisco, S; Magill, AJ; Miller, L; Miller, RS; Moon, JE; Ohrt, C; Tosh, D | 1 |
| Na-Bangchang, K; Ruengweerayut, R; Wernsdorfer, WH | 1 |
| Minodier, P; Noël, G; Parzy, D; Piarroux, R; Ranque, S; Retornaz, K; Tall, M | 1 |
| Björkman, A; Ferreira, PE; Gil, JP; Jörnhagen, L; Kone, A; Malmberg, M; Nosten, F; Petzold, M; Schmidt, BA; Veiga, MI | 1 |
| Bertin, G; Bonaventure, D; Briand, V; Carrieu, A; Cot, M; Deloron, P; Massougbodji, A | 1 |
| Chaijaroenkul, W; Maensathian, T; Muhamad, P; Na-Bangchang, K; Phompradit, P; Rueangweerayut, R; Sornjai, W | 1 |
| Gil, JP; Piedade, R | 1 |
| Bentura-Marciano, A; Chan, WC; Clark, J; Golenser, J; Guiguemde, AW; Guo, J; Guy, RK; Haynes, RK; Hunt, NH; Wong, HN | 1 |
| Borer, A; Kafka, M; Riesenberg, K; Saidel-Odes, L; Schlaeffer, F; Smolyakov, R | 1 |
| Brooms, JD; Cruz, L; España, R; Giron, A; Magris, M; Metzger, WG; Peña Pimentel, FN; Perez, L; Villalobos, N; Vivas-Martínez, S | 1 |
| Nevin, RL | 2 |
| Berger, F; Bertani, S; Bouchier, C; Ekala, MT; Legrand, E; Mercereau-Puijalon, O; Meynard, JB; Musset, L; Péneau, J; Volney, B; Yrinesi, J | 1 |
| Barón, C; Carrasquilla, G; Cousin, M; Fisher, LM; Lefèvre, G; Monsell, EM; Sander, O; Walter, V | 1 |
| Arango, EM; Carmona-Fonseca, J; Upegui, YA | 1 |
| Hatabu, T; Kano, S; Kobayashi, J; Li, C; Mannoor, MK; Phompida, S; Sato, Y; Toma, H; Vanisaveth, V; Watanabe, H | 1 |
| Bera, DK; Biswas, A; Chattopadhyay, G; Das, M; Das, S; Ganguly, S; Guha, SK; Kundu, PK; Maji, AK; Mullick, S; Ray, K; Saha, P | 1 |
| Abdulla, S; Binh, TQ; Borghini-Fuhrer, I; Duparc, S; Fleckenstein, L; Pénali, LK; Phyo, AP; Poravuth, Y; Rueangweerayut, R; Shin, CS; Tien, NT; Tinto, H; Uthaisin, C; Valecha, N | 1 |
| Bacchieri, A; Bhattacharyya, PC; Corsi, M; Dev, V; Dubashi, N; Gargano, N; Ghosh, SK; Kumar, A; Rao, BH; Srivastava, B; Tommasini, S; Ubben, D; Valecha, N | 1 |
| Boulos, M; Daher, A; dos Santos, RL; Junger, W; Ladislau, JL; Leon, AP; Lucena, MB; Magalhães, I; Marchesini, PB; Ribeiro, I; Santelli, AC | 1 |
| Alker, AP; MacArthur, JR; Meshnick, SR; Satimai, W; Vijaykadga, S; Wongsrichanalai, C | 1 |
| Delacollette, C; Kaewkungwal, J; Khamsiriwatchara, A; Lawpoolsri, S; Potithavoranan, T; Sangvichean, A; Satimai, W; Sawang, S; Singhasivanon, P; Sudathip, P; Vijaykadga, S | 1 |
| Charman, SA; Gamo-Benito, J; Humberstone, A; Jamsen, KM; McCaw, J; Moehrle, J; Price, RN; Simpson, JA; Smith, K; Zaloumis, S | 1 |
| Amaratunga, C; Anderson, JM; Anderson, TJ; Dondorp, AM; Duong, S; Fairhurst, RM; Fay, MP; Jiang, H; Lim, P; Lindegardh, N; Mao, S; Mu, J; Phelps, ES; Song, J; Sreng, S; Stepniewska, K; Su, XZ; Suon, S; White, NJ; Zhou, C | 1 |
| Holtermann, MK | 1 |
| Abdur, R; Barrette, A; Bouth, DM; Duong, S; Leang, R; Menard, D; Ringwald, P | 1 |
| Abiola, A; Ba, MC; Faye, B; Gaye, O; Lo, AC; Ndiaye, JL; Ndiaye, M; Sow, D; Sylla, K; Tine, RC | 1 |
| Dellamonica, P; Gari-Toussaint, M; Keundjian, A; Le Fichoux, Y; Mondain, V; Pradines, B | 1 |
| Alin, H; Ashton, M; Bergqvist, Y; Karlsson, MO; Svensson, US | 1 |
| Kain, KC; Ohrt, C; Sutamihardja, MA; Tang, D | 1 |
| Andersen, EM; Gozalo, AS; Hoffman, SL; Jones, TR; Lucas, C; Magill, AJ; Narum, DL; Obaldia, N; Sim, BK; Stroncek, DF | 1 |
| Ali, A; Dobi, S | 1 |
| Alberti, C; Bédos, JP; Bruneel, F; Chevret, S; Durand, R; Hocqueloux, L; Le Bras, J; Régnier, B; Vachon, F; Wolff, M | 1 |
| Wooltorton, E | 1 |
| Al-Aniezi, A; Hira, PR; Lqbal, J; Sher, A | 1 |
| Cambon, N; Chalermrut, K; Krudsood, S; Looareesuwan, S; Mueller, EA; Pittrow, D; Silachamroon, U | 1 |
| Dyk Dao, L; Rabinovich, SA; Van Ha, N | 1 |
| Atteke, C; Aubouy, A; Bakary, M; Deloron, P; Lébibi, J; Ndong, JM | 1 |
| Hijar, G; Kain, KC; Marouiño, W; Montoya, Y; Pillai, DR; Ruebush, TK; Wongsrichanalai, C | 1 |
| Arróspide, N; Arrunátegui, M; Barat, LM; Cabezas, C; Carrillo, C; Chafloque, ML; Garavito, G; Gutierrez, S; MacArthur, JR; Marquiño, W; Oblitas, FE; Pardavé, B; Ruebush, TK | 1 |
| Bouchaud, O; Durand, R; Godineau, N; Jezic, Z; Keundjian, A; Le Bras, J; Pradines, B; Ralaimazava, P | 1 |
| Jambou, R; Randrianarijaona, A; Randrianarivelojosia, M; Randrianasolo, L; Ratsimbasoa, A | 1 |
| Faiz, MA; Hossain, MA; Miller, RS; Noedl, H; Pang, LW; Rahman, MR; Samad, R; Wongsrichanalai, C; Yunus, EB | 1 |
| Alkadru, AM; Awad, MI; Baraka, OZ; Behrens, RH; Eltayeb, IB | 1 |
| Schilthuis, HJ; Stricker, BH; Sturkenboom, MC; van Riemsdijk, MM | 1 |
| Buchachart, K; Chalermrut, K; Charusabha, C; Duangdee, C; Haoharn, O; Krudsood, S; Looareesuwan, S; Treeprasertsuk, S | 1 |
| Chalermrut, K; Krudsood, S; Looareesuwan, S; Pengruksa, C; Silachamroon, U; Srivilairit, S; Treeprasertsuk, S; Wilairatana, P | 1 |
| Ariey, F; Duchemin, JB; Harisoa, JL; Mauclere, P; Pietra, V; Rabarijaona, LP; Raharimalala, LA; Rakotomanana, F; Ranaivo, L; Randrianarivelojosia, M; Robert, V | 1 |
| Betschart, B; Jelinek, T; Löscher, T; Nothdurft, HD; Sonnenburg, FV; Wichmann, O | 1 |
| Dagan, A; Flescher, E; Gatt, S; Gold, D; Pankova-Kholmyansky, I; Skutelsky, E; Zaslavsky, Z | 1 |
| Pfeifer, C; Strauss, R | 1 |
| Diarra, A; Konate, A; Moran, AC; Newman, RD; Parise, ME; Sawadogo, R; Sirima, SB; Yameogo, M | 1 |
| Hoelscher, M; Löscher, T | 1 |
| Peters, W; Robinson, BL; Stewart, LB | 1 |
| Cabezas, C; Calampa, C; Falconí, E; Huilca, M; Marquiño, W; Naupay, R; Ruebush, TK | 1 |
| Chaikachonpatd, S; Chanthapakajee, K; Chindarat, S; Kaewkaukul, N; Lim, K; Silpasakorn, S; Suputtamongkol, Y; Thamlikitkul, V | 1 |
| Carme, B; Delattre, P; Demar, M; Dubos, F | 2 |
| Falchook, GS; Malone, CM; Shandera, WX; Upton, S | 1 |
| Ciach, M; Crandall, I; Kain, KC; Zong, K | 1 |
| Beer, MD; Cook, GC; Croft, AM; Whitehouse, DP | 1 |
| Fateye, BA; Sowunmi, A | 1 |
| Ayomi, E; Baird, JK; Bangs, MJ; Barcus, MJ; Basri, H; Elyazar, IR; Fryauff, DJ; Marwoto, H; Richie, TL | 1 |
| Binh, TQ; De Vries, PJ; Giao, PT; Hung, LQ; Kager, PA; Nam, NV | 1 |
| Chen, RJ; Fu, LC; Guo, WZ; Guo, XB; Ou, FZ; Tan, B; Zheng, QJ | 1 |
| Cetron, M; Kozarsky, P; Parise, M; Schwartz, E | 1 |
| Fischer, PR; Stauffer, W | 1 |
| Cambon, N; Gomez, EA; Jurado, MH | 1 |
| Dalvi, SS; Desai, S; Gogtay, NJ; Kadam, VS; Kamtekar, KD; Kshirsagar, NA | 1 |
| Rakotoson, JD; Randremanana, RV; Randriamanantena, A; Randrianarivelojosia, M; Randrianasolo, L; Ratsimbasoa, A | 1 |
| Bégué, P; Grimprel, E; Parez, N; Pillon, V; Quinet, B | 1 |
| Brockman, A; Katterman, N; Kyaw, MK; Lwin, S; Smithuis, F; van der Broek, I; White, NJ | 1 |
| Hayton, K; Su, XZ | 1 |
| Avila, JC; Marquiño, W; Mollinedo, R; Ruebush, TK; Villaroel, R; Zegarra, J | 1 |
| Alecrim, WD; Daniel-Ribeiro, CT; Martínez-Espinosa, FE | 1 |
| Brown, ML; Geyer, JA; Terrell, JC; Trotta, RF | 1 |
| Amklad, I; Looareesuwan, S; Rojanawatsirivej, C; Vijaykadga, S; Wilairatna, P | 1 |
| Bunnag, D; Chittamas, S; Kanda, T; Looareesuwan, S; Pornkulprasit, V; Rojanawatsirivej, C; Thimasarn, K; Wattanakoon, Y | 1 |
| Hatabu, T; Kano, S; Kawazu, S; Rivera, PT; Suzuki, J; Suzuki, M; Valenzuela, RF; Villacorte, EA | 1 |
| Kawabata, M; Looareesuwan, S; Matsuo, T; Shirakawa, T; Singhasivanon, P | 1 |
| Chim, P; Fandeur, T; Lim, P; Maciejewski, L; Nhem, S; Sem, R | 1 |
| Carme, B; Delattre, P; Demar, M; Dubos, F; Gendrel, D | 1 |
| Binh, TQ; de Vries, PJ; Giao, PT; Holman, R; Hung, le Q; Kager, PA; Nam, NV | 1 |
| Annerberg, A; Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; White, NJ; Yapom, R | 1 |
| Adam, I; Ali, DA; Alwaseila, A; Elbashir, MI; Kheir, MM | 1 |
| Ashley, EA; Brockman, A; Hutagalung, R; Krudsood, S; Leowattana, W; Looareesuwan, S; McGready, R; Nosten, F; Phaiphun, L; Srivilairit, S; White, NJ; Wilairatana, P | 1 |
| Litmanovich, M; Storch, S; Weiner, P; Zamir, C; Zamir, D | 1 |
| Annerberg, A; Christophel, EM; Dittrich, S; Jelinek, T; Lindegardh, N; Monti, F; Phetsouvanh, R; Phompida, S; Stohrer, JM; Thongpaseuth, V; Vanisaveth, V | 1 |
| Kyaw, MK; Lwin, S; Savran, O; Shahmanesh, M; Smithuis, F; White, NJ | 1 |
| Chim, P; Denis, MB; Fandeur, T; Lim, C; Lim, P; Nemh, S; Poravuth, Y; Seila, S; Sem, R; Socheat, D; Tsuyuoka, R | 1 |
| Bouchaud, O; Cha, O; Coulaud, JP; Durand, R; Fontanet, AL; Houzé, S; Keundjian, A; Le Bras, J; Ralaimazava, P; Schiemann, R | 1 |
| Bisoffi, Z; Gaiera, G; Gregis, G; Gulletta, M; Marocco, S; Matteelli, A; Saleri, N; Scolari, C; Tedoldi, S; Visonà, R | 1 |
| Kollaritsch, H; Prajakwong, S; Rojanawatsirivet, C; Wernsdorfer, G; Wernsdorfer, WH; Woitsch, B | 1 |
| Pilz, JB; Rojanawatsirivet, C; Sirichaisinthop, J; Wernsdorfer, G; Wernsdorfer, WH; Wiedermann, G | 1 |
| Bangchang, KN; Congpuong, K; Rojanawatsirivet, C; Thongphua, S; Thongsri, K; Vijaykadga, S; Wernsdorfer, WH; Wilairatana, P | 1 |
| Meshnick, SR; Prajakwong, S; Shanks, GD; Thimasarn, K; Wongsrichanalai, C | 1 |
| Edstein, MD; Gregory, RM; Kitchener, SJ; Nasveld, PE | 1 |
| A-Elbasit, IE; Adam, I; Elbashir, MI | 1 |
| Buathong, N; McDaniel, P; Meshnick, SR; Miller, RS; Nelson, AL; Purfield, A; Sriwichai, S; Uthaimongkol, N; Wongsrichanalai, C | 1 |
| Combes, JC; Garnier, JM; Minodier, P; Noël, G; Retornaz, K; Salles, M; Walters, H | 1 |
| Karbwang, J; Na-Bangchang, K; Thanavibul, A; Tippawangkosol, P | 1 |
| Ashley, EA; Barends, M; Hutagalung, R; Looareesuwan, S; McGready, R; Nosten, F; Phaiphun, L; Proux, S; Slight, T; Thwai, KL; White, NJ | 1 |
| Bualombai, P; Congpuong, K; Mungthin, M; Na Bangchang, K; Wernsdorfer, WH | 1 |
| Bangchang, KN; Chaijaroenkul, W; Mungthin, M; Ward, SA | 1 |
| Bangali, AM; Barends, M; Das, S; Faiz, AM; Kamal, M; Liem, L; Maung, UA; Peters, A; Rahman, M; Rahman, MR; van den Broek, IV | 1 |
| Chalermrut, K; Krudsood, S; Leowattana, W; Looareesuwan, S; Silachamroon, U; Srivilairit, S; Tangpukdee, N; Thanachartwet, W; Thimasarn, K; Wilaiaratana, P | 1 |
| Attanath, P; Chaivisuth, A; Chanthavanich, P; Na-Bangchang, K; Pengsaa, K; Pojjaroen-Anant, C; Sabchareon, A; Sirivichayakul, C; Thaiarporn, I; Wisetsing, P; Wongsuwan, A | 1 |
| Garner, P; Jones, K; Taylor-Robinson, D | 1 |
| Binh, VQ; Dai, B; Dao, NV; Edstein, MD; Ngoa, ND; Quoc, NP; Rieckmann, KH; The, ND; Thuy, le T | 1 |
| Ashley, EA; Brockman, A; Hutagalung, R; Jelinek, T; McGready, R; Nosten, FH; Paiphun, L; Singhasivanon, P; Thwai, KL; White, NJ | 1 |
| Acikel, CH; Dogru, T; Harlak, A; Hayat, L; Keskin, O; Kilic, S; Kocar, IH; Polat, Z; Sonmez, A; Yilmaz, MI | 1 |
| Petersen, JE | 1 |
| Kremsner, PG; Krishna, S; Lell, B; Ramharter, M; Uhlemann, AC | 1 |
| Bukirwa, H; Orton, L | 1 |
| Krishna, S; Uhlemann, AC | 1 |
| Baruah, S; Campbell, P; Narain, K; Rogers, CC | 1 |
| Duffy, PE; Sibley, CH | 1 |
| Chalermrut, K; Kano, S; Krudsood, S; Looareesuwan, S; Pengruksa, C; Phongtananant, S; Silachamroon, U; Srivilairit, S; Tangpukdee, N; Thanachartwet, W; Wilairatana, P | 1 |
| Cholpol, S; Nakavej, A; Phoungmanee, D; Rojanawatsirivej, C; Vijaykadga, S; Wongsrichanalai, C | 1 |
| Adedeji, AA; Bamgboye, AE; Bolaji, OM; Fateye, BA; Gbotosho, GO; Happi, TC; Oduola, AM; Sowunmi, A | 1 |
| Carmona-Fonseca, J; Guzmán, V | 1 |
| Baird, JK; Fryauff, DJ; Maguire, JD; Marwoto, H; Richie, TL | 1 |
| Vinetz, JM | 1 |
| Counillon, E; Del Giudice, P; Delaunay, P; Vandenbos, F | 1 |
| Krishna, S; Woodrow, CJ | 1 |
| Chirouze, C; Créantor, C; Faucher, JF; Hoen, B; Hustache-Mathieu, L; Millon, L | 1 |
| de Gentile, L; Guilleux, M; Jousset, N; Le Bouil, A; Rougé-Maillart, C; Turcant, A | 1 |
| Ashley, EA; Brockman, A; Carrara, VI; Gilbos, V; Krudsood, S; Leemingsawat, S; Looareesuwan, S; McGready, R; Nosten, F; Proux, S; Rojanawatsirivet, C; Singhasivanon, P; Sirilak, S; Thonglairuam, J; White, N | 1 |
| Lee, HY; Tan, CH; Tor, PC | 1 |
| Duffy, PE; Mutabingwa, TK | 1 |
| Ashley, E; Aye, KZ; Barends, M; Htet, L; Kyaw, MK; Lindegardh, N; Lwin, S; Phe, O; Singtoroj, T; Smithuis, F; Stepniewska, K; White, NJ | 1 |
| Ashley, EA; Hae, R; Hutagalung, R; Lindegårdh, N; McGready, R; Nosten, F; Singhasivanon, P; Stepniewska, K; White, NJ | 1 |
| Fidock, DA; Krishna, S; Sidhu, AB; Uhlemann, AC; Valderramos, JC; Valderramos, SG | 1 |
| Shen, WJ; Thiero, M | 1 |
| Bhatt, KM; Bhatt, SM; Samia, BM; Wasunna, KM | 1 |
| Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; Stepniewska, K; Thongpraseuth, V; White, NJ | 1 |
| Browning, J; Dell, ML; Tran, TM | 1 |
| Christophel, EM; Denis, MB; Incardona, S; Lim, C; Lim, P; Narann, TS; Poravuth, Y; Ringwald, P; Seila, S; Sem, R; Socheat, D; Tsuyuoka, R | 1 |
| Ashley, EA; Barends, M; Leowattana, W; Lwin, KM; McGready, R; Nawamaneerat, W; Nosten, F; Olliaro, P; Phaiphun, L; Proux, S; Simon, WH; Singhasivanon, P; Stepniewska, K; Taylor, W; Thwai, KL; Wangseang, N; White, NJ | 1 |
| A'shikin, AN; Khairul, MF; Low, JH; Min, TH; Nasriyyah, CH; Norazmi, MN; Raju, SS; Ravichandran, M | 1 |
| Andrews, KT; Gardiner, DL; McCarthy, J; Melville, L; Skinner-Adams, TS | 1 |
| Hitani, A; Kimura, M; Nakamura, T; Nawa, Y; Ohtomo, H | 1 |
| Anderson, TJ; Barends, M; Jaidee, A; Krishna, S; Nair, S; Nash, D; Nosten, F; Sudimack, D; Uhlemann, AC | 1 |
| Annerberg, A; Christophel, EM; Denis, MB; Fandeur, T; Lim, P; Lindegardh, N; Ringwald, P; Socheat, D; Top, SN; Tsuyuoka, R; Yi, P | 1 |
| Ashley, E; Carrara, V; McGready, R; Nosten, F; Price, R; Singhasivanon, P | 1 |
| Aydin, K; Ergüven, S; Ozkaya, G; Unal, S; Yildirim, T | 1 |
| Basano, SA; Bianco, A; Camargo, LM; Olliaro, P; Taylor, WR | 1 |
| Baird, JK; Binka, F; Fryauff, DJ; Hoffman, SL; Koram, KA; Nkrumah, F; Owusu-Agyei, S; Utz, G | 1 |
| Anderson, T; Barends, M; Brockman, A; Jaidee, A; Mayxay, M; Nair, S; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; Sudimack, D; White, NJ | 1 |
| Ashley, EA; Brockman, A; Chan, S; Goubert, L; Janssens, B; Nong, S; Socheat, D; Uong, S; Van Damme, W; van Herp, M | 1 |
| Alker, AP; Ariey, F; Bouth, DM; Fandeur, T; Lim, P; Maguire, JD; Meshnick, SR; Sem, R; Shah, NK; Tsuyuoka, R; Wongsrichanalai, C; Yi, P | 1 |
| Chaivisuth, A; Chanthavanich, P; Na-Bangchang, K; Pengsaa, K; Pojjaroen-Anant, C; Sabchareon, A; Sirivichayakul, C; Thaiarporn, I; Wisetsing, P | 1 |
| Hung, le N; Hung, NC; Na-Bangchang, K; Thuy, le TD | 1 |
| Abuaku, B; Duah, NO; Koram, KA; Quashie, NB | 1 |
| Andrianantenaina, HB; Ariey, F; Domarle, O; Randrianarivelojosia, M; Rason, MA; Raveloson, A | 1 |
| Dieng, Y; Faye, B; Faye, O; Gaye, O; Ndiaye, D; Ndiaye, JL | 1 |
| Aubouy, A; Bertin, G; Deloron, P; Fievet, N; Kinde-Gazard, D; Kiniffo, R; Kossou, H; Massougbodji, A; Sagbo, JC | 1 |
| Burgner, D; Cherian, S | 1 |
| Chong, MT; Danh, PT; Diem Thuy, le T; Hung, le N; Na-Bangchang, K; Van Binh, N; Van Thang, N | 1 |
| Barnwell, JW; Bounngaseng, A; Collins, WE; Galland, GG; Grady, KK; Hall, P; Huber, C; Nace, D; Ruebush, TK; Sullivan, JJ; Sullivan, JS; Williams, A; Williams, T | 1 |
| Blair, S; Carmona, J; Maestre, A; Montoya, P; Tobón, A | 1 |
| Gozalo, AS; Hall, BT; Lucas, CM; Magill, AJ; Qin, J | 1 |
| Adehossi, E; Brouqui, P; Delmont, J; Parola, P; Ranque, S | 1 |
| Adegnika, AA; Agnandji, ST; Bélard, S; Bouyou-Akotet, MK; Cambon, N; Heidecker, JL; Issifou, S; Kombila, M; Kremsner, PG; Kurth, FM; Mamfoumbi, MM; Missinou, MA; Ramharter, M | 1 |
| Bernasconi, A; Casapia, M; D'Alessandro, U; Delgado, C; Erhart, A; Fanello, C; Gamboa, D; Grande, T; Llanos-Cuentas, A; Torres, K | 1 |
| Adam, M; Favier, R; Grimprel, E; Parez, N; Quinet, B; Valeyre, P | 1 |
| Croft, AM; Garner, P | 4 |
| Bouchaud, O; D'Ortenzio, E; Fontanet, A; Godineau, N; Houze, S; Le Bras, J; Matheron, S | 1 |
| Ashley, EA; Lwin, KM; McGready, R; Nosten, F; Proux, S; Silamut, K | 1 |
| Zarocostas, J | 1 |
| Arango, E; Cravo, P; Do Rosário, VE; Maestre, A; Restrepo-Pineda, E | 1 |
| Meshnick, SR; Wongsrichanalai, C | 1 |
| Mills, A; Socheat, D; Van Damme, W; White, NJ; Yeung, S | 1 |
| Crevoisier, C; Handschin, J; Stürchler, D | 1 |
| Chongsuphajaisiddhi, T; Luxemburger, C; Nosten, F; Raimond, SD; White, NJ | 1 |
| Alvar, J; Amela, C; Benito, A; Molina, R; Roche, J | 1 |
| Andrial, M; Looareesuwan, S; Vanijanonta, S; Viravan, C; Wilairatana, P | 1 |
| Graninger, W; Looareesuwan, S; Presterl, E; Wenisch, C | 1 |
| Cook, GC | 1 |
| Eichenlaub, D; Jelinek, T; Löscher, T; Schelbert, P | 1 |
| Del Nero, L; Lamizana, L; Nebié, I; Pietra, V | 2 |
| Nosten, F; Price, RN | 1 |
| Cobelens, FG; Eggelte, TA; Kager, PA; Wetsteyn, JC | 1 |
| Brogden, RN; Holliday, SM; Palmer, KJ | 1 |
| Deacon, HE; Freese, JA; Sharp, BL | 1 |
| Karbwang, J; Na-Bangchang, K | 1 |
| Hoffman, SL; Johnson, A; Koech, D; Oloo, AJ; Weiss, WR | 1 |
| Dolan, G; Edstein, MD; Keeratithakul, D; Nosten, F; Phaipun, L; Teja-Isavatharm, P; Ter Kuile, FO; Webster, HK; White, NJ | 1 |
| Chongsuphajaisiddhi, T; Salazar, NP; Wernsdorfer, WH | 1 |
| Wilberschied, L | 1 |
| Behrens, RH; Day, JH | 1 |
| Bangchang, KN; Harinasuta, T; Karbwang, J; Thanavibul, A; Wattanakoon, Y | 1 |
| Basco, LK; Le Bras, J; Makler, MM; Marquet, F | 1 |
| Chen, PQ; Guo, XB; Li, GQ | 1 |
| Chongsuphajaisiddhi, T; Eh, JP; Luxemburger, C; Nosten, F; ter Kuile, FO; White, NJ; Woodrow, C | 1 |
| Chatnugrob, P; Eamsila, C; Lasserre, R; Mittelholzer, ML; Nopavong Na Ayuthya, A; Singharaj, P; Stürchler, D; Webster, HK; Yooyen, P | 1 |
| Canfield, C; Charoenlarp, P; Kyle, DE; Lasserre, R; Looareesuwan, S; Vanijanonta, S; Viravan, C; Webster, HK; Wilairatana, P | 1 |
| Aouba, A; Guiguemde, TR; Lamizana, L; Ouedraogo, JB | 1 |
| Canfield, CJ; Charoenlarp, P; Kyle, DE; Looareesuwan, S; Vanijanonta, S; Viravan, C; Wilairatana, P | 1 |
| Colebunders, R; Van den Ende, J; Van den Enden, E; Van Gompel, A | 1 |
| Nosten, F | 1 |
| Hovette, P; Martet, G; Merouze, F; Nicolas, P; Touze, JE | 1 |
| Andrial, M; Charoenlarp, P; Looareesuwan, S; Vanijanonta, S; Viravan, C; Wilairatana, P | 1 |
| Casassus, P; Danis, M; Datry, A; Felix, H; Gay, F; Gentilini, M; Lortholary, O | 1 |
| Bernard, KW; Campbell, CC; Eng, T; Hightower, AW; Lobel, HO; Miani, M | 1 |
| DeFraites, RF; Hanson, RK; Sánchez, JL; Sharp, TW | 1 |
| Chongsuphajaisiddhi, T; Dolan, G; Edstein, MD; Luxemburger, C; Nosten, F; Phaipun, L; ter Kuile, FO; Webster, HK; White, NJ | 1 |
| Chongsuphajaisiddhi, T; Kyle, DE; Luxemburger, C; Nosten, F; ter Kuile, FO; White, NJ; Woodrow, C | 1 |
| Fuchs, E; Funk, M; Naef, U; Nevill, C; Phillips-Howard, P; Schildknecht, J; Schlagenhauf, P; Steffen, R; Stürchler, D | 1 |
| Luxemburger, C; Nosten, F; ter Kuile, FO; White, NJ | 1 |
| Fleckenstein, L; Jongsakul, K; Karnasuta, C; Loesuttiviboon, L; Ohrt, CK; Schuster, B; Shanks, GD; Watt, G | 1 |
| White, NJ | 1 |
| Bergqvist, Y; Fontanet, AL; Hellgren, U; Johnston, BD; Rooney, W; Walker, AM | 1 |
| Back, DJ; Bunnag, D; Harinasuta, T; Karbwang, J; Na Bangchang, K; Thanavibul, A | 1 |
| Aoki, M; Kamei, K; Miyashita, T; Nishiya, H; Ohyatsu, I; Ono, Y; Shibuya, T; Sugiyama, H; Tokumura, Y; Yamaguchi, M | 1 |
| Boudreau, E; Bunnag, D; Chongsuphajaisiddhi, T; Maelankiri, L; Nopdonrattakoon, L; Nosten, F; Tangkitchot, S; ter Kuile, F; White, NJ | 1 |
| Bangchang, KN; Bunnag, D; Harinasuta, T; Karbwang, J; Rooney, W; Thimasarn, K | 1 |
| Haller, A; Speich, R | 1 |
| Fontanet, AL; Walker, AM | 1 |
| Nordlander, E; Smithuis, FM; ter Kuile, FO; van Woensel, JB; Vantha, WS | 1 |
| Fowler, VG; Irare, SG; Lemnge, M; Malecela, E; Mashaka, M; Mhina, J; Mtoi, R; Mtui, S | 1 |
| Angel, VH; Friman, G; Hellgren, U; Mittelholzer, ML; Rombo, L; Stürchler, D | 1 |
| Boudreau, E; Dausel, L; Hanson, R; Johnson, R; Novakowski, W; Redmond, D; Sanchez, J; Schuster, B | 1 |
| Banmairuroi, V; Bunnag, D; Harinasuta, T; Karbwang, J; Na Bangchang, K | 1 |
| Bunnag, D; Harinasuta, T; Karbwang, J; Na Bangchang, K; Rooney, W; Thimasarn, K | 1 |
| Canfield, C; Charoenlarp, P; Kyle, DE; Looareesuwan, S; Vanijanonta, S; Viravan, C; Wilairatana, P | 1 |
| Cowman, AF; Galatis, D; Thompson, JK | 1 |
| Fontanet, AL; Hours, M; Johnston, DB; Macdonald, M; Rooney, W; Sturchler, D; Thimasarn, K; Walker, AM; Wirth, DF | 1 |
| Bray, PG; Howells, RE; Ndifor, AM; Ngu, JL; Ward, SA | 1 |
| Doherty, J | 1 |
| Bunnag, D; Chittamas, S; Harinasuta, T; Horton, J; Karbwang, J; Looareesuwan, S; Serville, P; Viravan, C | 1 |
| Magill, AJ; Smoak, BL | 1 |
| Kyle, DE; Martin, RK; Milhous, WK; Thaithong, S; Volkman, SK; Wilson, CM; Wirth, DF | 1 |
| Bergqvist, Y; Breyer, S; Burgmann, H; Feistauer, S; Feucht, M; Graninger, W; Hellgren, U; Uhl, F; Winkler, S | 1 |
| Davis, TM; Edwards, G; McGrath, CS; Pukrittayakamee, S; Supanaranond, W; Ward, SA; White, NJ | 1 |
| Davis, DR; Hutton, DC; Rieckmann, KH; Simpson, R; Wheatley, PF; Yeo, AE | 1 |
| Ager, AL; Canfield, CJ; Heiffer, MH; Klayman, DL; Kyle, DE; Milhous, WK; Rossan, RN; Schuster, BG; Shmuklarsky, MJ; Tang, DB | 1 |
| Danis, M; Gentilini, M; Katlama, C; Nozais, JP; Paris, L; Raynaud de Lage, C; Robert, C | 1 |
| Schubarth, P | 1 |
| Bradley, D | 1 |
| Gras, C; Guelain, J; Guisset, M; Laroche, R; Martet, G; Merlin, M; Pottier, G; Touze, JE | 1 |
| Davis, TM; Nagachinta, B; Pukrittayakamee, S; Supanaranond, W; White, NJ | 1 |
| Bendtzen, K; Jakobsen, PH; Staalsø, T; Stürchler, D | 1 |
| Wright, D | 1 |
| Adio, RA; Oduola, AM; Ogundahunsi, OA; Salako, LA; Sowunmi, A | 1 |
| Alin, MH; Ashton, M; Bjorkman, A; Bwijo, BA; Kihamia, CM; Mtey, GJ; Premji, Z | 1 |
| Batchelor, R; Burans, JP; Iriye, C; Lobel, HO; Longer, CF; Magill, AJ; Rozmajzl, P; Sharp, TW; Smoak, B; Thornton, SA; Wallace, MR | 1 |
| Andrial, M; Looareesuwan, S; Pitisuttithum, P; Vanijanonta, S; Viravan, C; Wilairatana, P | 1 |
| Laomiphol, A; Palananth, C; Rooney, W; Sirichaisinthop, J; Tansophalaks, S; Tháithong, S; Thamewat, U; Thimasarn, K; Vijaykadga, S; Yamokgul, P | 1 |
| Green, MD; Hopperus Buma, AP; Kager, PA; Kyle, DE; Lobel, HO; Ohrt, C; Tendeloo, DC; Todd, GD; van Ameijden, EJ; van Gool, T; van Thiel, PP; Veltink, RL | 1 |
| Watkins, WM | 1 |
| Plasai, V; Spielman, A | 1 |
| Breman, JG; Heymann, DL; Slutsker, L; Steketee, RW; Wirima, JJ | 1 |
| Breman, JG; Heymann, DL; Khoromana, CO; Roberts, JM; Slutsker, L; Steketee, RW; Wirima, JJ | 1 |
| Breman, JG; Heymann, DL; Hightower, AW; Slutsker, L; Steketee, RW; Wirima, JJ | 1 |
| Breman, JG; Heymann, DL; Khoromana, CO; Slutsker, L; Steketee, RW; Wirima, JJ | 1 |
| Breman, JG; Heymann, DL; Khoromana, CO; Slutsker, WL; Steketee, RW; Wirima, JJ | 1 |
| Basco, LK; Le Bras, J; Rhoades, Z; Wilson, CM | 1 |
| Attanath, P; Bourahla, A; Chongsuphajaisiddhi, T; Farinotti, R; Gimenez, F; Martin, C; Sabchearon, A; Singhasivanon, V | 1 |
| Agbo, M; Emembolu, JO; Lege-Oguntoye, L; Okeyeh, JN | 1 |
| Bergqvist, Y; Ericsson, O; Handschin, J; Hellgren, U; Johnson, R; Letz, R; Lobel, H; Mannino, S; Rombo, L; Schlagenhauf, P; Steffen, R; Stürchler, D; Tschopp, A; Vranjes, N | 1 |
| Hopperus Buma, AP; Jaspers, CA; Kager, PA; van Hulst, RA; van Thiel, PP | 1 |
| Ilesanmi, AO; Oduola, AM; Salako, LA; Sowunmi, A | 1 |
| Alin, MH; Ashton, M; Björkman, A; Kihamia, CM; Mtey, GJ | 1 |
| Banmairuroi, V; Karbwang, J; Molunto, P; Na-Bangchang, K; Thanavibul, A | 2 |
| Ditta-in, M; Harinasuta, T; Karbwang, J; Laothavorn, P; Na-Bangchang, K; Thanavibul, A | 1 |
| Byers, M; Miller, JH; Warrell, DA; Whiteoak, R | 1 |
| Bouquety, JC; Carme, B; Gay, F; Hayette-Gorremans, MP; Ndounga, M | 1 |
| Handschin, J; Kremsner, PG; Nkeyi, M; Philipps, J; Radloff, PD; Stürchler, D | 1 |
| Kremsner, PG; Mittelholzer, ML; Nkeyi, M; Philipps, J; Radloff, PD; Sturchler, D | 1 |
| Bethell, DB; Day, NP; Ly, VC; Mai, NT; Nguyen, TH; Tran, TH; Waller, D; White, NJ | 1 |
| Chongsuphajaisiddhi, T; Kyle, D; Luxemburger, C; Nosten, F; Phaipun, L; Price, R; Teja-Isavatharm, P; ter Kuile, FO; White, NJ | 1 |
| Burgmann, H; Graninger, W; Looareesuwan, S; Vanijanonta, S; Viravan, C; Vorbach, H; Zedwitz-Liebenstein, K | 1 |
| Winstanley, P | 1 |
| Furukawa, H; Ohno, T; Shirasaka, A; Sugiyama, T | 1 |
| Chongsuphajaisiddhi, T; Luxemburger, C; Nosten, F; Price, RN; Ter Kuile, FO; White, NJ | 1 |
| Adak, T; Ansari, MA; Biswas, S; Devi, CU; Pillai, CR; Sharma, YD | 1 |
| Emembolu, JO; Lege-Oguntoye, L; Okoyeh, JN; Sarki, U | 1 |
| Chiwakata, CB; Dietrich, M; Egbring, R; Gaus, W; Hassemer, M; Hemmer, CJ; Hogel, J; Hort, G; Kern, P; Nawroth, PP; Seitz, R | 1 |
| Lege-Oguntoye, L; Ogunrinde, GO; Okoyeh, JN; Ugbode, RO | 1 |
| Congpuong, K; Karbwang, J; Na-Bangchang, K; Sirichaisinthop, J; Suprakorb, K | 1 |
| Kyle, DE; Looareesuwan, S; Pitisuttithum, P; Vanijanonta, S; Viravan, C; Wilairatana, P | 1 |
| Garg, MR; Gopinathan, N; Kshirsagar, NA | 1 |
| Pillans, PI; Tish, KN | 1 |
| Davis, TM; Martin, RB | 1 |
| Barguil, Y; Descamps, I; Genelle, B; Levenes, H; Monchy, D | 1 |
| Green, MD; Hopperus Buma, AP; Jaspers, CA; Lobel, HO; Todd, GD | 1 |
| Aung, H; Aung, S; Kyaw, MP; Lwin, M; Oo, H; Sint, N; Thein, H; Tun, SM; Win, Y | 1 |
| Brockman, A; Gathmann, I; Gemperli, B; Looareesuwan, S; Luxemburger, C; Nosten, F; Royce, C; Slight, T; van Vugt, M; White, NJ | 1 |
| Attanath, P; Brewer, TG; Chanthavanich, P; Chongsuphajaisiddhi, T; Heppner, DG; Mookmanee, D; Phanuaksook, P; Poonpanich, Y; Prarinyanupharb, V; Sabchareon, A; Teja-Isavadharm, P | 1 |
| Kerr, L; Maradit, H; Vanhauwere, B | 1 |
| Boutes, S; Karbwang, J; Na-Bangchang, K; Riengchainam, S; Tan-ariya, P; Ubalee, R | 1 |
| Ellis, CJ | 1 |
| Laffitte, E | 1 |
| Bygbjerg, IC; Gøtzsche, PC; Rønn, AM; Rønne-Rasmussen, J | 1 |
| Boele van Hensbroek, M; Kager, PA; Wetsteyn, JC; Zijlmans, CW | 1 |
| Doury, JC; Fusai, T; Pradines, B; Rogier, C; Tall, A; Trape, JF | 1 |
| Chanyakhun, P; Palananth, C; Rooney, W; Sirichaisinthop, J; Thimasarn, K | 1 |
| Chene, L; Chongsuphajaisiddhi, T; Daubersies, P; Druilhe, P; Gentil, C; Langsley, G; Mellouk, S; Patarapotikul, J | 1 |
| Kremsner, PG; Philipps, J; Radloff, PD; Wernsdorfer, W | 1 |
| Handschin, J; Kremsner, PG; Lehman, LG; Lell, B; Schmidt-Ott, JR; Sturchler, D | 1 |
| Milhous, WK; Pang, L; Silveira, MS; Wirth, DF; Zalis, MG | 1 |
| Behrens, RH; Bradley, D; Reyburn, H; Warhurst, D | 1 |
| Jelinek, T; Muehlberger, N; Nothdurft, HD; Schlipkoeter, U; von Sonnenburg, F | 1 |
| Coulibaly, SO; Dutheil, Y; Guiguemdé, TR; Ouédraogo, JB; Tall, F; Tinto, H; Traoré, B; Zampa, H | 1 |
| Chongsuphajaisiddhi, T; Looareesuwan, S; Viriyavejakul, P; Wilairatana, P | 1 |
| Bunnag, D; Harinasuta, T; Kanda, T; Karbwang, J; Pungpak, S; Thimasarn, K | 1 |
| Barber, AM; Grady, K; Green, M; Lobel, HO; Miani, M; Todd, GD; Varma, JK | 1 |
| Chung, SY; Das, R; Oon, CT | 1 |
| Aung, S; Lwin, M; Shwe, T | 1 |
| Hatz, C; Markwalder, K | 1 |
| di Piazza, JP; Durand, R; Le Bras, J; Longuet, C; Parzy, D; Pradines, B | 1 |
| Cho, T; Chongsuphajaisiddhi, T; Hkirijaroen, L; McGready, R; Nosten, F; Simpson, J; White, NJ | 1 |
| Chongsuphajaisiddhi, T; Heppner, DG; Luxemburger, C; Nosten, F; Price, R; Simpson, JA; Teja-Isavatharm, P; Than, MM; White, NJ | 1 |
| Bregani, ER; Figini, G; Tien, TV | 1 |
| Chalermrut, K; Chokejindachai, W; Gathmann, I; Gemperli, B; Looareesuwan, S; Royce, C; Wernsdorfer, W; Wilairatana, P | 1 |
| Bourgeade, A; Delmont, J | 1 |
| Voskuil, PH | 1 |
| Burgel, PR; Camara, P; Hovette, P; Klotz, F; Mbaye, PS; Sane, M | 1 |
| Whitty, CJ | 1 |
| Aung, S; Ejov, MN; Sein, K; Tun, T | 1 |
| Le Bras, J | 1 |
| Hien, TT; Nosten, F; White, NJ | 1 |
| McIntosh, HM; Olliaro, P | 1 |
| Juckett, G | 1 |
| Gherardin, T | 1 |
| Canfield, CJ; Chalermarut, K; Hutchinson, DB; Looareesuwan, S; Rattanapong, Y; Wilairatana, P | 1 |
| Chongsuphajaisiddhi, T; Kham, A; Luxemburger, C; McGready, R; Nosten, F; Phaipun, L; Price, R; Simpson, J; ter Kuile, F; van Vugt, M; White, NJ | 1 |
| White, N | 1 |
| Schlagenhauf, P | 1 |
| Chongsuphajaisiddhi, T; Luxemburger, C; Nosten, F; Phaipun, L; Price, R; Simpson, JA; ter Kuile, F; van Vugt, M; White, NJ | 1 |
| Hills, F; Krudsood, S; Looareesuwan, S; Porter, RS; Sjostrom, L; Warrell, DA; Wilairatana, P | 1 |
| Alaribe, AA; Chukwuani, CM; Ekanem, OJ; Ezedinachi, EN; Haller, L; Meremikwu, MM; Ojar, EA; Umotong, AB | 1 |
| Bray, PG; Mungthin, M; Ward, SA | 1 |
| Kremsner, PG; Kun, JF; Lehman, LG; Lell, B; Schmidt-Ott, R | 1 |
| Botella de Maglia, J; Espacio Casanovas, A | 1 |
| Chaovanakawee, S; Karbwang, J; Na-Bangchang, K; Saenglertsilapachai, S; Tippanangkosol, P; Ubalee, R | 1 |
| Cerutti, C; de Alencar, FE; Durlacher, RR; Pang, LW; Segurado, AA | 1 |
| Clerinx, J; De Paep, R; Van den Ende, J | 1 |
| Aarons, L; Chongsuphajaisiddhi, T; Looareesuwan, S; Nosten, F; Price, R; Simpson, JA; Teja-Isavatharm, P; ter Kuile, F; White, NJ | 1 |
| Brockman, A; Cassar, C; Duraisingh, M; Krishna, S; Nosten, F; Price, RN; van Vugt, M; White, NJ | 1 |
| Angkasekwinai, P; Buranakiti, A; Chaiyaroj, SC; Cowman, AF; Looressuwan, S | 1 |
| Duraisingh, MT; Jones, P; Pinder, M; Sambou, I; von Seidlein, L; Warhurst, DC | 2 |
| Karbwang, J; Na-Bangchang, K; Palacios, PA; Saengtertsilapachai, S; Ubalee, R; Wernsdorfer, WH | 1 |
| Havaldar, PV; Mogale, KD | 1 |
| Burgmann, H; Chullawichit, S; Daxböck, F; El-Menyawi, I; Graninger, W; Looareesuwan, S; Stoiser, B; Thalhammer, F | 1 |
| Green, ST; Jones, DA; Leach, MJ; Mainwaring, CJ; Nayak, N; Winfield, DA | 1 |
| McGready, R; Nosten, F | 1 |
| Auparakkitanon, S; Chavalitshewinkoon-Petmitr, P; Pongvilairat, G; Wilairat, P | 1 |
| Angus, BJ; Htoo, SE; Looareesuwan, S; Mann, C; Nosten, F; Poletto, C; Price, RN; Simpson, JA; Van Vugt, M; White, NJ | 1 |
| Contini, C; Cultrera, R | 1 |
| Bussaratid, V; Chokejindachai, W; Hendriksen, C; Krudsood, S; Looareesuwan, S; Scheiwe, MW; Silachamroon, U; Viriyavejakul, P; Wilairatana, P | 1 |
| Aung, S; Lwin, M; Mar, KK; Shwe, T; Win, LL; Zaw, AK | 1 |
| Behrens, RH; Day, JH; Evans, MR | 1 |
| Chongsuphajaisiddhi, T; de Vries, A; Nosten, F; Simpson, J; Thwai, KL; Vincenti, M; White, NJ; Yei, P | 1 |
| Sirichaisinthop, J; Thimasarn, K; Wongsrichanalai, C | 1 |
| Myrvang, B | 1 |
| Blystad, H | 1 |
| Jambou, R; Milijaona, R; Raharimalala, L; Ranaivo, L; Rason, MA; Roux, J | 1 |
| Minei-Rachmilewitz, T | 1 |
| Matalon, A; Yinnon, A | 1 |
| Brockman, A; Looareesuwan, S; Luxemburger, C; McGready, R; Nosten, F; Price, R; ter Kuile, F; Thway, KL; van Vugt, M; White, NJ | 1 |
| Saul, A | 1 |
| Barlow, GD; Nathwani, D | 1 |
| Brandts, C; Kremsner, PG; Philipps, J; Schwenke, A; Wernsdorfer, WH; Winkler, S | 1 |
| Kramer, MH; Lobel, HO | 1 |
| Khusmith, S; Laothavorn, J; Na-Bangchang, K; Trisirivanich, S | 1 |
| Brasseur, P; Cuzin-Ouattara, N; Druilhe, P; Moreno, A; Nebie, I; Sanon, S | 1 |
| Kain, KC; Keystone, JS; Shanks, GD | 1 |
| Beck, B; Blum, J; Funk, M; Furrer, H; Genton, B; Hatz, FR; Holzer, B; Loutan, L; Markwalder, K; Raeber, PA; Schlagenhauf, P; Siegl, G; Steffen, R; Stürchler, D; Wyss, R | 1 |
| Congpuong, K; Karwacki, JJ; Miller, RS; Pang, L; Sirichaisinthop, J; Thimasarn, K; Wongsrichanalai, C | 1 |
| Kaye, D | 1 |
| Almog, S; Potasman, I; Rotenberg, M; Sadetzki, S; Schwartz, E | 1 |
| Peragallo, MS | 1 |
| Croft, AM; Geary, KG | 1 |
| Anh, CV; Davis, TM; Giang, LT; Hang, NT; Hewitt, S; Quang, HH; Thoa, NT; Thuan, LK; Thuy, PT; Trung, TN; Tuan, NT | 1 |
| Kremsner, PG; Kun, JF; Lell, B; Mawili-Mboumba, DP; Ntoumi, F | 1 |
| Bailly, F; Dusmet, M; Fitting, JW; Lemoine, R; Schnyder, P; Udry, E | 1 |
| World, MJ | 1 |
| Micha, ST; Wang, W; Yang, W | 1 |
| Ali, D; Barat, LM; Green, MD; Kazembe, PN; Kolczak, MS; MacArthur, J; Macheso, A; Ruebush, TK; Stennies, GM | 1 |
| Kollaritsch, H; Krudsood, S; Looareesuwan, S; Noedl, H; Viriyavejakul, P; Wernsdorfer, WH; Wiedermann, G; Wilairatana, P | 1 |
| Cunha, ML; Pang, LW; Piovesan-Alves, F | 1 |
| Bounyasong, S | 1 |
| Juven, Y; Potasman, I; Schwartz, E; Weller, B | 1 |
| D'Acremont, V; Darioli, R; Genton, B; Landry, P; Pécoud, A; Stuerchler, D | 1 |
| Belsare, H; Patel, AB | 1 |
| Ghosh, SK; Sharma, VP; Yadav, RS | 1 |
| Akindele, JA; Sowunmi, A; Walker, O | 1 |
| Bunnag, D; Chindanond, D; Chittamas, S; Fernex, M; Harinasuta, T; Kristiansen, S; Malikul, S; Mittelholzer, ML; Sturchler, D | 1 |
| Adio, RA; Dickschat, U; Mittelholzer, ML; Reber-Liske, R; Salako, LA; Sowunmi, A; Stürchler, D; Walker, O | 1 |
| Badoual, J | 1 |
| Brasseur, P; Druilhe, P; Kouamouo, J; Moyou, RS | 1 |
| Arnold, K; Canfield, C; Charoenlarp, P; Kyle, D; Looareesuwan, S; Suntharasamai, P; Vanijanonta, S; Viravan, C; Webster, K; Wilairatana, P | 1 |
| Bangchang, KN; Bunnag, D; Chongsuphajaisiddhi, T; Harinasuta, T; Karbwang, J; Thanavibul, A | 1 |
| Hla, KK; Shwe, T | 1 |
| Chongsuphajaisiddhi, T; Edstein, MD; Luxemburger, C; Nosten, F; Phaipun, L; ter Kuile, FO; Thieren, M; Webster, HK; White, NJ | 1 |
| Canfield, CJ; Charoenlarp, P; Kyle, DE; Looareesuwan, S; Vanijanonta, S; Viravan, C; Webster, HK; Wilairatana, P | 1 |
| Bunnag, D; Chitamas, S; Harinasuta, T; Karbwang, J; Viravan, C | 1 |
| Fadat, G; Gardon, J; Gazin, P; Hengy, C; Jambou, R; Louis, FJ; Louis, JP; Trebucq, A | 1 |
| Bunnag, D; Harinasuta, T; Karbwang, J; Laothavorn, P; Na Bangchang, K | 1 |
| Jatapadma, S; Ketrangsee, S; Rooney, W; Thimasarn, K; Vijaykadga, S; Yamokgul, P | 1 |
| Brasseur, P; Druilhe, P; Kouamouo, J; Moyou-Somo, R | 1 |
| Chia, JK; Co, S; Nakata, MM | 1 |
| Currie, PF; Douglas, JG; Green, ST; Nathwani, D; Smith, NC | 1 |
| Shah, PM | 1 |
| Reisinger, EC | 1 |
| Back, DJ; Bunnag, D; Karbwang, J; Na Bangchang, K; Thanavibul, A | 1 |
| Salako, LA; Sowunmi, A | 1 |
| Chuanak, N; Sookto, P; Thimasarn, K; Webster, HK; Wernsdorfer, WH; Wimonwattrawatee, T; Wongsrichanalai, C | 1 |
| Bauchet, J; Hatin, I; Le Bras, J; Legros, F; Trape, JF | 1 |
| Basco, LK; Bouchaud, O; Coulaud, JP; Farinotti, R; Gillotin, C; Gimenez, F; Le Bras, J; Rabenjarson, E; Ringwald, P | 1 |
| Chongsuphajaisiddhi, T; Frejacques, L; Luxemburger, C; Nosten, F; ter Kuiile, F; White, NJ | 1 |
| Baudon, D; Cordoliani, G; Da Conceicao, S; Delolme, H; Doury, JC; Hovette, P; Lecamus, JL; Martet, G; Raphenon, G; Touze, JE | 1 |
| Holmberg, H; Rombo, L; Vikerfors, T | 1 |
| Allaouchiche, B; Biron, F; Boibieux, A; Gaussorgues, P; Gerard-Boncompain, M; Peyramond, D; Robert, D; Salord, F; Sirodot, M | 1 |
| Cacoub, P; Colas, C; De Gennes, C; Godeau, P; Lê Thi Huong, Du; Nollet, D; Piette, JC | 1 |
| Thomas, JE | 1 |
| Banmairuroi, V; Bunnag, D; Harinasuta, T; Karbwang, J; Molunto, P; Na Bangchang, K | 1 |
| Shanks, GD; Suriyamongkol, V; Timsaad, S | 1 |
| Bunnag, D; Harinasuta, T; Karbwang, J; Na Bangchang, K; Thanavibul, A | 1 |
| Ayivi, B; Bégué, P; Quinet, B; Ter Sakarian, M | 1 |
| Abraham, E; Brachet-Liermain, A; Dumestre-Toulet, V; Le Bras, M; Raccurt, CP; Ripert, C | 1 |
| Denis, MB; Giboda, M; Kouznetsov, RL | 1 |
| Boudreau, EF; Chaikummao, S; Pang, LW; Witayarut, C | 1 |
| Edstein, MD; Kowinwiphat, W; Panpunnung, S; Shanks, GD; Suriyamongkol, V; Watanasook, C; Watt, G; Webster, HK | 1 |
60 review(s) available for mefloquine and Malaria, Falciparum
| Article | Year |
|---|---|
Using genetic methods to define the targets of compounds with antimalarial activity.
Topics: Animals; Anopheles; Antimalarials; Drug Resistance; Genetic Association Studies; Genome, Protozoan; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Plasmodium falciparum | 2013 |
Efficacy of three anti-malarial regimens for uncomplicated Plasmodium falciparum malaria in Cambodia, 2009-2011: a randomized controlled trial and brief review.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; Child, Preschool; Humans; Malaria, Falciparum; Mefloquine; Randomized Controlled Trials as Topic; Recurrence | 2022 |
Transition Metal Complexes as Antimalarial Agents: A Review.
Topics: Antimalarials; Chloroquine; Coordination Complexes; Drug Resistance; Humans; Malaria; Malaria, Falciparum; Mefloquine; Plasmodium falciparum | 2023 |
Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis.
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Atovaquone; Clindamycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 2020 |
Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Atovaquone; Cameroon; Child; Colombia; Drug Combinations; Ethiopia; Humans; Malaria, Falciparum; Mefloquine; Proguanil; Randomized Controlled Trials as Topic; Thailand; Treatment Failure | 2021 |
Mefloquine for preventing malaria during travel to endemic areas.
Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Doxycycline; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Primaquine; Proguanil; Randomized Controlled Trials as Topic; Travel-Related Illness | 2017 |
Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.
Topics: Adult; Antimalarials; Artemisinins; Child; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Non-Randomized Controlled Trials as Topic; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine; Time Factors | 2018 |
Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Humans; Liver; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Randomized Controlled Trials as Topic | 2019 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Insecticide-Treated Bednets; Insecticides; Malaria; Malaria Vaccines; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Primary Prevention; Pyrimethamine; Quinine; Quinolines; Seasons; Sulfadoxine | 2014 |
Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Quinolines | 2013 |
Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Quinolines; Randomized Controlled Trials as Topic | 2014 |
Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Liver; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Randomized Controlled Trials as Topic | 2014 |
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2014 |
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2015 |
WITHDRAWN: Drugs for preventing malaria in travellers.
Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Doxycycline; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Primaquine; Proguanil; Randomized Controlled Trials as Topic; Travel | 2015 |
Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Risk; Sulfadoxine | 2017 |
Artemisinin-based combination therapy for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2009 |
Drugs for preventing malaria in travellers.
Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Doxycycline; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Primaquine; Proguanil; Randomized Controlled Trials as Topic; Travel | 2009 |
Artemisinin-based combination therapies and their introduction in Japan.
Topics: Animals; Antimalarials; Artemether; Artemisia annua; Artemisinins; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Japan; Lumefantrine; Malaria, Cerebral; Malaria, Falciparum; Mefloquine; Plasmodium falciparum | 2010 |
Azithromycin for treating uncomplicated malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Azithromycin; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Proguanil; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Treatment Failure | 2011 |
The pharmacogenetics of antimalaria artemisinin combination therapy.
Topics: Aminoquinolines; Antimalarials; Artemisinins; Artesunate; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Drug Combinations; Drug Resistance; Ethanolamines; Evidence-Based Medicine; Fluorenes; Genetic Markers; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Pharmacogenetics; Plasmodium falciparum; Polymorphism, Single Nucleotide | 2011 |
Mefloquine gap junction blockade and risk of pregnancy loss.
Topics: Abortion, Spontaneous; Animals; Antimalarials; Female; Gap Junctions; Humans; Malaria, Falciparum; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Risk Factors | 2012 |
Primaquine for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2012 |
Safety evaluation of the drugs available to prevent malaria.
Topics: Adult; Animals; Antimalarials; Chemical and Drug Induced Liver Injury; Chloroquine; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Randomized Controlled Trials as Topic; Travel | 2002 |
Genetic and biochemical aspects of drug resistance in malaria parasites.
Topics: Animals; Antimalarials; Chloroquine; Dihydropteroate Synthase; Drug Resistance; Drug Resistance, Multiple; Humans; Linkage Disequilibrium; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Mutation; Phenanthrenes; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2004 |
Malaria: uncomplicated, caused by Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Proguanil; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
[Malaria chemoprophylaxis].
Topics: Antimalarials; Atovaquone; Chloroquine; Contraindications; Doxycycline; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Mefloquine; Naphthoquinones; Practice Guidelines as Topic; Pregnancy; Proguanil; Risk Assessment; Travel | 2005 |
Artesunate plus mefloquine versus mefloquine for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Sesquiterpenes | 2005 |
Antimalarial multi-drug resistance in Asia: mechanisms and assessment.
Topics: Animals; Antimalarials; Asia; ATP-Binding Cassette Transporters; Chloroquine; Dihydropteroate Synthase; DNA, Protozoan; Drug Resistance, Multiple; Folic Acid Antagonists; Genes, Protozoan; Humans; Malaria, Falciparum; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Plasmodium falciparum; Protozoan Proteins; Tetrahydrofolate Dehydrogenase | 2005 |
[Cytochrome P-450 and the response to antimalarial drugs].
Topics: Administration, Oral; Adult; Amodiaquine; Animals; Antimalarials; Biotransformation; Child; Chloroquine; Cytochrome P-450 Enzyme System; Databases as Topic; Disease Models, Animal; Genotype; Humans; Malaria; Malaria, Falciparum; Mefloquine; Mice; Murinae; Mutation; Nutritional Status; Phenotype; Plasmodium berghei; Polymorphism, Genetic; Proguanil; Rats | 2006 |
Antimalarial drugs: recent advances in molecular determinants of resistance and their clinical significance.
Topics: Africa; Amino Alcohols; Animals; Antimalarials; Artemisinins; Asia, Southeastern; Biological Transport; Calcium-Transporting ATPases; Chloroquine; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Gene Amplification; Humans; Malaria, Falciparum; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Models, Biological; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Quinine; Sesquiterpenes | 2006 |
WITHDRAWN: Mefloquine for preventing malaria in non-immune adult travellers.
Topics: Adult; Antimalarials; Female; Humans; Malaria; Malaria, Falciparum; Male; Mefloquine; Randomized Controlled Trials as Topic; Travel; Treatment Outcome | 2008 |
New antimalarials. A risk-benefit analysis.
Topics: Animals; Antimalarials; Artemisinins; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Pregnancy; Risk Assessment; Sesquiterpenes | 1995 |
Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.
Topics: Animals; Humans; Malaria, Falciparum; Mefloquine | 1993 |
Clinical application of mefloquine pharmacokinetics in the treatment of P falciparum malaria.
Topics: Drug Interactions; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Mefloquine | 1994 |
Quinine toxicity when given with doxycycline and mefloquine.
Topics: Adult; Doxycycline; Drug Therapy, Combination; Hearing Disorders; Humans; Malaria, Falciparum; Male; Mefloquine; Quinine | 1994 |
[Malaria: the most important emergency in subjects returning from the tropics].
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Emergencies; Humans; Malaria; Malaria, Falciparum; Mefloquine; Plasmodium; Pyrimethamine; Quinidine; Quinine; Sulfadoxine | 1993 |
Prophylaxis against malaria for travellers from the United Kingdom. Malaria Reference Laboratory and the Ross Institute.
Topics: Animals; Child; Child, Preschool; Chloroquine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Proguanil; Travel | 1993 |
[Current role of doxycycline in the chemoprophylaxis of Plasmodium falciparum malaria].
Topics: Asia, Southeastern; Doxycycline; Humans; Malaria, Falciparum; Mefloquine; South America | 1993 |
Pharmacology and pharmacokinetics of new antimalarials.
Topics: Africa; Antimalarials; Artemether; Artemisinins; Drug Costs; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Phenanthrenes; Sesquiterpenes; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
[The treatment of malaria].
Topics: Adult; Antimalarials; Chloroquine; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Phenanthrenes; Pregnancy; Primaquine | 1997 |
Artesunate suppositories: an effective treatment for severe falciparum malaria in rural areas.
Topics: Acute Disease; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Rural Health; Sesquiterpenes; Suppositories | 1997 |
Mefloquine and malaria prophylaxis.
Topics: Antimalarials; Central Nervous System Diseases; Drug Administration Schedule; Humans; Malaria, Falciparum; Mefloquine | 1998 |
[1998 malaria therapy].
Topics: Adult; Antimalarials; Child; Drug Resistance, Multiple; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Pregnancy; Quinine; Switzerland | 1998 |
Use of artemisinin derivatives for the control of malaria.
Topics: Antimalarials; Artemisinins; Drug Resistance; Drug Therapy, Combination; Humans; Incidence; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Prospective Studies; Refugees; Risk Factors; Seasons; Sesquiterpenes; Thailand; Treatment Outcome; Vietnam | 1998 |
Treatment of uncomplicated malaria with artemisinin derivatives. A systematic review of randomised controlled trials.
Topics: Adult; Antimalarials; Artemisinins; Child; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Randomized Controlled Trials as Topic; Research Design; Sesquiterpenes; Time Factors; Treatment Outcome | 1998 |
Malaria prevention in travelers.
Topics: Animals; Antimalarials; Bedding and Linens; Chloroquine; Doxycycline; Humans; Malaria; Malaria, Falciparum; Mefloquine; Patient Education as Topic; Plasmodium falciparum; Primaquine; Proguanil; Protective Clothing; Teaching Materials; Travel | 1999 |
Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives.
Topics: Acute Disease; Antimalarials; Artemether; Artemisinins; Artesunate; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Sesquiterpenes | 1999 |
Mefloquine for malaria chemoprophylaxis 1992-1998: a review.
Topics: Antimalarials; Drug Resistance; Female; Humans; Malaria, Falciparum; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Travel | 1999 |
Mefloquine for preventing malaria in non-immune adult travellers.
Topics: Adult; Antimalarials; Female; Humans; Malaria; Malaria, Falciparum; Male; Mefloquine; Travel | 2000 |
[Malaria in Norway--diagnosis, treatment and prevention].
Topics: Antimalarials; Chloroquine; Humans; Insect Bites and Stings; Malaria; Malaria, Falciparum; Mefloquine; Norway; Practice Guidelines as Topic; Primaquine; Travel | 2000 |
Mefloquine for preventing malaria in non-immune adult travellers.
Topics: Adult; Antimalarials; Female; Humans; Malaria; Malaria, Falciparum; Male; Mefloquine; Randomized Controlled Trials as Topic; Travel | 2000 |
Mefloquine for preventing malaria in non-immune adult travellers.
Topics: Adult; Antimalarials; Female; Humans; Malaria; Malaria, Falciparum; Male; Mefloquine; Randomized Controlled Trials as Topic; Travel; Treatment Outcome | 2000 |
Antimalarial chemoprophylaxis in infants and children.
Topics: Antimalarials; Child; Child, Preschool; Chloroquine; Doxycycline; Humans; Infant; Malaria, Falciparum; Mefloquine; Primaquine | 2001 |
Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens.
Topics: Animals; Antimalarials; Atovaquone; Azithromycin; Chloroquine; Drug Resistance; Health Planning Guidelines; Humans; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Primaquine; Proguanil | 2001 |
[Malaria--chemoprophylaxis 2001].
Topics: Africa; Antimalarials; Asia; Atovaquone; Chloroquine; Contraindications; Doxycycline; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Mefloquine; Naphthoquinones; Practice Guidelines as Topic; Proguanil; South America; Switzerland; Travel | 2001 |
Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Plasmodium falciparum; Sesquiterpenes; Thailand | 2001 |
The Italian army standpoint on malaria chemoprophylaxis.
Topics: Antimalarials; Chloroquine; Doxycycline; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Humans; Italy; Malaria; Malaria, Falciparum; Mefloquine; Military Personnel; Proguanil; Tropical Climate | 2001 |
The malaria threat.
Topics: Antimalarials; Chloroquine; Doxycycline; Drug Resistance; Health Policy; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Military Personnel; Proguanil | 2001 |
Plasmodium falciparum malaria in pregnancy: a review.
Topics: Animals; Chloroquine; Critical Care; Female; Humans; Immunocompromised Host; Malaria, Falciparum; Mefloquine; Pregnancy; Pregnancy Complications, Infectious | 1992 |
181 trial(s) available for mefloquine and Malaria, Falciparum
| Article | Year |
|---|---|
Counter-Selection of Antimalarial Resistance Polymorphisms by Intermittent Preventive Treatment in Pregnancy.
Topics: Adult; Antimalarials; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Infant, Newborn; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Polymorphism, Genetic; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Real-Time Polymerase Chain Reaction; Sulfadoxine | 2020 |
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
Topics: Adolescent; Adult; Amodiaquine; Anthraquinones; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Treatment Outcome; Young Adult | 2020 |
A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Mefloquine; Myanmar; Pregnancy; Premature Birth; Quinolines; Thailand | 2021 |
Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.
Topics: Administration, Oral; Antimalarials; Artemether, Lumefantrine Drug Combination; Child; Child, Preschool; Female; Heterocyclic Compounds, 1-Ring; Humans; Kenya; Malaria, Falciparum; Male; Mefloquine; Peroxides; Plasmodium falciparum; Quinolines; Spiro Compounds; Treatment Outcome | 2021 |
Changing Antimalarial Drug Sensitivities in Uganda.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Aspartic Acid Endopeptidases; Child; Child, Preschool; Chloroquine; Drug Resistance; Ethanolamines; Female; Fluorenes; Gene Expression; Humans; Infant; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Quinolines; Uganda; Young Adult | 2017 |
Efficacy of two artemisinin-based combinations for the treatment of malaria in pregnancy in India: a randomized controlled trial.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; Incidence; India; Intention to Treat Analysis; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2018 |
Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children.
Topics: Antimalarials; Artesunate; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Infant; Kenya; Malaria, Falciparum; Male; Mefloquine; Prospective Studies; Recurrence | 2019 |
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Cambodia; Drug Resistance, Multiple; Drug Therapy, Combination; Female; High-Throughput Nucleotide Sequencing; Humans; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Mutation; Plasmodium falciparum; Prospective Studies; Protozoan Proteins; Quinolines; Thailand; Treatment Failure; Vietnam; Young Adult | 2019 |
Safety, efficacy and population pharmacokinetics of fixed-dose combination of artesunate-mefloquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in India.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Demography; Drug Therapy, Combination; Endemic Diseases; Female; Humans; India; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Plasmodium falciparum; Treatment Outcome; Young Adult | 2013 |
Population pharmacokinetics of mefloquine, administered as a fixed-dose combination of artesunate-mefloquine in Indian patients for the treatment of acute uncomplicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; India; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Treatment Outcome; Young Adult | 2014 |
Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Burkina Faso; Drug Combinations; Female; Humans; Malaria, Falciparum; Mefloquine; Plasma; Pregnancy; Pregnancy Complications, Infectious; Young Adult | 2014 |
Population pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplicated Plasmodium falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Cross-Over Studies; Female; Healthy Volunteers; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Monte Carlo Method; Plasma; Young Adult | 2015 |
Sporozoite immunization of human volunteers under mefloquine prophylaxis is safe, immunogenic and protective: a double-blind randomized controlled clinical trial.
Topics: Adolescent; Adult; Antibodies; Antimalarials; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chloroquine; DNA, Protozoan; Double-Blind Method; Erythrocytes; Granzymes; Healthy Volunteers; Humans; Immunity, Cellular; Lysosomal-Associated Membrane Protein 1; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Sporozoites; Young Adult | 2014 |
Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Azithromycin; Chloroquine; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Treatment Outcome; Uganda; Young Adult; Zambia | 2014 |
Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment.
Topics: Adolescent; Adult; Antigens, Bacterial; Antigens, Surface; Antimalarials; Artemisinins; Cambodia; Child; Child, Preschool; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinolines; Treatment Failure; Young Adult | 2015 |
Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries.
Topics: Adolescent; Adult; Africa; Aminoquinolines; Antimalarials; Chemoprevention; Double-Blind Method; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Placebos; Treatment Outcome; Young Adult | 2015 |
Linking Murine and Human Plasmodium falciparum Challenge Models in a Translational Path for Antimalarial Drug Development.
Topics: Adult; Animals; Antimalarials; Cohort Studies; Disease Models, Animal; Drug Administration Schedule; Drug Dosage Calculations; Erythrocytes; Female; Healthy Volunteers; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Mefloquine; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Plasmodium falciparum | 2016 |
No Clinical or Molecular Evidence of Plasmodium falciparum Resistance to Artesunate-Mefloquine in Northwestern Brazil.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Brazil; Child; Child, Preschool; DNA, Protozoan; Dose-Response Relationship, Drug; Drug Combinations; Fever; Follow-Up Studies; Humans; Malaria, Falciparum; Mefloquine; Middle Aged; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Treatment Outcome; Young Adult | 2016 |
Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
Topics: Africa South of the Sahara; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Patient Safety; Polymerase Chain Reaction | 2016 |
Gametocyte clearance in uncomplicated and severe Plasmodium falciparum malaria after artesunate-mefloquine treatment in Thailand.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Germ Cells; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Severity of Illness Index; Thailand; Treatment Outcome | 2008 |
Efficacy of Artequick versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Primaquine; Prospective Studies; Quinolines; Thailand; Treatment Outcome | 2008 |
A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Base Sequence; DNA Primers; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mali; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Treatment Outcome | 2008 |
Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Drug Administration Schedule; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Peru; Plasmodium falciparum; Time Factors; Treatment Outcome; Young Adult | 2009 |
Artemisinin resistance in Plasmodium falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypoxanthine; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Recurrence; Young Adult | 2009 |
The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Asia; Asia, Southeastern; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Nervous System Diseases; Neurologic Examination | 2009 |
Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
Topics: Antimalarials; Dapsone; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Half-Life; Humans; Immunization Schedule; Incidence; Infant; Infant Mortality; Logistic Models; Malaria, Falciparum; Male; Mefloquine; Multivariate Analysis; Proguanil; Pyrimethamine; Safety; Sulfadoxine; Tanzania; Treatment Outcome | 2009 |
Therapeutic efficacy and effects of artesunate-mefloquine and mefloquine alone on malaria-associated anemia in children with uncomplicated Plasmodium falciparum malaria in southwest Nigeria.
Topics: Anemia; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Hematocrit; Humans; Infant; Malaria, Falciparum; Mefloquine; Nigeria; Treatment Failure | 2009 |
[Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects on gametocytic development].
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Drug Resistance; Drug Therapy, Combination; Female; Fever; Germ Cells; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Patient Compliance; Pilot Projects; Plasmodium falciparum; Primaquine; Treatment Outcome; Young Adult | 2009 |
Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial.
Topics: Abdominal Pain; Animals; Anthelmintics; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Female; Humans; Incidence; Malaria, Falciparum; Male; Mefloquine; Parasite Egg Count; Plasmodium falciparum; Praziquantel; Schistosoma haematobium; Schistosomiasis haematobia; Treatment Outcome | 2010 |
Efficacy and safety of a new pediatric artesunate-mefloquine drug formulation for the treatment of uncomplicated falciparum malaria in Gabon.
Topics: Administration, Oral; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Developing Countries; Drug Combinations; Female; Gabon; Humans; Malaria, Falciparum; Male; Mefloquine | 2010 |
Tolerability and efficacy of a pediatric granule formulation of artesunate-mefloquine in young children from Cameroon with uncomplicated falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Cameroon; Child; Child, Preschool; Dosage Forms; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine | 2010 |
New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Drug Resistance, Multiple; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Treatment Outcome; Young Adult | 2010 |
Intravenous ibuprofen (IV-ibuprofen) controls fever effectively in adults with acute uncomplicated Plasmodium falciparum malaria but prolongs parasitemia.
Topics: Acute Disease; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Double-Blind Method; Drug Therapy, Combination; Fever; Humans; Ibuprofen; Injections, Intravenous; Malaria, Falciparum; Mefloquine; Parasitemia; Plasmodium falciparum; Treatment Outcome | 2010 |
Use of area under the curve to evaluate the effects of antimalarial drugs on malaria-associated anemia after treatment.
Topics: Amodiaquine; Anemia; Antimalarials; Area Under Curve; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Hematocrit; Humans; Infant; Malaria; Malaria, Falciparum; Male; Mefloquine; Nigeria; Plasmodium falciparum | 2011 |
An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Quinolines; Young Adult | 2010 |
Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Myanmar; Plasmodium falciparum; Primaquine; Treatment Outcome; Young Adult | 2010 |
Artesunate-mefloquine combination therapy in acute Plasmodium falciparum malaria in young children: a field study regarding neurological and neuropsychiatric safety.
Topics: Africa; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Mental Disorders; Nervous System Diseases; Plasmodium falciparum | 2010 |
A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Laos; Malaria, Falciparum; Male; Mefloquine; Quinolines; Young Adult | 2010 |
Artesunate/mefloquine paediatric formulation vs. artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum in Anonkoua kouté, Côte d'Ivoire.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Epidemiologic Methods; Ethanolamines; Female; Fever; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Treatment Outcome | 2011 |
Effect of artesunate and mefloquine in combination on the Fridericia corrected QT intervals in Plasmodium falciparum infected adults from Thailand.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Electrocardiography; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Torsades de Pointes; Young Adult | 2011 |
Plasmodium falciparum infection during suppressive prophylaxis with mefloquine does not induce an antibody response to merozoite surface protein-1(42).
Topics: Adult; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Cohort Studies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Protozoan Proteins | 2011 |
Randomized, prospective, three-arm study to confirm the auditory safety and efficacy of artemether-lumefantrine in Colombian patients with uncomplicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Audiometry; Child; Colombia; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Evoked Potentials, Auditory, Brain Stem; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Proguanil; Prospective Studies; Treatment Outcome; Young Adult | 2012 |
Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Colombia; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Germ Cells; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Primaquine; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2012 |
Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Biomarkers; Calcium-Transporting ATPases; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; India; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2012 |
Pyronaridine-artesunate versus mefloquine plus artesunate for malaria.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Drug Combinations; Drug Resistance; Female; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Naphthyridines; Proportional Hazards Models; Young Adult | 2012 |
Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Asia; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; India; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Quinolines; Treatment Outcome; Young Adult | 2012 |
Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Cambodia; Drug Resistance; Female; Genotype; Glucosephosphate Dehydrogenase; Humans; Malaria, Falciparum; Male; Mefloquine; Microsatellite Repeats; Plasmodium falciparum; Treatment Outcome; Young Adult | 2012 |
Efficacy and tolerability of a new formulation of artesunate-mefloquine for the treatment of uncomplicated malaria in adult in Senegal: open randomized trial.
Topics: Adolescent; Adult; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Base Sequence; Chemistry, Pharmaceutical; DNA, Protozoan; Drug Combinations; Female; Genes, Protozoan; Humans; Malaria, Falciparum; Male; Mefloquine; Merozoite Surface Protein 1; Parasite Load; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Senegal; Treatment Outcome; Young Adult | 2012 |
Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Drug Interactions; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Middle Aged; Models, Biological; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship | 2002 |
Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Central Nervous System Diseases; Child; Double-Blind Method; Drug Administration Schedule; Drug Packaging; Drug Resistance; Drug Therapy, Combination; Female; Fever; Humans; Malaria, Falciparum; Male; Mefloquine; Nausea; Plasmodium falciparum; Sesquiterpenes; Thailand; Treatment Outcome | 2002 |
Lack of prediction of mefloquine and mefloquine-artesunate treatment outcome by mutations in the Plasmodium falciparum multidrug resistance 1 (pfmdr1) gene for P. falciparum malaria in Peru.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; ATP-Binding Cassette Transporters; Base Sequence; Cohort Studies; DNA, Protozoan; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Molecular Sequence Data; Mutation; Peru; Plasmodium falciparum; Predictive Value of Tests; Protozoan Proteins; Sequence Alignment; Sesquiterpenes | 2003 |
Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Peru; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2003 |
A comparative clinical trial of combinations of dihydroartemisinin plus azithromycin and dihydroartemisinin plus mefloquine for treatment of multidrug resistant falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Azithromycin; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Statistics, Nonparametric; Thailand | 2002 |
An open randomized clinical trial of Artecom vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Quinolines; Sesquiterpenes; Thailand; Trimethoprim | 2002 |
Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Peru; Recurrence; Sesquiterpenes; Treatment Outcome; Vomiting | 2003 |
The efficacy of combined mefloquine-artesunate versus mefloquine-primaquine on subsequent development of Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Carrier State; Child; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Plasmodium falciparum; Primaquine; Secondary Prevention; Sesquiterpenes | 2003 |
[Efficacy and tolerance of mefloquine in the treatment of infants and children with Plasmodium falciparum malaria].
Topics: Adolescent; Antimalarials; Body Weight; Child; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Treatment Outcome | 2003 |
Malaria in a cohort of Javanese migrants to Indonesian Papua.
Topics: Adolescent; Adult; Antimalarials; Child; Chloroquine; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Incidence; Indonesia; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Papua New Guinea; Parasitemia; Prevalence; Transients and Migrants | 2003 |
[A randomized comparative study of naphtoquine, mefloquine and artsunate in the treatment of falciparum malaria].
Topics: Adolescent; Adult; Aminoquinolines; Antimalarials; Artemisinins; Artesunate; Child; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes | 2003 |
Randomised efficacy and safety study of two 3-day artesunate rectal capsule/mefloquine regimens versus artesunate alone for uncomplicated malaria in Ecuadorian children.
Topics: Administration, Rectal; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Ecuador; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2003 |
Optimising operational use of artesunate-mefloquine: a randomised comparison of four treatment regimens.
Topics: Adolescent; Adult; Aged; Anemia; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Female; Hemoglobins; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Rural Health; Sesquiterpenes | 2004 |
Efficacy of mefloquine and mefloquine-artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon region of Bolivia.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Bolivia; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Sesquiterpenes; Treatment Outcome | 2004 |
Monitoring the therapeutic efficacy of antimalarials against uncomplicated falciparum malaria in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Primaquine; Sesquiterpenes; Statistics, Nonparametric; Thailand; Treatment Outcome | 2003 |
Six-years monitoring the efficacy of the combination of artesunate and mefloquine for the treatment of uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Thailand | 2003 |
Artesunate with mefloquine at various intervals for non-severe Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome; Vietnam | 2004 |
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Laos; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2004 |
Mefloquine in the treatment of falciparum malaria during pregnancy in Eastern Sudan.
Topics: Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Risk Assessment; Sudan; Treatment Outcome | 2004 |
Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinolines; Sesquiterpenes; Thailand | 2004 |
Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Biological Availability; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Korea; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Sesquiterpenes; Treatment Outcome | 2004 |
Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Treatment Failure | 2004 |
Mefloquine versus quinine plus sulphalene-pyrimethamine (metakelfin) for treatment of uncomplicated imported falciparum malaria acquired in Africa.
Topics: Adult; Africa; Antimalarials; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Endpoint Determination; Female; Follow-Up Studies; Humans; Italy; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Prospective Studies; Pyrimethamine; Quinine; Sulfalene | 2005 |
Efficacies of mefloquine alone and of artesunate followed by mefloquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Topics: Administration, Oral; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Genotype; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Plasmodium falciparum; Sesquiterpenes; Sudan; Treatment Outcome | 2005 |
[Mefloquine versus halofantrine in children suffering from acute uncomplicated falciparum malaria].
Topics: Adolescent; Antimalarials; Child; Child, Preschool; Female; Humans; Infant; Long QT Syndrome; Malaria, Falciparum; Male; Mefloquine; Phenanthrenes; Treatment Outcome | 2005 |
Pharmacokinetics of the four combination regimens of dihydroartemisinin/mefloquine in acute uncomplicated falciparum malaria.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Sesquiterpenes | 2005 |
A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinolines; Sesquiterpenes | 2005 |
Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Artesunate; Bangladesh; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Time Factors; Treatment Outcome | 2005 |
Life-saving rectal artesunate for complicated malaria in children.
Topics: Administration, Rectal; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child Welfare; Child, Preschool; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Malaria, Cerebral; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Suppositories; Thailand; Treatment Outcome | 2005 |
A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Thailand | 2005 |
Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon.
Topics: Adolescent; Animals; Antimalarials; ATP-Binding Cassette Transporters; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Resistance; Gabon; Genes, MDR; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2005 |
A randomized trial comparing the efficacy of four treatment regimens for uncomplicated falciparum malaria in Assam state, India.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; India; Infant; Malaria, Falciparum; Male; Mefloquine; Prospective Studies; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2006 |
An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Quinolines; Sesquiterpenes; Thailand; Treatment Outcome | 2005 |
Predictors of the failure of treatment with pyrimethamine-sulfadoxine in children with uncomplicated falciparum malaria.
Topics: Aging; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Nigeria; Predictive Value of Tests; Pyrimethamine; Risk Factors; Sulfadoxine; Time Factors; Treatment Failure | 2006 |
Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia.
Topics: Adult; Antimalarials; Child; Chloroquine; Drug Resistance; Humans; Indonesia; Japan; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Treatment Outcome | 2006 |
Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Myanmar; Plasmodium falciparum; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome | 2006 |
Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2006 |
[Coartem and fansimef in the treatment of falciparum malaria].
Topics: Abdominal Pain; Adolescent; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fever; Fluorenes; Humans; Malaria, Falciparum; Male; Mali; Mefloquine; Nausea; Pyrimethamine; Skin; Sulfadoxine; Time Factors; Treatment Outcome | 2006 |
Efficacy and safety of an artesunate/mefloquine combination, (artequin) in the treatment of uncomplicated P. falciparum malaria in Kenya.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kenya; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Remission Induction; Sesquiterpenes | 2006 |
An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos).
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Female; Humans; Laos; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Quinolines; Recurrence; Sesquiterpenes; Treatment Failure; Treatment Outcome | 2006 |
An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Quality Control; Sesquiterpenes; Tablets; Thailand; Treatment Outcome | 2006 |
Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.
Topics: Acute Disease; Adolescent; Adult; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Dietary Supplements; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Sesquiterpenes; Treatment Failure; Treatment Outcome | 2006 |
Mefloquine treatment for uncomplicated falciparum malaria in young children 6-24 months of age in northern Ghana.
Topics: Animals; Antimalarials; Child, Preschool; Cohort Studies; Diarrhea; Female; Ghana; Humans; Infant; Linear Models; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Plasmodium falciparum; Prospective Studies; Vomiting | 2007 |
A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia.
Topics: Adolescent; Adult; Aged; Anemia; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Therapy, Combination; Female; Genome, Protozoan; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome | 2007 |
Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.
Topics: Adolescent; Adult; Aged; Animals; Artemisinins; Artesunate; Cambodia; Child; Drug Resistance; Female; Genotype; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Recurrence; Sesquiterpenes; Thailand | 2007 |
Comparative study of the effectiveness and pharmacokinetics of two rectal artesunate/oral mefloquine combination regimens for the treatment of uncomplicated childhood falciparum malaria.
Topics: Administration, Oral; Administration, Rectal; Adolescent; Antimalarials; Artemisinins; Artesunate; Body Weight; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes; Single-Blind Method; Treatment Outcome | 2007 |
Pharmacokinetics of mefloquine with dihydroartemisinin as 2-day regimens in patients with uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Drug Administration Schedule; Drug Therapy, Combination; Humans; Interviews as Topic; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2007 |
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Infant; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Senegal; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Dramatically decreased therapeutic efficacy of chloroquine and sulfadoxine-pyrimethamine, but not mefloquine, in southern Benin.
Topics: Administration, Oral; Animals; Antigens, Protozoan; Antimalarials; Benin; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Merozoite Surface Protein 1; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2007 |
Clinical efficacy of high dose monotherapy of oral dihydroartemisinin in uncomplicated falciparum malaria in viet nam.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome; Vietnam | 2007 |
Pharmacokinetics of two paediatric artesunate mefloquine drug formulations in the treatment of uncomplicated falciparum malaria in Gabon.
Topics: Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Gabon; Humans; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes; Tablets | 2007 |
A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Peru; Quinolines; Sesquiterpenes | 2007 |
Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Quinine; Sesquiterpenes; Time Factors; Treatment Outcome | 1995 |
Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil.
Topics: Adolescent; Child; Chloroquine; Doxycycline; Drug Administration Schedule; Humans; Kenya; Malaria, Falciparum; Mefloquine; Primaquine; Proguanil | 1995 |
Comparison of capillary whole blood, venous whole blood, and plasma concentrations of mefloquine, halofantrine, and desbutyl-halofantrine measured by high-performance liquid chromatography.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chromatography, High Pressure Liquid; Humans; Linear Models; Malaria, Falciparum; Mefloquine; Middle Aged; Phenanthrenes; Reproducibility of Results | 1994 |
[The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinine].
Topics: Animals; Anopheles; Antimalarials; Artemisinins; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes | 1994 |
Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Follow-Up Studies; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Plasmodium falciparum; Recurrence; Sesquiterpenes; Thailand; Time Factors | 1994 |
Prevention of Plasmodium falciparum malaria by Fansimef and Lariam in the northeastern part of Thailand.
Topics: Adult; Animals; Antibodies, Protozoan; Blood; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Male; Mefloquine; Military Personnel; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Thailand | 1993 |
Randomised trial of mefloquine-tetracycline and quinine-tetracycline for acute uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Aged; Animals; Drug Administration Schedule; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinine; Tetracycline | 1994 |
Randomized trial of mefloquine-doxycycline, and artesunate-doxycycline for treatment of acute uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Doxycycline; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Recurrence; Sesquiterpenes | 1994 |
Artemisinin: large community studies.
Topics: Administration, Oral; Antimalarials; Antiprotozoal Agents; Artemether; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Prospective Studies; Sesquiterpenes; Suppositories | 1994 |
Randomized trial of mefloquine alone and artesunate followed by mefloquine for the treatment of acute uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes | 1994 |
Long-term malaria prophylaxis with weekly mefloquine.
Topics: Africa, Western; Chloroquine; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Humans; Long-Term Care; Malaria, Falciparum; Mefloquine; Proguanil | 1993 |
Mefloquine or doxycycline prophylaxis in US troops in Somalia.
Topics: Animals; Chloroquine; Doxycycline; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Military Personnel; Patient Compliance; Plasmodium falciparum; Premedication; Somalia; United States | 1993 |
Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Drug Resistance; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Phenanthrenes; Plasmodium falciparum; Prospective Studies; Recurrence; Refugees; Thailand; Treatment Failure | 1993 |
Cardiac effects of antimalarial treatment with halofantrine.
Topics: Adolescent; Adult; Antimalarials; Electrocardiography; Female; Heart; Humans; Malaria, Falciparum; Male; Mefloquine; Phenanthrenes; Prospective Studies | 1993 |
Efficacy and tolerance of extended-dose halofantrine for drug-resistant falciparum malaria in Thailand.
Topics: Adult; Animals; Chi-Square Distribution; Diarrhea; Dizziness; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Tetracycline; Thailand; Vomiting | 1994 |
Falciparum malaria in eastern Thailand: a randomized trial of the efficacy of a single dose of mefloquine.
Topics: Adult; Animals; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Thailand; Treatment Failure | 1994 |
Pharmacokinetics of mefloquine alone or in combination with artesunate.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes | 1994 |
Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study.
Topics: Adult; Anemia; Double-Blind Method; Drug Resistance; Female; Follow-Up Studies; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Myanmar; Outcome Assessment, Health Care; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Thailand | 1994 |
Predictors of treatment failure in multiple drug-resistant falciparum malaria: results from a 42-day follow-up of 224 patients in eastern Thailand.
Topics: Adolescent; Adult; Child; Cohort Studies; Diarrhea; Drug Resistance; Female; Follow-Up Studies; Hemoglobins; Humans; Malaria, Falciparum; Male; Mefloquine; Prognosis; Proportional Hazards Models; Risk Factors; Survival Analysis; Thailand; Treatment Outcome; Vomiting | 1993 |
Comparison of two mefloquine regimens for treatment of Plasmodium falciparum malaria on the northeastern Thai-Cambodian border.
Topics: Adolescent; Adult; Cambodia; Child; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Prospective Studies; Recurrence; Refugees; Thailand | 1993 |
Comparative tolerability and kinetics during long-term intake of Lariam and Fansidar for malaria prophylaxis in nonimmune volunteers.
Topics: Adult; Antimalarials; Double-Blind Method; Drug Combinations; Half-Life; Humans; Linear Models; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Patient Dropouts; Pyrimethamine; Sulfadoxine | 1993 |
Tolerability of prophylactic Lariam regimens.
Topics: Adult; Anorexia; Chloroquine; Depression; Dizziness; Double-Blind Method; Dreams; Drug Tolerance; Eye; Humans; Irritable Mood; Malaria, Falciparum; Male; Mefloquine; Military Personnel; Nausea; Psychomotor Performance; Sleep; Sleep Initiation and Maintenance Disorders; Travel; United States | 1993 |
Mefloquine monitoring in acute uncomplicated malaria treated with Fansimef and Lariam.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Drug Combinations; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine | 1993 |
Clinical trials with halofantrine in acute uncomplicated falciparum malaria in Thailand.
Topics: Adolescent; Adult; Antimalarials; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Phenanthrenes; Thailand | 1993 |
Recent military experience with malaria chemoprophylaxis.
Topics: Antimalarials; Australia; Chloroquine; Dapsone; Doxycycline; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Military Personnel; Primaquine; Pyrimethamine | 1993 |
Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drugs, Chinese Herbal; Erythrocytes; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Recurrence; Sesquiterpenes; Tanzania | 1995 |
Comparative clinical trial of artesunate followed by mefloquine in the treatment of acute uncomplicated falciparum malaria: two- and three-day regimens.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes | 1996 |
In vivo study of the response of Plasmodium falciparum to standard mefloquine/sulfadoxine/pyrimethamine (MSP) treatment among gem miners returning from Cambodia.
Topics: Adult; Animals; Antimalarials; Cambodia; Chi-Square Distribution; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Mining; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Thailand; Transients and Migrants | 1995 |
Long-term malaria chemoprophylaxis with mefloquine in Dutch marines in Cambodia.
Topics: Adolescent; Adult; Animals; Antimalarials; Cambodia; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Military Personnel; Netherlands | 1996 |
Comparability of treatment groups and risk factors for parasitemia at the first antenatal clinic visit in a study of malaria treatment and prevention in pregnancy in rural Malawi.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Female; Humans; Malaria, Falciparum; Malawi; Mefloquine; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Prospective Studies; Risk Factors; Rural Population; Seasons | 1996 |
Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Female; Fetal Blood; Humans; Malaria, Falciparum; Malawi; Mefloquine; Obstetric Labor Complications; Parasitemia; Placenta Diseases; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Rural Population; Treatment Outcome | 1996 |
Objectives and methodology in a study of malaria treatment and prevention in pregnancy in rural Malawi: The Mangochi Malaria Research Project.
Topics: Antimalarials; Chloroquine; Female; Fetal Death; Follow-Up Studies; Humans; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Longitudinal Studies; Malaria, Falciparum; Malawi; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Research Design; Rural Population; Surveys and Questionnaires; Treatment Outcome | 1996 |
Stereoselective pharmacokinetics of mefloquine in young children.
Topics: Antimalarials; Area Under Curve; Half-Life; Humans; Infant; Malaria, Falciparum; Mefloquine; Stereoisomerism; Thailand | 1996 |
Open comparison of artemether and mefloquine in uncomplicated Plasmodium falciparum hyperparasitaemia in children.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Erythrocytes; Female; Follow-Up Studies; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Plasmodium falciparum; Retrospective Studies; Sesquiterpenes | 1996 |
Clinical efficacy and pharmacokinetics of artemisinin monotherapy and in combination with mefloquine in patients with falciparum malaria.
Topics: Administration, Oral; Adult; Animals; Antimalarials; Artemisinins; Drug Therapy, Combination; Female; Half-Life; Humans; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes | 1996 |
Pharmacokinetics of mefloquine, when given alone and in combination with artemether, in patients with uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Biological Availability; Drug Interactions; Humans; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes | 1995 |
A comparative clinical trial of artemether and the sequential regimen of artemether-mefloquine in multidrug resistant falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes | 1995 |
Pharmacokinetics of mefloquine when given as a single and two divided-dose regimens.
Topics: Adolescent; Adult; Antimalarials; Area Under Curve; Biological Availability; Half-Life; Humans; Malaria, Falciparum; Male; Mefloquine; Metabolic Clearance Rate; Middle Aged | 1995 |
Arteflene compared with mefloquine for treating Plasmodium falciparum malaria in children.
Topics: Adolescent; Antimalarials; Artemisinins; Bridged Bicyclo Compounds, Heterocyclic; Child; Humans; Malaria, Falciparum; Mefloquine; Styrenes | 1996 |
Post-malaria neurological syndrome.
Topics: Adolescent; Adult; Antimalarials; Child; Female; Humans; Incidence; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Nervous System Diseases; Prospective Studies; Risk Factors; Syndrome; Vietnam | 1996 |
Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Child; Child, Preschool; Dizziness; Drug Resistance, Multiple; Female; Gastrointestinal Diseases; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Prospective Studies; Sleep Wake Disorders | 1995 |
Mefloquine in infants and young children.
Topics: Administration, Oral; Adult; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Prospective Studies; Random Allocation; Vomiting | 1996 |
Sensitivity of Plasmodium falciparum to reduced dose of mefloquine in pregnant women in Nigeria.
Topics: Animals; Antimalarials; Female; Humans; Malaria, Falciparum; Mefloquine; Nigeria; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic | 1996 |
Supportive pentoxifylline in falciparum malaria: no effect on tumor necrosis factor alpha levels or clinical outcome: a prospective, randomized, placebo-controlled study.
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Antimalarials; Biopterins; Drug Therapy, Combination; Female; Humans; L-Lactate Dehydrogenase; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Neopterin; Parasitemia; Pentoxifylline; Phenanthrenes; Phosphodiesterase Inhibitors; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Tumor Necrosis Factor-alpha | 1997 |
Responses of multidrug-resistant Plasmodium falciparum parasites to mefloquine in Nigerian children.
Topics: Animals; Anti-Infective Agents; Antimalarials; Child; Child, Preschool; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Microbial Sensitivity Tests; Nigeria; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1997 |
Compliance with a 2 day course of artemether-mefloquine in an area of highly multi-drug resistant Plasmodium falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Patient Compliance; Plasmodium falciparum; Sesquiterpenes; Thailand; Treatment Outcome | 1997 |
Open randomized trial of oral artemether alone and a sequential combination with mefloquine for acute uncomplicated falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes | 1997 |
Clearance of young parasite forms following treatment of falciparum malaria in humans: comparison of three simple mathematical models.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Drug Therapy, Combination; Humans; Kinetics; Lactones; Linear Models; Malaria, Falciparum; Mefloquine; Middle Aged; Models, Biological; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 1997 |
Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Double-Blind Method; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Prospective Studies; Sesquiterpenes; Treatment Outcome | 1998 |
Comparative clinical trial of artesunate suppositories and oral artesunate in combination with mefloquine in the treatment of children with acute falciparum malaria.
Topics: Administration, Oral; Antimalarials; Artemisinins; Artesunate; Child; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Pilot Projects; Recurrence; Sesquiterpenes; Suppositories; Thailand | 1998 |
A comparative study of artesunate and artemether in combination with mefloquine on multidrug resistant falciparum malaria in eastern Thailand.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Thailand; Treatment Outcome | 1997 |
Malaria chemotherapy trial at a minimal effective dose of mefloquine/sulfadoxine/pyrimethamine compared with equivalent doses of sulfadoxine/pyrimethamine or mefloquine alone.
Topics: Adolescent; Antimalarials; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sulfadoxine | 1998 |
Two doses of artemether/mefloquine or artesunate/mefloquine combination for multidrug resistant falciparum Malaria.
Topics: Acute Disease; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Thailand; Treatment Outcome | 1997 |
Influence of blister packaging on the efficacy of artesunate + mefloquine over artesunate alone in community-based treatment of non-severe falciparum malaria in Myanmar.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Double-Blind Method; Drug Packaging; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Patient Compliance; Sesquiterpenes | 1998 |
Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes | 1999 |
A randomized, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Double-Blind Method; Drug Administration Schedule; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Outcome Assessment, Health Care; Sesquiterpenes; Treatment Failure | 1999 |
Response of falciparum malaria to different antimalarials in Myanmar.
Topics: Adolescent; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Mefloquine; Myanmar; Pyrimethamine; Sulfadoxine | 1999 |
Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Atovaquone; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Naphthoquinones; Proguanil; Thailand; Treatment Outcome | 1999 |
Low-dose treatment with sulfadoxine-pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains.
Topics: Africa; Animals; Antimalarials; Child; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genotype; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Point Mutation; Polymorphism, Genetic; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1999 |
Comparative clinical trial of four regimens of dihydroartemisinin-mefloquine in multidrug-resistant falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes; Treatment Outcome | 1999 |
Pharmacokinetics and bioequivalence evaluation of three commercial tablet formulations of mefloquine when given in combination with dihydroartemisinin in patients with acute uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Biological Availability; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Recurrence; Sesquiterpenes; Tablets; Thailand; Therapeutic Equivalency; Time Factors | 2000 |
A clinical trial of combination of artesunate and mefloquine in the treatment of acute uncomplicated falciparum malaria: a short and practical regimen.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Thailand; Time Factors; Treatment Outcome | 1998 |
Treatment of falciparum malaria in Vietnamese children: the need for combination therapy and optimized dosage regimens.
Topics: Adolescent; Adult; Age Factors; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Linear Models; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Parasitic Sensitivity Tests; Recurrence; Regression Analysis; Sesquiterpenes; Statistics, Nonparametric; Vietnam | 2001 |
Efficacy of dihydroartemisinin-mefloquine on acute uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Child; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Nausea; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome; Vomiting | 2001 |
Efficacy of mefloquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum infection in Machinga District, Malawi, 1998.
Topics: Animals; Antimalarials; Child, Preschool; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Malawi; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2001 |
In vivo-in vitro model for the assessment of clinically relevant antimalarial cross-resistance.
Topics: Adult; Animals; Antimalarials; Artemisinins; Chloroquine; Cross Reactions; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Models, Biological; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Recurrence; Sesquiterpenes | 2001 |
Randomized trial of artesunate and mefloquine in comparison with quinine sulfate to treat P. falciparum malaria pregnant women.
Topics: Adult; Analysis of Variance; Antimalarials; Artemisinins; Artesunate; Female; Gestational Age; Humans; Malaria, Falciparum; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Probability; Prospective Studies; Quinine; Sesquiterpenes; Thailand; Treatment Outcome | 2001 |
Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Double-Blind Method; Drug Combinations; Humans; Incidence; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1992 |
Mefloquine-sulphadoxine-pyrimethamine (Fansimef, Roche) in the prophylaxis of Plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Double-Blind Method; Drug Combinations; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine | 1992 |
Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes | 1992 |
Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Drug Resistance; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Thailand | 1992 |
The effect of artemether plus mefloquine on Myanmar patients with complicated falciparum malaria.
Topics: Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Humans; Malaria, Cerebral; Malaria, Falciparum; Mefloquine; Myanmar; Quinine; Recurrence; Sesquiterpenes; Survival Rate | 1992 |
High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Animals; Child; Child, Preschool; Drug Resistance; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Probability; Recurrence; Sex Factors; Treatment Outcome | 1992 |
Clinical trials of mefloquine with tetracycline.
Topics: Acute Disease; Adolescent; Adult; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Prospective Studies; Pyrimethamine; Sulfadoxine; Tetracycline | 1992 |
Effect of mefloquine on electrocardiographic changes in uncomplicated falciparum malaria patients.
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Bradycardia; Electrocardiography; Heart Rate; Hospitals, Special; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Thailand; Tropical Medicine | 1992 |
Comparative trial on the response of Plasmodium falciparum to halofantrine and mefloquine in Trat Province, eastern Thailand.
Topics: Administration, Oral; Adult; Antimalarials; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Phenanthrenes; Thailand; Treatment Outcome | 1992 |
[Self-medication of 193 travelers in the tropics. Recommendations for clinical counseling of tropical travelers and organization of a tropical travel pharmacy].
Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Nonprescription Drugs; Pharmaceutical Services; Prospective Studies; Pyrimethamine; Self Medication; Sulfadoxine; Travel; Tropical Medicine | 1992 |
Pharmacokinetics of mefloquine in the presence of primaquine.
Topics: Adult; Animals; Diarrhea; Drug Interactions; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Primaquine; Surveys and Questionnaires | 1992 |
Evaluation of the relative efficacy of various antimalarial drugs in Nigerian children under five years of age suffering from acute uncomplicated falciparum malaria.
Topics: Acute Disease; Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Mefloquine; Nigeria; Pyrimethamine; Quinine; Sulfadoxine | 1992 |
Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Animals; Antimalarials; Cambodia; Chloroquine; Confidence Intervals; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine; Survival Analysis; Thailand | 1991 |
369 other study(ies) available for mefloquine and Malaria, Falciparum
| Article | Year |
|---|---|
3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
Topics: Animals; Antimalarials; Drug Resistance; Hep G2 Cells; Humans; Liver; Malaria; Malaria, Falciparum; Mice; Piperidones; Plasmodium berghei; Plasmodium falciparum | 2013 |
Design, synthesis and biological evaluation of 3-[4-(7-chloro-quinolin-4-yl)-piperazin-1-yl]-propionic acid hydrazones as antiprotozoal agents.
Topics: Antiprotozoal Agents; Drug Design; Entamoeba histolytica; Entamoebiasis; Humans; Hydrazones; Malaria, Falciparum; Plasmodium falciparum; Propionates | 2014 |
Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: part 1.
Topics: Animals; Antimalarials; Biological Availability; Drug Design; Drug Resistance; Drug Stability; Gene Library; Half-Life; High-Throughput Screening Assays; Imidazoles; Malaria; Malaria, Falciparum; Mice; Mice, SCID; Parasitic Sensitivity Tests; Plasmodium; Plasmodium berghei; Plasmodium falciparum; Protein Kinase Inhibitors; Protein Kinases; Pyridazines; Rats; Structure-Activity Relationship | 2014 |
A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial Imidazopyridazines.
Topics: Animals; Antimalarials; Ether-A-Go-Go Potassium Channels; Humans; Liver; Malaria; Malaria, Falciparum; Mice; Plasmodium berghei; Plasmodium falciparum; Pyrazoles; Pyridines; Rats; Structure-Activity Relationship | 2015 |
Novel molecule combinations and corresponding hybrids targeting artemisinin-resistant Plasmodium falciparum parasites.
Topics: Antimalarials; Artemisinins; Atovaquone; Dose-Response Relationship, Drug; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship; Triclosan | 2021 |
Discovery and development of 2-aminobenzimidazoles as potent antimalarials.
Topics: Antimalarials; Benzimidazoles; Dose-Response Relationship, Drug; Drug Discovery; HEK293 Cells; Humans; Malaria, Falciparum; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2021 |
Procainamide-SAHA Fused Inhibitors of hHDAC6 Tackle Multidrug-Resistant Malaria Parasites.
Topics: Antimalarials; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Hydroxamic Acids; Malaria, Falciparum; Molecular Structure; Plasmodium falciparum; Procainamide; Structure-Activity Relationship | 2021 |
MEFAS, a hybrid of artesunate-mefloquine active against asexual stages of Plasmodium vivax in field isolates, inhibits malaria transmission.
Topics: Animals; Antimalarials; Artesunate; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Plasmodium falciparum; Plasmodium vivax | 2021 |
Mechanistic basis for multidrug resistance and collateral drug sensitivity conferred to the malaria parasite by polymorphisms in PfMDR1 and PfCRT.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Drug Resistance, Multiple; Lumefantrine; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Parasites; Plasmodium falciparum; Protein Isoforms; Protozoan Proteins | 2022 |
Genome-wide functional screening of drug-resistance genes in Plasmodium falciparum.
Topics: Antimalarials; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Protozoan Proteins | 2022 |
Prevalence and characterization of piperaquine, mefloquine and artemisinin derivatives triple-resistant Plasmodium falciparum in Cambodia.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Prevalence; Quinolines | 2023 |
Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes | 2023 |
Regulated rutin co-administration reverses mitochondrial-mediated apoptosis in Plasmodium berghei-infected mice.
Topics: Animals; Apoptosis; Artemisinins; Artesunate; Drug Therapy, Combination; Malaria, Falciparum; Male; Mefloquine; Mice; Mitochondria; Plasmodium berghei; Rutin | 2020 |
Association of Lipid Levels with Mefloquine and Carboxy-Mefloquine Concentrations in Patients with Uncomplicated Falciparum Malaria.
Topics: Adult; Antimalarials; Artesunate; Biotransformation; Brazil; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Drug Therapy, Combination; Erythrocytes; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Severity of Illness Index; Triglycerides | 2020 |
A Computer Modelling Approach To Evaluate the Accuracy of Microsatellite Markers for Classification of Recurrent Infections during Routine Monitoring of Antimalarial Drug Efficacy.
Topics: Algorithms; Antimalarials; Artemether, Lumefantrine Drug Combination; Artesunate; Computational Biology; Computer Simulation; Data Interpretation, Statistical; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Microsatellite Repeats; Plasmodium falciparum; Reinfection; Treatment Failure | 2020 |
Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Resistance; Endemic Diseases; Humans; Infant; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Mali; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 2020 |
Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate.
Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Mefloquine; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells; Virus Replication | 2020 |
Evidence for linkage of pfmdr1, pfcrt, and pfk13 polymorphisms to lumefantrine and mefloquine susceptibilities in a Plasmodium falciparum cross.
Topics: Antimalarials; Cambodia; Drug Resistance; Ethanolamines; Fluorenes; Ghana; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Protozoan Proteins | 2020 |
Distribution and Temporal Dynamics of Plasmodium falciparum Chloroquine Resistance Transporter Mutations Associated With Piperaquine Resistance in Northern Cambodia.
Topics: Animals; Antimalarials; Biomarkers; Cambodia; Drug Resistance; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Mutation; Piperazines; Plasmodium falciparum; Prevalence; Protozoan Proteins; Quinolines; Real-Time Polymerase Chain Reaction | 2021 |
Atovaquone/Proguanil Resistance in an Imported Malaria Case in Chile.
Topics: Adult; Antimalarials; Artesunate; Atovaquone; Chile; Cytochromes b; Drug Combinations; Drug Resistance; Female; Gene Expression; Humans; Malaria, Falciparum; Male; Mefloquine; Mutation; Nigeria; Parasitemia; Plasmodium falciparum; Proguanil; Protozoan Proteins; Recurrence; Tetrahydrofolate Dehydrogenase; Travel | 2021 |
Association between ABCB1 Polymorphisms and Artesunate-Mefloquine Treatment Responses of Patients with Falciparum Malaria on the Thailand-Myanmar Border.
Topics: Adolescent; Adult; Antimalarials; Artesunate; ATP Binding Cassette Transporter, Subfamily B; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Plasmodium falciparum; Polymorphism, Genetic; Thailand; Young Adult | 2021 |
Arterolane-based combinations for the treatment of uncomplicated falciparum malaria in Kenyan children.
Topics: Antimalarials; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Female; Heterocyclic Compounds, 1-Ring; Humans; Kenya; Malaria, Falciparum; Male; Mefloquine; Peroxides; Plasmodium falciparum; Quinolines; Spiro Compounds | 2021 |
Antibody Responses to
Topics: Adaptive Immunity; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Chloroquine; Cohort Studies; Disease Resistance; Disease Susceptibility; Female; Humans; Immunoglobulin G; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Merozoite Surface Protein 1; Parasitemia; Parturition; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Proportional Hazards Models; Risk; Time Factors | 2017 |
Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia.
Topics: Adult; Antipruritics; Artemisinins; Cambodia; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Phylogeny; Plasmodium falciparum; Protozoan Proteins; Quinolines; Treatment Failure | 2017 |
Cellular mechanisms of action and resistance of Plasmodium falciparum to artemisinin.
Topics: Antimalarials; Antioxidants; Artemisinins; Artesunate; Drug Resistance; Hemeproteins; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Polymorphism, Genetic; Thailand | 2017 |
In vitro anti-malarial interaction and gametocytocidal activity of cryptolepine.
Topics: Alkaloids; Antimalarials; Chloroquine; Ethanolamines; Fluorenes; Gametogenesis; Ghana; Humans; Indole Alkaloids; Life Cycle Stages; Lumefantrine; Malaria; Malaria, Falciparum; Mefloquine; Plant Extracts; Plasmodium falciparum; Quinolines | 2017 |
Topics: Anti-Bacterial Agents; Antimalarials; Artemether; Artemisinins; Atovaquone; Azithromycin; Chloroquine; Doxycycline; Ethanolamines; Fluorenes; Humans; India; Lumefantrine; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 2017 |
Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling.
Topics: Antimalarials; Artemisinins; Asia, Southeastern; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Models, Theoretical; Plasmodium falciparum; Quinolines | 2018 |
Population pharmacokinetics of mefloquine given as a 3-day artesunate-mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai-Myanmar border.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Plasmodium falciparum; Thailand; Young Adult | 2018 |
Gametocyte Carriage, Antimalarial Use, and Drug Resistance in Cambodia, 2008-2014.
Topics: Adult; Antimalarials; Artemisinins; Cambodia; Drug Resistance, Multiple; Female; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Young Adult | 2018 |
Topics: Antimalarials; Artemisinins; Artesunate; Computer Simulation; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Models, Biological; Plasmodium falciparum; Quinolines; Treatment Failure | 2018 |
Absence of
Topics: Antimalarials; Artemether; Artesunate; Brazil; Drug Combinations; Drug Resistance; Epidemiological Monitoring; Gene Expression; Genetic Markers; Genotyping Techniques; Humans; Kelch Repeat; Malaria, Falciparum; Mefloquine; Molecular Epidemiology; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine | 2018 |
The Plasmodium falciparum cytoplasmic translation apparatus: a promising therapeutic target not yet exploited by clinically approved anti-malarials.
Topics: Antimalarials; Cytoplasm; Drug Resistance; Erythrocytes; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Protein Biosynthesis; Protozoan Proteins; Ribosomes | 2018 |
Application of the automated haematology analyzer XN-30 for discovery and development of anti-malarial drugs.
Topics: Antimalarials; Atovaquone; Automation, Laboratory; Chloroquine; Drug Discovery; Hematology; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Schizonts; Trophozoites | 2019 |
Plasmodium falciparum Clearance Is Pitting-Dependent With Artemisinin-Based Drugs but Pitting-Independent With Atovaquone-Proguanil or Mefloquine.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Proguanil; Young Adult | 2019 |
The effect of dose on the antimalarial efficacy of artesunate-mefloquine against
Topics: Antimalarials; Artesunate; Clinical Protocols; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Meta-Analysis as Topic; Research Design; Systematic Reviews as Topic; Treatment Outcome | 2019 |
Improving Methods for Analyzing Antimalarial Drug Efficacy Trials: Molecular Correction Based on Length-Polymorphic Markers
Topics: Algorithms; Antigens, Protozoan; Antimalarials; Artemisinins; Biomarkers; Clinical Trials as Topic; Gene Expression; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Merozoite Surface Protein 1; Models, Statistical; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Quinolines; Time Factors; Treatment Outcome | 2019 |
Modulation of PF10_0355 (MSPDBL2) alters Plasmodium falciparum response to antimalarial drugs.
Topics: Antimalarials; Base Sequence; DNA Copy Number Variations; Drug Resistance; Ethanolamines; Fluorenes; Gene Dosage; Gene Frequency; Genes, Protozoan; Lumefantrine; Malaria, Falciparum; Mefloquine; Mutation; Parasitic Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Sequence Analysis, DNA | 2013 |
High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.
Topics: Amodiaquine; Antimalarials; Artemisinins; Automation, Laboratory; Chloroquine; Drug Resistance; Drug Therapy, Combination; High-Throughput Screening Assays; Internet; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine | 2013 |
The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011.
Topics: Amodiaquine; Antimalarials; Chloroquine; DNA, Protozoan; Drug Resistance; Ethanolamines; Fluorenes; Haplotypes; Humans; Inhibitory Concentration 50; Kenya; Lumefantrine; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Retrospective Studies | 2013 |
Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; DNA, Protozoan; Drug Combinations; Female; Gene Dosage; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Multidrug Resistance-Associated Proteins; Myanmar; Parasitic Sensitivity Tests; Plasmodium falciparum; Thailand; Treatment Outcome; Young Adult | 2013 |
Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Combinations; Female; Genotype; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Recurrence; Treatment Outcome; Young Adult | 2013 |
Evidence for pyronaridine as a highly effective partner drug for treatment of artemisinin-resistant malaria in a rodent model.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Female; Flow Cytometry; Malaria, Falciparum; Mefloquine; Mice; Naphthyridines | 2014 |
Schizontemia as an indicator of severe malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Blood Chemical Analysis; Body Mass Index; Female; Hematologic Tests; Humans; Malaria, Falciparum; Male; Mefloquine; Schizonts; Severity of Illness Index | 2013 |
A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area.
Topics: Aminoquinolines; Antimalarials; Australia; Chemoprevention; Endemic Diseases; Humans; Incidence; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Military Personnel; Retrospective Studies; Timor-Leste; Travel; Treatment Outcome; United States | 2014 |
Imported malaria is stable from Africa but declining from Asia.
Topics: Adolescent; Adult; Africa; Aged; Antimalarials; Asia; Atovaquone; Chemoprevention; Child; Child, Preschool; Chloroquine; Delayed Diagnosis; Denmark; Drug Combinations; Female; Humans; Incidence; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Primaquine; Proguanil; Recurrence; Risk Factors; Severity of Illness Index; Travel; Young Adult | 2014 |
Plasmodium falciparum multidrug resistance protein 1 (pfmrp1) gene and its association with in vitro drug susceptibility of parasite isolates from north-east Myanmar.
Topics: Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Chloroquine; Drug Resistance; Ethanolamines; Fluorenes; Geography; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Mutation; Myanmar; Naphthyridines; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Selection, Genetic; Sequence Analysis, DNA | 2014 |
Bilateral subhyaloid haemorrhage in a conscious patient: a new spectrum of ocular involvement by Plasmodium falciparum.
Topics: Antimalarials; Artemisinins; Artesunate; Eye Hemorrhage; Female; Fundus Oculi; Humans; Malaria, Falciparum; Mefloquine; Patient Positioning; Plasmodium falciparum; Young Adult | 2014 |
Preliminary investigation of the contribution of CYP2A6, CYP2B6, and UGT1A9 polymorphisms on artesunate-mefloquine treatment response in Burmese patients with Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Aryl Hydrocarbon Hydroxylases; Asian People; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Drug Therapy, Combination; Female; Gene Expression; Genotype; Glucuronosyltransferase; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Polymorphism, Genetic; Treatment Outcome; UDP-Glucuronosyltransferase 1A9 | 2014 |
Genetic polymorphisms of candidate markers and in vitro susceptibility of Plasmodium falciparum isolates from Thai-Myanmar border in relation to clinical response to artesunate-mefloquine combination.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Drug Therapy, Combination; Female; Gene Dosage; Haplotypes; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation; Myanmar; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Thailand; Young Adult | 2014 |
Imported malaria in a non-endemic area: the experience of the university of Campinas hospital in the Brazilian Southeast.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anemia; Antimalarials; Artemether; Artemisinins; Brazil; Chloroquine; Comorbidity; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Parasitemia; Primaquine; Recurrence; Retrospective Studies; Tertiary Care Centers; Thrombocytopenia; Travel; Young Adult | 2014 |
Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.
Topics: Adult; Amodiaquine; Antimalarials; Artemisinins; Biological Transport; Child; Chloroquine; Drug Resistance; Erythrocytes; Ethanolamines; Female; Fluorenes; Gene Expression; Haplotypes; Humans; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Quinine; Senegal | 2014 |
Complex polymorphisms in the Plasmodium falciparum multidrug resistance protein 2 gene and its contribution to antimalarial response.
Topics: Amino Acid Sequence; Antimalarials; Artemisinins; Biological Transport; Chloroquine; Chromosomes; Drug Resistance, Multiple; Erythrocytes; Humans; INDEL Mutation; Malaria, Falciparum; Mefloquine; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Quinolines; Thailand | 2014 |
Effects of mefloquine use on Plasmodium vivax multidrug resistance.
Topics: Cambodia; Drug Resistance; French Guiana; Gene Expression Regulation; Humans; Madagascar; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Sudan | 2014 |
Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Cambodia; Chloroquine; Drug Resistance; Female; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Young Adult | 2015 |
How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Drug Resistance; Humans; Immunity, Innate; Malaria, Falciparum; Mefloquine; Models, Statistical; Parasitemia; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Treatment Outcome | 2015 |
In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Resistance; Epidemiological Monitoring; Ethanolamines; Fluorenes; Gene Dosage; Gene Expression; Genotype; Humans; Kenya; Lumefantrine; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins | 2015 |
Mefloquine for malarial prophylaxis in military personnel.
Topics: Antimalarials; Humans; Malaria, Falciparum; Mefloquine; Military Personnel; Psychoses, Substance-Induced; United Kingdom | 2015 |
Characterizing Types of Human Mobility to Inform Differential and Targeted Malaria Elimination Strategies in Northeast Cambodia.
Topics: Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Cambodia; Chloroquine; Disease Eradication; Health Surveys; Humans; Insect Vectors; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Plasmodium falciparum; Plasmodium vivax; Transients and Migrants | 2015 |
Value of mefloquine chemoprophylaxis in military personnel.
Topics: Antimalarials; Humans; Malaria, Falciparum; Mefloquine; Military Personnel | 2015 |
Authors' reply to Green and colleagues.
Topics: Antimalarials; Humans; Malaria, Falciparum; Mefloquine; Military Personnel | 2015 |
Assessment of the Worldwide Antimalarial Resistance Network Standardized Procedure for In Vitro Malaria Drug Sensitivity Testing Using SYBR Green Assay for Field Samples with Various Initial Parasitemia Levels.
Topics: Antimalarials; Artemisinins; Atovaquone; Benzothiazoles; Biological Assay; Chloroquine; Diamines; DNA, Protozoan; Drug Resistance; Erythrocytes; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Organic Chemicals; Parasitemia; Plasmodium falciparum; Public Health Surveillance; Quinolines; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Lead Selection of a New Aminomethylphenol, JPC-3210, for Malaria Treatment and Prevention.
Topics: Animals; Antimalarials; Cell Line; Cricetinae; HEK293 Cells; Hep G2 Cells; Humans; Malaria; Malaria, Falciparum; Mefloquine; Mice; Phenols; Plasmodium falciparum; Pyridines | 2016 |
Transmission-Blocking Potential of MEFAS, a Hybrid Compound Derived from Artesunate and Mefloquine.
Topics: Antimalarials; Artemisinins; Artesunate; Malaria, Falciparum; Mefloquine; Plasmodium falciparum | 2016 |
Back on TRAC: New trial launched in bid to outpace multidrug-resistant malaria.
Topics: Antimalarials; Artemisinins; Asia, Southeastern; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; India; Malaria; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Quinolines | 2016 |
The Community As the Patient in Malaria-Endemic Areas: Preempting Drug Resistance with Multiple First-Line Therapies.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Resistance, Microbial; Drug Therapy, Combination; Endemic Diseases; Health Policy; Humans; Malaria; Malaria, Falciparum; Mefloquine | 2016 |
Rubber workers on the front lines.
Topics: Adolescent; Agricultural Workers' Diseases; Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Combinations; Drug Substitution; Farmers; Hevea; Human Migration; Humans; Malaria, Falciparum; Male; Mefloquine; Mekong Valley; Rubber; Young Adult | 2016 |
Use mefloquine for UK troops only as "last resort," MPs tell Ministry of Defence.
Topics: Antimalarials; Drug Prescriptions; Guideline Adherence; Humans; Malaria, Falciparum; Mefloquine; Military Medicine; Military Personnel | 2016 |
Highly active ozonides selected against drug resistant malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Disease Models, Animal; Female; Humans; Malaria, Falciparum; Mefloquine; Mice; Parasitemia; Plasmodium falciparum | 2016 |
Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors.
Topics: Antimalarials; Artemisinins; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Myanmar; Plasmodium falciparum; Prospective Studies; Thailand | 2016 |
Artesunate-mefloquine: a malaria treatment for African children?
Topics: Antimalarials; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Mefloquine; Treatment Outcome | 2016 |
Genomic Analysis Reveals a Common Breakpoint in Amplifications of the Plasmodium vivax Multidrug Resistance 1 Locus in Thailand.
Topics: Antimalarials; DNA, Protozoan; Drug Resistance, Multiple; Gene Dosage; Genomics; Genotype; Humans; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Thailand | 2016 |
UK troops to continue to receive mefloquine despite concern over adverse events.
Topics: Antimalarials; Humans; Malaria, Falciparum; Mefloquine; Military Personnel; United Kingdom | 2016 |
In vitro sensitivity of antimalarial drugs and correlation with clinico-parasitological response following treatment with a 3-day artesunate-mefloquine combination in patients with falciparum malaria along the Thai-Myanmar border.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Thailand; Young Adult | 2017 |
Association between Polymorphisms in the Pf
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Asparagine; ATP-Binding Cassette Transporters; Chloroquine; Doxycycline; Drug Resistance; Ethanolamines; Fluorenes; Gene Expression; Humans; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Plasmodium falciparum; Polymorphism, Genetic; Protein Isoforms; Protozoan Proteins; Quinine; Quinolines; Repetitive Sequences, Amino Acid; Senegal | 2017 |
Lack of multiple copies of pfmdr1 gene in Papua New Guinea.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Genes, MDR; Genotype; Humans; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Papua New Guinea; Plasmodium falciparum; Polymorphism, Genetic | 2008 |
Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cell Line; Dose-Response Relationship, Drug; Humans; Magnetic Resonance Spectroscopy; Malaria; Malaria, Falciparum; Mefloquine; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum | 2008 |
Molecular surveillance for multidrug-resistant Plasmodium falciparum, Cambodia.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Resistance, Multiple; Female; Gene Dosage; Genes, Protozoan; Humans; Malaria, Falciparum; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Population Surveillance; Protozoan Proteins | 2008 |
Auditory assessment of patients with acute uncomplicated Plasmodium falciparum malaria treated with three-day mefloquine-artesunate on the north-western border of Thailand.
Topics: Acoustic Impedance Tests; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Audiometry; Drug Therapy, Combination; Evoked Potentials, Auditory, Brain Stem; Female; Hearing Loss; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Thailand | 2008 |
In vitro and in vivo properties of ellagic acid in malaria treatment.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Chloroquine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ellagic Acid; Erythrocytes; Female; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Mice; Mice, Inbred Strains; Molecular Structure; Molecular Weight; Parasitemia; Parasitic Sensitivity Tests; Plasmodium; Plasmodium falciparum; Schizonts; Trophozoites | 2009 |
Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Chloroquine; Drug Therapy, Combination; Female; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Survival Analysis; Treatment Failure | 2009 |
Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.
Topics: Adult; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Cambodia; Child; Clinical Trials as Topic; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Gene Dosage; Genetic Variation; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Survival Analysis; Thailand; Treatment Failure | 2009 |
Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness.
Topics: Animals; Antimalarials; Gene Amplification; Gene Dosage; Genotype; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins | 2009 |
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Clinical Trials as Topic; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Retrospective Studies; Thailand; Treatment Outcome | 2009 |
Childhood mefloquine-induced mania and psychosis: a case report.
Topics: Antimalarials; Antipsychotic Agents; Bipolar Disorder; Child; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Mefloquine; Psychoses, Substance-Induced; Risperidone; Treatment Outcome | 2009 |
Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
Topics: Africa; Animals; Antimalarials; Artemisinins; Asia, Southeastern; Clinical Trials as Topic; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorine; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Pregnancy; Quinolines | 2008 |
Evaluation of artemisone combinations in Aotus monkeys infected with Plasmodium falciparum.
Topics: Amodiaquine; Animals; Antimalarials; Aotus trivirgatus; Artemisinins; Drug Therapy, Combination; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Treatment Outcome | 2009 |
Mixed Plasmodium falciparum and Plasmodium vivax malaria in orthotopic liver transplant recipient.
Topics: Adult; Antimalarials; Blood Transfusion; Cadaver; Female; Humans; Liver Cirrhosis; Liver Transplantation; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Tissue Donors; Treatment Outcome | 2009 |
Mefloquine has more adverse effects than other drugs for malaria prophylaxis.
Topics: Antimalarials; Atovaquone; Doxycycline; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Proguanil; Review Literature as Topic; Suicide | 2009 |
Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance; Gene Dosage; Genetic Markers; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Myanmar; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine; Thailand | 2010 |
Effectiveness of malaria chemoprophylaxis against Plasmodium falciparum infection in UK travellers: retrospective observational data.
Topics: Antimalarials; Atovaquone; Chemoprevention; Doxycycline; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Proguanil; Retrospective Studies; Risk Factors; Travel; Treatment Outcome; United Kingdom | 2009 |
Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children.
Topics: Adolescent; Animals; Artemisinins; Artesunate; Blood; Child; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Prospective Studies | 2009 |
[Case report: two imported Plasmodium falciparum cases].
Topics: Antimalarials; Doxycycline; Drug Resistance; Fatal Outcome; Humans; Malaria, Falciparum; Male; Mefloquine; Quinine; Respiratory Distress Syndrome; Young Adult | 2009 |
Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Patient Compliance; Plasmodium falciparum; Thailand; Treatment Outcome; Young Adult | 2010 |
Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; Chloroquine; Drug Resistance, Bacterial; Geographic Information Systems; In Vitro Techniques; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Oligonucleotide Array Sequence Analysis; Plasmodium falciparum; Point Mutation; Polymorphism, Single Nucleotide; Quinine | 2010 |
Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum.
Topics: Alleles; Animals; Antimalarials; Artemisinins; Drug Resistance; Gene Amplification; Gene Dosage; Gene Expression; Genes, Protozoan; Humans; In Vitro Techniques; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; RNA, Messenger; RNA, Protozoan | 2010 |
Plasmodium falciparum malaria and Parvovirus B19; a case of acute co-infection.
Topics: Adult; Anemia; Anti-Inflammatory Agents; Antibodies, Viral; Antimalarials; Blood Transfusion; Humans; Immunoglobulin G; Immunoglobulin M; Malaria, Falciparum; Male; Mefloquine; Parvoviridae Infections; Parvovirus B19, Human; Plasmodium falciparum; Renal Insufficiency; Steroids; Viremia | 2010 |
Multiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in Cambodia.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Resistance; Malaria, Falciparum; Mefloquine; Microsatellite Repeats; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum | 2010 |
Symmetrical peripheral gangrene in childhood falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Child; Female; Gangrene; Humans; Malaria, Falciparum; Mefloquine; Primaquine | 2010 |
Mania associated with mefloquine prophylaxis.
Topics: Adult; Bipolar Disorder; Female; Humans; Malaria, Falciparum; Mefloquine | 2010 |
Letter to the editor of travel medicine and infectious disease.
Topics: Antimalarials; Atovaquone; Chemoprevention; Doxycycline; Drug Combinations; Humans; Malaria, Falciparum; Mefloquine; Proguanil; Travel Medicine | 2010 |
Early diagnosis and treatment of falciparum malaria in Cambodian trauma patients.
Topics: Adolescent; Adult; Analysis of Variance; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Cohort Studies; Early Diagnosis; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitic Sensitivity Tests; Prevalence; Risk Factors; Surgical Wound Infection; Wounds and Injuries | 2009 |
Dynamics of Plasmodium falciparum parasitemia regarding combined treatment regimens for acute uncomplicated malaria, Antioquia, Colombia.
Topics: Administration, Oral; Animals; Antimalarials; Artemisinins; Artesunate; Clinical Protocols; Colombia; Drug Therapy, Combination; Female; Humans; Malaria; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Patient Compliance; Plasmodium falciparum; Primaquine; Treatment Outcome | 2010 |
pfmdr1 amplification associated with clinical resistance to mefloquine in West Africa: implications for efficacy of artemisinin combination therapies.
Topics: Adult; Africa, Western; Artemisinins; Drug Resistance; Drug Therapy, Combination; Gene Dosage; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Treatment Failure | 2010 |
An outbreak of Plasmodium falciparum malaria in U.S. Marines deployed to Liberia.
Topics: Adult; Animals; Antimalarials; Disease Outbreaks; Humans; Insect Repellents; Liberia; Malaria, Falciparum; Male; Mefloquine; Military Personnel; Mosquito Control; Mosquito Nets; Patient Compliance; Plasmodium falciparum; Protective Clothing; United States; Young Adult | 2010 |
Residual antimalarial concentrations before treatment in patients with malaria from Cambodia: indication of drug pressure.
Topics: Adolescent; Adult; Antimalarials; Cambodia; Child; Child, Preschool; Chloroquine; Chromatography, Liquid; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Quinine; Quinolines; Selection, Genetic; Serum; Tandem Mass Spectrometry; Young Adult | 2010 |
Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mass Spectrometry; Mefloquine; Middle Aged; Myanmar; Plasma; Plasmodium falciparum; Thailand; Treatment Failure; Treatment Outcome; Young Adult | 2010 |
Mefloquine adverse effects with atypical facial lesions in an overweight patient.
Topics: Adult; Antimalarials; Blister; Drug Overdose; Female; Humans; Malaria, Falciparum; Mefloquine; Nose; Overweight | 2010 |
Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Gabon; Genotype; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Polymorphism, Genetic; Prevalence; Protozoan Proteins | 2011 |
In vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, quinine, mefloquine and halofantrine in Abidjan (Côte d'Ivoire).
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Child; Child, Preschool; Cote d'Ivoire; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Microbial Sensitivity Tests; Middle Aged; Phenanthrenes; Plasmodium falciparum; Quinine; Young Adult | 2010 |
Identification and functional validation of the novel antimalarial resistance locus PF10_0355 in Plasmodium falciparum.
Topics: Antimalarials; Drug Resistance; Ethanolamines; Fluorenes; Gene Dosage; Gene Expression; Genetic Association Studies; Genetic Loci; Genetic Variation; Genotype; Haplotypes; Linkage Disequilibrium; Lumefantrine; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Polymorphism, Single Nucleotide; Selection, Genetic | 2011 |
Distribution of mefloquine in the blood of Thai patients with acute uncomplicated falciparum malaria following administration of therapeutic doses of artesunate.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Sex Factors; Thailand; Time Factors; Treatment Outcome; Young Adult | 2011 |
Mefloquine for uncomplicated Plasmodium falciparum malaria in children.
Topics: Administration, Oral; Adolescent; Antiemetics; Antimalarials; Child; Child, Preschool; Drug Therapy, Combination; Female; France; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Prospective Studies; Travel; Treatment Outcome; Vomiting | 2011 |
Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance.
Topics: Animals; Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; Base Sequence; Drug Resistance; Ethanolamines; Fluorenes; Gene Frequency; Genotype; Haplotypes; Humans; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins | 2011 |
Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.
Topics: Adult; Antimalarials; Benin; Biomarkers; Chemoprevention; Clinical Trials as Topic; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Gene Dosage; Genotype; Humans; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Mutation, Missense; Plasmodium falciparum; Pregnancy; Pregnancy Complications; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
Polymorphisms of molecular markers of antimalarial drug resistance and relationship with artesunate-mefloquine combination therapy in patients with uncomplicated Plasmodium falciparum malaria in Thailand.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Resistance, Multiple; Drug Therapy, Combination; Genetic Markers; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Polymorphism, Genetic; Thailand | 2011 |
Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Malaria, Cerebral; Malaria, Falciparum; Mefloquine; Mice; Mice, Inbred C57BL; Microscopy; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Quinolines; Secondary Prevention; Survival Rate | 2012 |
Eritrean and Sudanese migrants presenting with malaria in Israel.
Topics: Adult; Antigens, Protozoan; Antimalarials; Chloroquine; Eritrea; Female; Hospitalization; Humans; Israel; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Plasmodium falciparum; Plasmodium vivax; Population Surveillance; Retrospective Studies; Sudan; Transients and Migrants; Treatment Outcome; Young Adult | 2011 |
High dose artesunate in combination with mefloquine: pharmacovigilance in the Venezuelan Amazon.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Diarrhea; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pharmacovigilance; Retrospective Studies; Venezuela; Vomiting; Young Adult | 2012 |
Biased measurement of neuropsychiatric adverse effects of pediatric mefloquine treatment.
Topics: Antimalarials; Female; Humans; Malaria, Falciparum; Male; Mefloquine | 2012 |
Discordant temporal evolution of Pfcrt and Pfmdr1 genotypes and Plasmodium falciparum in vitro drug susceptibility to 4-aminoquinolines after drug policy change in French Guiana.
Topics: Aminoquinolines; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Ethanolamines; Evolution, Molecular; Fluorenes; French Guiana; Gene Dosage; Haplotypes; Humans; Inhibitory Concentration 50; Longitudinal Studies; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Practice Guidelines as Topic; Protozoan Proteins; Quinine | 2012 |
Efficacy of mefloquine treatment and genetic profiles in uncomplicated Plasmodium falciparum malaria in southern Lao PDR.
Topics: Antimalarials; Child; Child, Preschool; Female; Genotype; Humans; Laos; Malaria, Falciparum; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Polymorphism, Genetic | 2011 |
Effect of artesunate-mefloquine fixed-dose combination in malaria transmission in Amazon basin communities.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Brazil; Child; Child, Preschool; Drug Combinations; Female; Hospitalization; Humans; Incidence; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Treatment Outcome; Young Adult | 2012 |
Delayed Plasmodium falciparum clearance following artesunate-mefloquine combination therapy in Thailand, 1997-2007.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Retrospective Studies; Thailand; Time Factors; Treatment Outcome; Young Adult | 2012 |
Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Epidemiological Monitoring; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Thailand; Treatment Outcome; Young Adult | 2012 |
Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development.
Topics: Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Dose-Response Relationship, Drug; Drug Combinations; Drug Discovery; Ethanolamines; Fluorenes; Host-Pathogen Interactions; Humans; Malaria, Falciparum; Mefloquine; Models, Statistical; Plasmodium falciparum; Quinolines | 2012 |
[New combination therapy against malaria].
Topics: Africa; Antimalarials; Artemisinins; Artesunate; Asia; Drug Combinations; Drug Resistance; Global Health; Humans; Malaria, Falciparum; Mefloquine; Naphthyridines | 2012 |
Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Cambodia; Child; Chloroquine; Drug Resistance; Drug Therapy, Combination; Female; Genotype; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Quinolines; Treatment Outcome; Young Adult | 2013 |
[Senegal and malaria. True prophylactic failure of mefloquine].
Topics: Antimalarials; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Senegal; Travel; Treatment Failure | 2002 |
Impact of microscopy error on estimates of protective efficacy in malaria-prevention trials.
Topics: Animals; Antimalarials; Diagnostic Errors; Double-Blind Method; Doxycycline; Humans; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Microscopy; Military Personnel; Plasmodium falciparum; Plasmodium vivax; Polymerase Chain Reaction; Randomized Controlled Trials as Topic; Reference Standards; Sensitivity and Specificity; Treatment Outcome | 2002 |
Anemia in parasite- and recombinant protein-immunized aotus monkeys infected with Plasmodium falciparum.
Topics: Anemia; Animals; Antigens, Protozoan; Antimalarials; Aotus trivirgatus; Carrier Proteins; Erythrocytes; Female; Malaria Vaccines; Malaria, Falciparum; Male; Mefloquine; Parasite Egg Count; Plasmodium falciparum; Protozoan Proteins; Time Factors | 2002 |
Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
Topics: Antimalarials; Clinical Trials as Topic; Developing Countries; Drug Approval; Drug Combinations; Drug Costs; Drug Interactions; Drug Resistance; Ethics, Medical; France; Humans; Malaria, Falciparum; Mefloquine; Naphthoquinones; Phenanthrenes; Proguanil; Quinine; Randomized Controlled Trials as Topic; Travel | 2002 |
[Malaria of native Africans after returning home from European residence].
Topics: Adult; Africa; Antimalarials; Diagnosis, Differential; Europe; Female; Humans; Malaria; Malaria, Falciparum; Male; Mefloquine | 2002 |
The clinical spectrum of severe imported falciparum malaria in the intensive care unit: report of 188 cases in adults.
Topics: Adolescent; Adult; Aged; Antimalarials; Community-Acquired Infections; Comorbidity; Cross Infection; Data Interpretation, Statistical; Exchange Transfusion, Whole Blood; Female; France; Glasgow Coma Scale; Humans; Injections, Intravenous; Intensive Care Units; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Phenanthrenes; Quinine; Retrospective Studies; Travel; World Health Organization | 2003 |
Mefloquine: contraindicated in patients with mood, psychotic or seizure disorders.
Topics: Animals; Antimalarials; Contraindications; Depression; Humans; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Psychoses, Substance-Induced; Seizures | 2002 |
Drug-resistant Plasmodium falciparum infection in immigrants and non-immune travellers.
Topics: Adult; Africa; Animals; Antimalarials; Asia, Southeastern; Chloroquine; Drug Resistance; Emigration and Immigration; Female; Humans; Inhibitory Concentration 50; Kuwait; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Travel | 2002 |
Use of nested PCR for differential diagnosis of falciparum malaria reinfection and relapse in drug-resistant patients.
Topics: Alleles; Animals; Antimalarials; Artemisinins; Artesunate; Diagnosis, Differential; DNA, Protozoan; Drug Resistance, Multiple; Genes, Protozoan; Genetic Markers; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Recurrence; Sesquiterpenes; Time Factors | 2002 |
In vitro activity of chloroquine, quinine, mefloquine and halofantrine against Gabonese isolates of Plasmodium falciparum.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Gabon; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Quinine | 2003 |
Treatment of imported uncomplicated malaria: a medical emergency.
Topics: Antimalarials; Drug Resistance, Microbial; Emergencies; Emergency Medical Services; France; Humans; Malaria, Falciparum; Mefloquine; Quinine | 2003 |
Profile and evolution of the chemosusceptibility of falciparum malaria imported into France in 2000.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; France; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Proguanil; Quinine; Triazines | 2002 |
In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar.
Topics: Animals; Antimalarials; Chloroquine; Drug Evaluation, Preclinical; Drug Resistance; Hospitals, Public; Hospitals, Urban; Humans; Madagascar; Malaria, Falciparum; Mefloquine; Microbial Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Quinine; Rural Health | 2002 |
Drug-resistant malaria in Bangladesh: an in vitro assessment.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Bangladesh; Chloroquine; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Sesquiterpenes | 2003 |
Descriptive study on the efficacy and safety of artesunate suppository in combination with other antimalarials in the treatment of severe malaria in Sudan.
Topics: Administration, Rectal; Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Doxycycline; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sesquiterpenes; Severity of Illness Index; Sudan; Sulfadoxine; Treatment Outcome | 2003 |
Utilisation of malaria prophylaxis: the effect of changes in guidelines in The Netherlands, 1993-1998.
Topics: Antimalarials; Drug Prescriptions; Drug Utilization; Humans; Malaria, Falciparum; Mefloquine; Netherlands; Practice Patterns, Physicians'; Proguanil; Travel | 2003 |
In vitro sensitivity of Plasmodium falciparum to amodiaquine compared with other major antimalarials in Madagascar.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Drug Resistance, Multiple; Humans; Inhibitory Concentration 50; Madagascar; Malaria, Falciparum; Mefloquine; Parasitemia; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; Triazines | 2002 |
Prophylaxis failure due to probable mefloquine resistant P falciparum from Tanzania.
Topics: Adult; Animals; Antimalarials; Drug Resistance; Female; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Plasmodium falciparum; Tanzania; Travel | 2003 |
Ceramide mediates growth inhibition of the Plasmodium falciparum parasite.
Topics: Animals; Antiprotozoal Agents; Apoptosis; Artemisinins; Ceramides; Glutathione; Growth Inhibitors; Lysophospholipids; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Sphingomyelin Phosphodiesterase; Sphingosine | 2003 |
Malaria in Austria 1990-2000.
Topics: Adolescent; Adult; Age Distribution; Animals; Austria; Chemoprevention; Child; Child, Preschool; Chloroquine; Disease Notification; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Patient Compliance; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Proguanil; Pyrimethamine; Sex Distribution; Sulfadoxine | 2003 |
Failure of a chloroquine chemoprophylaxis program to adequately prevent malaria during pregnancy in Koupéla District, Burkina Faso.
Topics: Adolescent; Adult; Animals; Antimalarials; Burkina Faso; Chemoprevention; Chloroquine; Cross-Sectional Studies; Culicidae; Disease Vectors; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Insecticides; Malaria, Falciparum; Mefloquine; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Treatment Outcome | 2003 |
[Malaria--case report].
Topics: Adult; Anti-Infective Agents; Antidiarrheals; Antimalarials; Chloroquine; Ciprofloxacin; Diarrhea; Emergencies; Fluid Therapy; Glasgow Coma Scale; Humans; Loperamide; Malaria, Cerebral; Malaria, Falciparum; Male; Mefloquine; Nigeria; Parasitemia; Positive-Pressure Respiration; Proguanil; Quinine; Respiratory Distress Syndrome; Travel | 2003 |
The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines.
Topics: Aminoquinolines; Animals; Antimalarials; Chloroquine; Disease Models, Animal; Drug Resistance; Drug Therapy, Combination; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Mice; Plasmodium berghei; Plasmodium chabaudi; Plasmodium yoelii; Primaquine; Time Factors | 2003 |
Postmalaria neurological syndrome after treatment of Plasmodium falciparum malaria in the United States.
Topics: Animals; Antimalarials; Female; Humans; Malaria, Cerebral; Malaria, Falciparum; Mefloquine; Middle Aged; Plasmodium falciparum; Psychotic Disorders; Syndrome | 2003 |
Reversal of mefloquine and quinine resistance in Plasmodium falciparum with NP30.
Topics: Animals; Antimalarials; Calcium Channel Blockers; Drug Resistance; Genotype; Humans; Malaria, Falciparum; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Quinine; Surface-Active Agents; Verapamil | 2003 |
Asymptomatic, recrudescent, chloroquine-resistant Plasmodium falciparum infections in Nigerian children: clinical and parasitological characteristics and implications for the transmission of drug-resistant parasites.
Topics: Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Nigeria; Plasmodium falciparum; Prevalence; Pyrimethamine; Recurrence; Statistics as Topic; Sulfadoxine; Treatment Failure | 2003 |
Atovaquone-proguanil for recrudescent Plasmodium falciparum in Vietnam.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Proguanil; Recurrence; Sesquiterpenes; Treatment Failure; Vietnam | 2003 |
Delayed onset of malaria--implications for chemoprophylaxis in travelers.
Topics: Antimalarials; Chloroquine; Drug Resistance; Endemic Diseases; Humans; Israel; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Population Surveillance; Time Factors; Travel; United States | 2003 |
[Mefloquine treatment in infants and children with Plasmodium falciparum malaria: an efficient and well tolerated treatment].
Topics: Adolescent; Animals; Antimalarials; Body Weight; Child; Child, Preschool; Humans; Infant; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Reproducibility of Results; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome; World Health Organization | 2003 |
Diagnosis and treatment of malaria in children.
Topics: Animals; Antimalarials; Atovaquone; Child; Chloroquine; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine | 2003 |
A cost-effectiveness analysis of three antimalarial treatments for acute, uncomplicated Plasmodium falciparum malaria in Mumbai, India.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Combinations; Economics, Pharmaceutical; Ethanolamines; Female; Fluorenes; Hospitalization; Humans; India; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes | 2003 |
Susceptibility of Plasmodium falciparum to the drugs used to treat severe malaria (quinine) and to prevent malaria (mefloquine, cycloguanil) in Comoros Union and Madagascar.
Topics: Animals; Antimalarials; Comoros; Drug Resistance; Humans; In Vitro Techniques; Madagascar; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Proguanil; Quinine; Triazines | 2004 |
[Treatment of uncomplicated Plasmodium falciparum malaria in children: comparison of halofantrine with mefloquine].
Topics: Antimalarials; Child; Humans; Malaria, Falciparum; Mefloquine; Phenanthrenes; Retrospective Studies; Treatment Failure | 2003 |
Malaria during pregnancy in a reference centre from the Brazilian Amazon: unexpected increase in the frequency of Plasmodium falciparum infections.
Topics: Adolescent; Adult; Antimalarials; Brazil; Child; Chloroquine; Cross-Sectional Studies; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Quinine | 2004 |
Defective DNA repair as a potential mechanism for the rapid development of drug resistance in Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; DNA Damage; DNA Repair; Drug Resistance; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Pyrimethamine; Quinine; Sesquiterpenes; Sulfanilamide; Sulfanilamides; Ultraviolet Rays | 2004 |
In vitro susceptibility of Plasmodium falciparum isolates to chloroquine and mefloquine in southeastern Mindanao Island, the Philippines.
Topics: Adolescent; Adult; Animals; Antimalarials; Chloroquine; Drug Resistance, Multiple; Female; Humans; In Vitro Techniques; Malaria, Falciparum; Male; Mefloquine; Parasitic Sensitivity Tests; Philippines; Plasmodium falciparum; Residence Characteristics | 2003 |
Effects of mefloquine usage on genetic polymorphism of Plasmodium falciparum in Thai-Myanmarese border.
Topics: Age Distribution; Animals; Base Sequence; Endemic Diseases; Haplotypes; Humans; Malaria, Falciparum; Mefloquine; Merozoite Surface Protein 1; Molecular Sequence Data; Pharmacogenetics; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Prevalence; Probability; Risk Assessment; Sex Distribution; Thailand; Treatment Outcome | 2003 |
The in-vitro antimalarial activity of ferrochloroquine, measured against Cambodian isolates of Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Sesquiterpenes | 2004 |
Safety of mefloquine in infants with acute falciparum malaria.
Topics: Acute Disease; Antimalarials; Chi-Square Distribution; Child, Preschool; Female; Guyana; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Retrospective Studies; Treatment Outcome | 2004 |
[Acute malaria in an Israeli tourist to Kenya].
Topics: Acidosis; Adult; Chloroquine; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Treatment Outcome | 1999 |
In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Chloroquine; Drug Resistance; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Quinine; Sesquiterpenes; Statistics, Nonparametric | 2005 |
Efficacy of antimalarial chemoprophylaxis among French residents travelling to Africa.
Topics: Adult; Africa South of the Sahara; Africa, Western; Antimalarials; Case-Control Studies; Chloroquine; Drug Therapy, Combination; Female; France; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Patient Compliance; Proguanil; Travel; Treatment Outcome | 2005 |
Comparative study of the in vitro sensitivity of Plasmodium falciparum to artemisinin in two border areas of Thailand.
Topics: Animals; Antimalarials; Artemisinins; Chi-Square Distribution; Data Interpretation, Statistical; Drug Resistance; Humans; Lactones; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Thailand | 2004 |
In vitro sensitivity of Plasmodium falciparum to lumefantrine in north-western Thailand.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Data Interpretation, Statistical; Drug Resistance, Multiple; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Thailand | 2004 |
Declining mefloquine sensitivity of Plasmodium falciparum along the Thai-Myanmar border.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Parasitic Sensitivity Tests; Plasmodium falciparum; Primaquine; Regression Analysis; Sesquiterpenes; Thailand; Treatment Outcome | 2004 |
Mefloquine--its 20 years in the Thai Malaria Control Program.
Topics: Animals; Antimalarials; Communicable Disease Control; Contraindications; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Program Evaluation; Pyrimethamine; Sulfadoxine; Thailand | 2004 |
Mefloquine and doxycycline malaria prophylaxis in Australian soldiers in East Timor.
Topics: Antimalarials; Australia; Cross-Sectional Studies; Doxycycline; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Military Personnel; Prospective Studies; Surveys and Questionnaires; Timor-Leste; Treatment Refusal | 2005 |
pfmdr1 genotyping and in vivo mefloquine resistance on the Thai-Myanmar border.
Topics: Adolescent; Adult; Animals; Antimalarials; ATP-Binding Cassette Transporters; Drug Resistance; Female; Genotype; Humans; Malaria, Falciparum; Male; Mefloquine; Myanmar; Plasmodium falciparum; Polymorphism, Single Nucleotide; Prospective Studies; Protozoan Proteins; Thailand | 2005 |
Molecular epidemiology of drug resistance markers of Plasmodium falciparum malaria in Thailand.
Topics: Animals; Antimalarials; ATP-Binding Cassette Transporters; Biomarkers; Chloroquine; Drug Resistance; Endemic Diseases; Genes, MDR; Genotype; Humans; Malaria, Falciparum; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Plasmodium falciparum; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Thailand | 2005 |
In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Quinine; Sesquiterpenes; Thailand; Time Factors | 2005 |
Fatty food does not alter blood mefloquine concentrations in the treatment of falciparum malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Biological Availability; Dietary Fats; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes; Treatment Outcome | 2005 |
The efficacy and tolerability of doxycycline and mefloquine in malaria prophylaxis of the ISAF troops in Afghanistan.
Topics: Adult; Afghanistan; Antimalarials; Chemoprevention; Doxycycline; Humans; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Military Personnel; Patient Compliance; Surveys and Questionnaires; Treatment Outcome; Turkey | 2005 |
Are we losing artemisinin combination therapy already?
Topics: Antimalarials; Artemisinins; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine | 2005 |
In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003.
Topics: Administration, Oral; Adolescent; Adult; Age Distribution; Aged; Antimalarials; Artemisinins; Artesunate; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Thailand; Treatment Failure; Treatment Outcome | 2006 |
Emerging chloroquine-resistant Plasmodium vivax (Benign Tertian) malaria: the need for alternative drug treatment.
Topics: Antimalarials; Drug Resistance; Humans; Malaria, Falciparum; Malaria, Vivax; Mefloquine | 2006 |
[Relapse of Plasmodium falciparum malaria in a patient treated with artesunate].
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Female; Humans; Malaria, Falciparum; Mefloquine; Recurrence; Sesquiterpenes; Treatment Outcome | 2006 |
[Atypical course of falciparum malaria in an asplenic patient].
Topics: Adult; Antimalarials; Humans; Malaria, Falciparum; Male; Mefloquine; Quinine; Recurrence; Splenectomy; Travel; Treatment Outcome | 2006 |
[Spectacular suicide associated with mefloquine].
Topics: Adult; Antimalarials; Humans; Malaria, Falciparum; Male; Mefloquine; Psychoses, Substance-Induced; Suicide; Travel | 2006 |
Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative.
Topics: Adult; Aged; Antimalarials; Artemisinins; Artesunate; Cross-Sectional Studies; Drug Therapy, Combination; Early Diagnosis; Female; Hospital Mortality; Hospitalization; Humans; Incidence; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; National Health Programs; Parasitic Sensitivity Tests; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Refugees; Sesquiterpenes; Thailand; Tropical Climate | 2006 |
Mefloquine-induced mania in a 22-year-old Chinese man.
Topics: Acute Disease; Adult; Animals; Antimalarials; Bipolar Disorder; Chloroquine; Contraindications; Humans; Malaria, Falciparum; Male; Mefloquine; Nonprescription Drugs; Risk Factors; Risperidone; Singapore | 2006 |
Artemisinin combination therapies.
Topics: Adult; Africa; Antimalarials; Artemisinins; Artesunate; Asia; Child, Preschool; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Quinolines; Sesquiterpenes | 2006 |
Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin.
Topics: Animals; Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; DNA, Protozoan; Drug Resistance, Multiple; Ethanolamines; Fluorenes; Genes, MDR; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Quinine; Sesquiterpenes | 2006 |
Psychosis with paranoid delusions after a therapeutic dose of mefloquine: a case report.
Topics: Adult; Antimalarials; Humans; Malaria, Falciparum; Male; Mefloquine; Psychoses, Substance-Induced | 2006 |
Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Sesquiterpenes; Treatment Outcome | 2006 |
Fluoxetine potentiates chloroquine and mefloquine effect on multidrug-resistant Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Cells, Cultured; Chloroquine; Drug Resistance, Multiple; Drug Synergism; Erythrocytes; Fluoxetine; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Plasmodium falciparum | 2006 |
Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Chloroquine; Drug Synergism; HIV Protease Inhibitors; Humans; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Ritonavir; Saquinavir | 2007 |
Efficacy and safety of atovaquone-proguanil compared with mefloquine in the treatment of nonimmune patients with uncomplicated P. falciparum malaria in Japan.
Topics: Adult; Antimalarials; Atovaquone; Child, Preschool; Female; Humans; Immunocompetence; Infant; Japan; Malaria, Falciparum; Male; Mefloquine; Proguanil | 2006 |
Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites.
Topics: Animals; Antimalarials; ATP-Binding Cassette Transporters; Drug Resistance, Multiple; Evolution, Molecular; Gene Amplification; Gene Dosage; Genome, Protozoan; Malaria, Falciparum; Mefloquine; Microsatellite Repeats; Myanmar; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Thailand | 2007 |
In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Sesquiterpenes; Treatment Outcome | 2006 |
[A plasmodium alciparum malaria case originated from Mozambique: clues for the diagnosis and therapy].
Topics: Animals; Antimalarials; Canada; Chloroquine; Doxycycline; Drug Resistance; Erythrocytes; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Mozambique; Parasitemia; Plasmodium falciparum; Quinine; Secondary Prevention; Travel; Turkey | 2006 |
An in vivo test to assess mefloquine 25 mg/kg for the treatment of uncomplicated falciparum malaria in Rondônia, Brazil.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged | 2006 |
In vitro antimalarial drug susceptibility and pfcrt mutation among fresh Plasmodium falciparum isolates from the Lao PDR (Laos).
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Resistance; Ethanolamines; Female; Fluorenes; Humans; Inhibitory Concentration 50; Laos; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Protozoan Proteins; Sesquiterpenes | 2007 |
The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Resistance; Ghana; Humans; Infant; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Sesquiterpenes | 2007 |
Prevalent pfmdr1 n86y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; DNA, Protozoan; Drug Resistance; Humans; Inhibitory Concentration 50; Madagascar; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; Protozoan Proteins; Quinine; Rural Population | 2007 |
Selective ambulatory management of Plasmodium falciparum malaria in paediatric refugees.
Topics: Adolescent; Ambulatory Care; Antimalarials; Atovaquone; Australia; Child; Child, Preschool; Female; Follow-Up Studies; Hospitalization; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Patient Compliance; Proguanil; Quinine; Refugees | 2007 |
Adaptation of a multi-drug resistant strain of Plasmodium falciparum from Peru to Aotus lemurinus griseimembra, A. nancymaae, and A. vociferans monkeys.
Topics: Animals; Antimalarials; Aotidae; Chloroquine; Cytochromes b; Dihydropteroate Synthase; Disease Models, Animal; DNA, Protozoan; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Mefloquine; Monkey Diseases; Parasitemia; Peru; Plasmodium falciparum; Sequence Analysis, DNA; Tetrahydrofolate Dehydrogenase | 2007 |
[Polymorphisms of the pfmdr1 gene in field samples of Plasmodium falciparum and their association with therapeutic response to antimalarial drugs and severe malaria in Colombia].
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Colombia; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins | 2007 |
Anemia and antibodies to the 19-kDa fragment of MSP1 during Plasmodium falciparum infection in Aotus monkeys.
Topics: Anemia; Animals; Antibodies, Protozoan; Antimalarials; Aotidae; Disease Models, Animal; Erythrocytes; Malaria, Falciparum; Mefloquine; Merozoite Surface Protein 1; Monkey Diseases; Parasitemia; Plasmodium falciparum | 2007 |
Mefloquine versus 3-day oral quinine-clindamycin in uncomplicated imported falciparum malaria.
Topics: Administration, Oral; Adult; Antimalarials; Clindamycin; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Quinine; Travel | 2007 |
[Tolerance and efficacy of mefloquine as the first line treatment of uncomplicated P. falciparum malaria in children].
Topics: Adolescent; Antiemetics; Child; Child, Preschool; Cohort Studies; Food; Humans; Infant; Isonipecotic Acids; Malaria, Falciparum; Mefloquine; Retrospective Studies; Vomiting | 2008 |
Prolonged Plasmodium falciparum infection in immigrants, Paris.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Case-Control Studies; Child; Child, Preschool; Emigration and Immigration; Female; Humans; Incidence; Infant; Logistic Models; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Paris; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Risk Factors; Time Factors; Travel | 2008 |
Clinically uncomplicated Plasmodium falciparum malaria with high schizontaemia: a case report.
Topics: Adult; Animals; Artemisinins; Artesunate; Blood; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Schizonts; Sesquiterpenes; Thailand; Trophozoites | 2008 |
New combined pill to treat malaria is launched.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Humans; Malaria, Falciparum; Mefloquine; Sesquiterpenes; Tablets | 2008 |
Studies on antimalarial drug susceptibility in Colombia, in relation to Pfmdr1 and Pfcrt.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Colombia; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Protozoan Proteins | 2008 |
Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border.
Topics: Animals; Antimalarials; Artemisinins; Cambodia; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Thailand; Treatment Failure | 2008 |
Cost of increasing access to artemisinin combination therapy: the Cambodian experience.
Topics: Animals; Antimalarials; Artemisinins; Cambodia; Costs and Cost Analysis; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine | 2008 |
Mefloquine in malaria prophylaxis: low efficacy or low compliance?
Topics: Antimalarials; Chemoprevention; Half-Life; Humans; Malaria, Falciparum; Mefloquine; Patient Compliance | 1995 |
In vitro susceptibility of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine, and sulfadoxine/pyrimethamine in Equatorial Guinea.
Topics: Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Equatorial Guinea; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Regression Analysis; Sulfadoxine | 1995 |
Efficacy and tolerability of a sequential, artesunate suppository plus mefloquine, treatment of severe falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Suppositories; Time Factors; Treatment Outcome | 1995 |
Circulating L-selectin is elevated in patients with Plasmodium falciparum malaria.
Topics: Animals; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Cell Adhesion Molecules; Humans; L-Selectin; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Thailand | 1995 |
Malaria prophylaxis. Mefloquine toxicity should limit its use to treatment alone.
Topics: Africa; Antimalarials; Chloroquine; Humans; Malaria; Malaria, Falciparum; Mefloquine; Proguanil; Travel | 1995 |
Quinine resistant falciparum malaria acquired in east Africa.
Topics: Adult; Africa, Eastern; Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Male; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Tetracycline | 1995 |
Sensitivity to antimalarial drugs by Plasmodium falciparum in Goundry, Oubritenga province, Burkina Faso.
Topics: Amodiaquine; Animals; Antimalarials; Burkina Faso; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; National Health Programs; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1994 |
Is mefloquine prophylaxis ineffective for short-term travellers?
Topics: Animals; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Resistance; Gambia; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Travel | 1995 |
Drug-resistant Plasmodium falciparum malaria in the eastern Transvaal.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1994 |
A symposium on containment of mefloquine-resistant falciparum malaria in Southeast Asia with special reference to border malaria.
Topics: Aftercare; Antimalarials; Cambodia; Clinical Protocols; Drug Monitoring; Drug Resistance; Emigration and Immigration; Health Policy; Humans; Malaria, Falciparum; Mefloquine; Mosquito Control; Myanmar; Population Surveillance; Residence Characteristics; Thailand | 1994 |
Malaria in Kansas, 1988-1993.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Resistance; Female; Humans; Kansas; Malaria; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Primaquine; Travel | 1994 |
Delay in onset of malaria with mefloquine prophylaxis.
Topics: Humans; Malaria, Falciparum; Male; Mefloquine; Travel | 1995 |
Plasmodium falciparum and Plasmodium vivax: lactate dehydrogenase activity and its application for in vitro drug susceptibility assay.
Topics: Animals; Antimalarials; Chloroquine; Colorimetry; Erythrocytes; Humans; L-Lactate Dehydrogenase; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Phenanthrenes; Plasmodium falciparum; Plasmodium vivax; Quinine | 1995 |
Ten-year surveillance of drug-resistant malaria in Burkina Faso (1982-1991).
Topics: Adolescent; Animals; Antimalarials; Burkina Faso; Child; Chloroquine; Drug Resistance; Humans; Longitudinal Studies; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Prevalence; Pyrimethamine; Quinine; Retrospective Studies; Sulfadoxine | 1994 |
Development of hyperreactive malarious splenomegaly in an 8 year-old Caucasian boy, 18 months after residence in Africa.
Topics: Animals; Antibodies, Protozoan; Child; Fluorescent Antibody Technique; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Splenomegaly; Syndrome | 1994 |
[Cytokines and malaria. A study of TNF-alpha, IL1-beta, IL6 and IL2R in 28 patients].
Topics: Adolescent; Adult; Amodiaquine; C-Reactive Protein; Chloroquine; Humans; Interleukin-1; Interleukin-6; Leukocyte Count; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Middle Aged; Neutrophils; Platelet Count; Prognosis; Receptors, Interleukin-2; Retrospective Studies; Tumor Necrosis Factor-alpha | 1994 |
Susceptibility of Plasmodium falciparum to chloroquine and mefloquine in Ouagadougou area (Burkina Faso).
Topics: Animals; Burkina Faso; Child; Child, Preschool; Chloroquine; Drug Evaluation; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Treatment Outcome | 1993 |
[Subacute Plasmodium falciparum malaria in 43 patients returning from areas with chloroquine in Africa].
Topics: Adult; Africa; Aged; Antibodies, Protozoan; Blood Cell Count; Chloroquine; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Risk Factors; Time Factors; Travel | 1994 |
Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.
Topics: Adult; Antimalarials; Chloroquine; Female; Humans; Kenya; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Proguanil; Pyrimethamine; Sulfadoxine; Travel | 1993 |
Mefloquine prophylaxis.
Topics: Chloroquine; Humans; Malaria, Falciparum; Mefloquine | 1993 |
Mefloquine.
Topics: Humans; Malaria, Falciparum; Mefloquine | 1994 |
[A case of mefloquine-resistant Plasmodium falciparum malaria with convulsion after antimalarial treatment].
Topics: Adult; Animals; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Male; Mefloquine; Seizures; Travel; Uganda | 1994 |
Mefloquine level monitoring in patients with multidrug resistant Plasmodium falciparum on the Thai Myanmar border.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Cambodia; Chromatography, High Pressure Liquid; Drug Combinations; Drug Monitoring; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Primaquine; Pyrimethamine; Sulfadoxine; Thailand; Treatment Outcome | 1993 |
Central anticholinergic syndrome with the antimalarial drug mefloquine.
Topics: Central Nervous System Diseases; Delirium; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Syndrome | 1994 |
Malaria chemoprophylactic regimens for travellers.
Topics: Chloroquine; Doxycycline; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Proguanil; Travel | 1994 |
Efficacy of chloroquine on Plasmodium falciparum transmitted at Amani, eastern Usambara Mountains, north-east Tanzania: an area where malaria has recently become endemic.
Topics: Adolescent; Adult; Amodiaquine; Animals; Child; Child, Preschool; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Female; Follow-Up Studies; Hemoglobins; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinine; Regression Analysis; Sickle Cell Trait; Tanzania | 1993 |
Mefloquine levels in patients with mefloquine resistant Plasmodium falciparum in the eastern part of Thailand.
Topics: Adolescent; Adult; Animals; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Thailand; Time Factors | 1993 |
Treatment of acute uncomplicated falciparum malaria with a short course of artesunate followed by mefloquine.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes | 1993 |
Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine.
Topics: Animals; Chromosome Mapping; Drug Resistance; Gene Amplification; Gene Expression; Genes, Protozoan; Humans; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine | 1994 |
High prevalence of mefloquine-resistant falciparum malaria in eastern Thailand.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Cohort Studies; Confidence Intervals; Drug Resistance; Female; Humans; Incidence; Infant; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Prevalence; Proportional Hazards Models; Thailand; Treatment Failure | 1993 |
Enhancement of drug susceptibility in Plasmodium falciparum in vitro and Plasmodium berghei in vivo by mixed-function oxidase inhibitors.
Topics: Adolescent; Animals; Child; Child, Preschool; Chloroquine; Cimetidine; Cytochrome P-450 Enzyme Inhibitors; Desipramine; Drug Interactions; Drug Resistance, Microbial; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mixed Function Oxygenases; Plasmodium berghei; Plasmodium falciparum | 1993 |
Control of falciparum malaria.
Topics: Animals; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum | 1993 |
Failure of mefloquine chemoprophylaxis for malaria in Somalia.
Topics: Adult; Animals; Humans; Malaria, Falciparum; Male; Mefloquine; Military Personnel; Somalia; United States | 1993 |
Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand.
Topics: Animals; Antimalarials; Base Sequence; DNA, Protozoan; Drug Resistance; Gene Amplification; Genes, Protozoan; Humans; Malaria, Falciparum; Mefloquine; Molecular Sequence Data; Phenanthrenes; Plasmodium falciparum; RNA, Messenger; RNA, Protozoan; Thailand | 1993 |
[Mefloquine and sulfadoxine/pyrimethamine overdose in malaria tropica].
Topics: Adult; Diazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Haloperidol; Humans; Malaria, Falciparum; Male; Mefloquine; Psychoses, Substance-Induced; Pyrimethamine; Sulfadoxine; Thioridazine | 1993 |
Interactions among primaquine, malaria infection and other antimalarials in Thai subjects.
Topics: Acute Disease; Administration, Oral; Adult; Drug Interactions; Humans; Malaria, Falciparum; Male; Mefloquine; Primaquine; Quinine; Thailand | 1993 |
Comparison of beta-artemether and beta-arteether against malaria parasites in vitro and in vivo.
Topics: Animals; Antimalarials; Aotus trivirgatus; Artemether; Artemisinins; Chloroquine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Malaria; Malaria, Falciparum; Male; Mefloquine; Mice; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes; Structure-Activity Relationship | 1993 |
[Blackwater fever after ingestion of mefloquine. Three cases].
Topics: Adult; Aged; Blackwater Fever; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged | 1993 |
Abnormal circulatory control in falciparum malaria: the effects of antimalarial drugs.
Topics: Acute Disease; Adolescent; Adult; Aged; Analysis of Variance; Antimalarials; Blood Pressure; Convalescence; Female; Heart Rate; Humans; Hypotension, Orthostatic; Linear Models; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Prospective Studies; Quinine | 1993 |
The antimalarial drug, Ro 42-1611 (arteflene), does not affect cytoadherence and cytokine-inducing properties of Plasmodium falciparum malaria parasites.
Topics: Adult; Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Bridged Bicyclo Compounds, Heterocyclic; Cell Adhesion; Cell Survival; Chloroquine; Cytokines; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Humans; Immunoglobulin G; Interleukin-1; Interleukin-6; Lipopolysaccharides; Lymphocytes; Malaria, Falciparum; Mefloquine; Melanoma; Plasmodium falciparum; Styrenes; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1995 |
Mefloquine and scuba diving.
Topics: Antimalarials; Diving; Humans; Malaria, Falciparum; Mefloquine; Nervous System Diseases | 1995 |
Acute psychosis after mefloquine. Report of six cases.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Psychoses, Substance-Induced; Time Factors | 1995 |
Canadian recommendations for the prevention and treatment of malaria among international travellers. Committee to Advise on Tropical Medicine and Travel (CATMAT).
Topics: Animals; Antimalarials; Canada; Child; Chloroquine; Culicidae; Drug Resistance; Female; Humans; Malaria; Malaria, Falciparum; Mefloquine; Pregnancy; Recurrence; Risk Factors; Travel | 1995 |
Malaria among United States troops in Somalia.
Topics: Anti-Bacterial Agents; Antimalarials; Chemoprevention; Chloroquine; Clothing; Cohort Studies; Doxycycline; Drug Resistance; Humans; Malaria, Cerebral; Malaria, Falciparum; Male; Mefloquine; Military Personnel; Population Surveillance; Prospective Studies; Protective Devices; Pyrimethamine; Quinine; Risk Factors; Somalia; Sulfadoxine; Treatment Failure; Treatment Refusal; United States | 1996 |
Mefloquine insusceptibility of malaria in Thailand not promoted by nonregulated drug-use.
Topics: Adult; Animals; Antimalarials; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Medicine, Traditional; Mefloquine; Middle Aged; Mining; Plasmodium falciparum; Rural Health; Self Medication; Thailand | 1996 |
[Malaria prevention: recommendations adapted once more. Work Group Malaria Prophylaxis].
Topics: Adult; Antimalarials; Child; Child, Preschool; Humans; Infant; Malaria, Falciparum; Mefloquine | 1996 |
The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Female; Fetal Growth Retardation; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Malaria, Falciparum; Malawi; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Risk Factors; Rural Population; Treatment Outcome | 1996 |
Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Female; Fetal Death; Fever; Humans; Malaria, Falciparum; Malawi; Mefloquine; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Rural Population | 1996 |
Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa.
Topics: Africa South of the Sahara; Alleles; Animals; Antimalarials; Base Sequence; Chloroquine; Codon; DNA Fingerprinting; DNA, Protozoan; Drug Resistance, Multiple; Genes, Protozoan; Genetic Variation; Humans; Malaria, Falciparum; Mefloquine; Phenotype; Plasmodium falciparum | 1995 |
Malaria in pregnancy: efficacy of a low dose of mefloquine in an area holoendemic for multi-drug resistant Plasmodium falciparum.
Topics: Adult; Antimalarials; Drug Resistance, Multiple; Female; Humans; Malaria, Falciparum; Mefloquine; Nigeria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Treatment Outcome | 1996 |
Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance.
Topics: Adolescent; Adult; Africa; Drug Tolerance; Female; Humans; Longitudinal Studies; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Patient Compliance; Sex Factors; Stereoisomerism; Surveys and Questionnaires; Travel | 1996 |
Tolerance of mefloquine chemoprophylaxis in Dutch military personnel.
Topics: Adult; Antimalarials; Cambodia; Diarrhea; Dizziness; Electrocardiography; Heart; Humans; Leukocyte Count; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Military Personnel; Netherlands; Psychomotor Performance | 1996 |
Imported falciparum malaria in British troops returning from Kenya.
Topics: Adolescent; Adult; Antimalarials; Humans; Kenya; Malaria, Falciparum; Male; Mefloquine; Military Personnel; Travel; United Kingdom | 1994 |
In vitro drug sensitivity and clinical aspects of Plasmodium falciparum malaria in African children.
Topics: Animals; Child; Child, Preschool; Chloroquine; Congo; Humans; Infant; Malaria, Falciparum; Mefloquine; Parasitemia; Plasmodium falciparum; Quinine | 1995 |
Minimal effective dose of mefloquine/sulfadoxine/pyrimethamine in mild Plasmodium falciparum malaria.
Topics: Adolescent; Antimalarials; Child; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Pilot Projects; Pyrimethamine; Sulfadoxine | 1995 |
Serum laminin and basic fibroblast growth factor concentrations in patients with complicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Fibroblast Growth Factor 2; Humans; Kinetics; Laminin; Malaria, Falciparum; Mefloquine; Middle Aged; Sesquiterpenes | 1996 |
Mefloquine: the benefits outweigh the risks.
Topics: Antimalarials; Humans; Malaria, Falciparum; Mefloquine; Risk | 1996 |
Hemophagocytic syndrome induced by Plasmodium falciparum malaria infection.
Topics: Adult; Antimalarials; Biomarkers; Cytokines; Histiocytosis, Non-Langerhans-Cell; Humans; Malaria, Falciparum; Male; Mefloquine; Quinine | 1996 |
High prevalence of chloroquine resistant Plasmodium falciparum infection in Rajasthan epidemic.
Topics: Animals; Antibodies, Protozoan; Antimalarials; Chloroquine; Disease Outbreaks; Drug Resistance, Microbial; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin G; Immunoglobulin M; India; Malaria, Falciparum; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Quinine; Seroepidemiologic Studies; Sulfadoxine; Tumor Necrosis Factor-alpha | 1996 |
Mefloquine induced grand mal seizure in a case of uncomplicated falciparum malaria.
Topics: Antimalarials; Epilepsy, Tonic-Clonic; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged | 1996 |
Recrudescence of Plasmodium falciparum malaria contracted in Lombok, Indonesia after quinine/doxycycline and mefloquine: case report.
Topics: Adult; Animals; Anti-Bacterial Agents; Antimalarials; Doxycycline; Drug Combinations; Drug Resistance, Multiple; Humans; Indonesia; Malaria, Cerebral; Malaria, Falciparum; Male; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Recurrence | 1997 |
[29 cases of malaria introduced into New Caledonia from 1992 to 1995].
Topics: Adolescent; Adult; Antimalarials; Female; France; Hospitalization; Humans; Incidence; Length of Stay; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; New Caledonia; Quinine; Retrospective Studies; Travel | 1997 |
Comparison of whole blood and serum levels of mefloquine and its carboxylic acid metabolite.
Topics: Antimalarials; Cambodia; Carboxylic Acids; Humans; Malaria, Falciparum; Mefloquine; Military Personnel; Netherlands | 1997 |
A simplified in vivo drug sensitivity test for malaria in the field.
Topics: Adult; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Myanmar; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Time Factors | 1997 |
Post-marketing surveillance of prophylactic mefloquine (Lariam) use in pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Abortion, Spontaneous; Adult; Antimalarials; Female; Humans; Malaria, Falciparum; Mefloquine; Pregnancy; Pregnancy Trimester, Third; Product Surveillance, Postmarketing; Prospective Studies; Teratogens | 1998 |
In vitro blood schizonticidal activity of sera containing mefloquine-quinine against Plasmodium falciparum.
Topics: Animals; Antimalarials; Drug Therapy, Combination; Erythrocytes; Humans; In Vitro Techniques; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Plasmodium falciparum; Quinine | 1997 |
On achieving consensus on the prevention of malaria.
Topics: Antimalarials; Chemoprevention; Chloroquine; Guidelines as Topic; Humans; Malaria, Falciparum; Mefloquine; Travel | 1998 |
[Convulsions and mefloquine prophylaxis].
Topics: Antimalarials; France; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Seizures; Travel; Vietnam | 1997 |
Neuropsychiatric manifestations after mefloquine therapy for Plasmodium falciparum malaria: comparing a retrospective and a prospective study.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antimalarials; Bias; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Mental Disorders; Nervous System Diseases; Prevalence; Prospective Studies; Research Design; Retrospective Studies; Surveys and Questionnaires | 1998 |
In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Erythrocytes; Humans; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Senegal; Sesquiterpenes | 1998 |
A primary malarial infection is composed of a very wide range of genetically diverse but related parasites.
Topics: Africa; Animals; Antimalarials; Biomarkers; Chloroquine; Clone Cells; Culicidae; Drug Resistance; Genetic Variation; Humans; Insect Bites and Stings; Malaria, Falciparum; Mefloquine; Parasitology; Phenotype; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Quinine; Thailand | 1998 |
Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Follow-Up Studies; Gabon; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Sesquiterpenes; Sulfadoxine | 1998 |
Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: evidence for quinine resistance.
Topics: Animals; Antimalarials; ATP-Binding Cassette Transporters; Brazil; DNA, Protozoan; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Genes, Protozoan; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Quinine | 1998 |
The effect of chemoprophylaxis on the timing of onset of falciparum malaria.
Topics: Antimalarials; Chemoprevention; Chloroquine; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Proguanil; Retrospective Studies; Time Factors; Travel | 1998 |
Effectiveness of chemoprophylaxis and other determinants of malaria in travellers to Kenya.
Topics: Adult; Animals; Antimalarials; Case-Control Studies; Chloroquine; Humans; Kenya; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Proguanil; Risk Factors; Travel | 1998 |
In vitro sensitivity of Plasmodium falciparum to halofantrine compared with chloroquine, quinine and mefloquine in the region of Bobo-Dioulasso, Burkina Faso (West Africa).
Topics: Animals; Antimalarials; Burkina Faso; Chloroquine; Drug Resistance; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine | 1998 |
Monitoring for mefloquine-resistant Plasmodium falciparum in Africa: implications for travelers' health.
Topics: Adult; Africa South of the Sahara; Animals; Antimalarials; Cohort Studies; Drug Resistance; Female; Government Agencies; Humans; Incidence; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Prospective Studies; Travel; Treatment Failure; United States | 1998 |
Treatment of severe falciparum malaria with artesunate and mefloquine.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Retrospective Studies; Sesquiterpenes; Treatment Outcome | 1998 |
[Considering disparities in resistance of Plasmodium falciparum in Africa in chemoprevention decisions].
Topics: Africa; Animals; Antimalarials; Chloroquine; Cross-Cultural Comparison; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Folic Acid Antagonists; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Proguanil; Seasons; Travel; Triazines | 1998 |
Quinine and mefloquine in the treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy.
Topics: Adolescent; Adult; Animals; Antimalarials; Drug Resistance, Multiple; Female; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Quinine; Thailand; Treatment Outcome | 1998 |
Mefloquine-induced grand mal seizure in tubercular meningitis.
Topics: Adult; Antimalarials; Epilepsy, Tonic-Clonic; Humans; Malaria, Falciparum; Male; Mefloquine; Tuberculosis, Meningeal | 1998 |
[The proper use of antimalarial drugs currently available].
Topics: Animals; Antimalarials; Chemoprevention; Chloroquine; Contraindications; Drug Combinations; Drug Resistance; Endemic Diseases; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Phenanthrenes; Plasmodium; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Proguanil; Pyrimethamine; Quinine; Sulfadoxine; Travel | 1998 |
[Convulsions during prophylactic use of mefloquine].
Topics: Antimalarials; Contraindications; Doxycycline; Drug Resistance, Microbial; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Seizures | 1999 |
[Pulmonary manifestations associated with malaria].
Topics: Adult; Anti-Bacterial Agents; Antimalarials; Bronchitis; Child; Chloroquine; Female; Humans; Infant, Newborn; Lung Diseases; Malaria, Falciparum; Male; Mefloquine; Oxygen Inhalation Therapy; Phenanthrenes; Pleurisy; Pregnancy; Pregnancy Complications, Parasitic; Pulmonary Edema; Quinidine; Quinine; Respiratory Distress Syndrome, Newborn; Travel | 1998 |
Malaria prophylaxis for the 1990s and beyond.
Topics: Antimalarials; Atovaquone; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Mefloquine; Naphthoquinones; Proguanil | 1997 |
In vitro susceptibility of African Plasmodium falciparum isolates to dihydroartemisinin and the risk factors for resistance to qinghaosu.
Topics: Africa; Animals; Antimalarials; Artemisinins; Chloroquine; Cross Reactions; Drug Evaluation, Preclinical; Drug Resistance; France; Humans; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Sesquiterpenes; Travel | 1998 |
Mefloquine as malaria prophylaxis.
Topics: Antimalarials; Australia; Humans; Malaria, Falciparum; Mefloquine; Risk Assessment | 1999 |
Antimalarial drug resistance and combination chemotherapy.
Topics: Animals; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Sesquiterpenes | 1999 |
Risk factors for gametocyte carriage in uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Carrier State; Child; Child, Preschool; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Multivariate Analysis; Parasitemia; Phenanthrenes; Plasmodium falciparum; Prospective Studies; Quinine; Regression Analysis; Risk Factors; Seroepidemiologic Studies; Sesquiterpenes; Thailand | 1999 |
Polyclonal anti-tumor necrosis factor-alpha Fab used as an ancillary treatment for severe malaria.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Female; Humans; Immunoassay; Immunoglobulin Fab Fragments; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-1; Interleukin-2; Interleukin-6; Interleukin-8; Kinetics; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Pilot Projects; Plasmodium falciparum; Sesquiterpenes; Tumor Necrosis Factor-alpha | 1999 |
Efficacy and tolerability of a low-dose mefloquine-sulfadoxine-pyrimethamine combination compared with chloroquine in the treatment of acute malaria infection in a population with multiple drug-resistant Plasmodium falciparum.
Topics: Adolescent; Adult; Animals; Antimalarials; Blood; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Nigeria; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Random Allocation; Sulfadoxine | 1999 |
Phenotypic and genotypic characteristics of recently adapted isolates of Plasmodium falciparum from Thailand.
Topics: Animals; Antimalarials; Blotting, Western; Chloroquine; DNA Fingerprinting; DNA, Protozoan; Drug Resistance; Electrophoresis, Agar Gel; Gene Dosage; Genotype; Humans; Malaria, Falciparum; Mefloquine; Penfluridol; Phenanthrenes; Phenotype; Plasmodium falciparum; Polymerase Chain Reaction; Quinine; Thailand; Verapamil | 1999 |
[Prevention of malaria].
Topics: Anti-Bacterial Agents; Antimalarials; Chloroquine; Doxycycline; Female; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Primaquine; Proguanil; Risk Assessment; Risk Factors; Time Factors; Travel | 1999 |
In vivo efficacy of mefloquine for the treatment of Falciparum malaria in Brazil.
Topics: Adolescent; Adult; Animals; Antimalarials; Brazil; Drug Resistance; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Treatment Outcome | 1999 |
Suboptimal prophylaxis for P. falciparum.
Topics: Antimalarials; Chloroquine; Fatal Outcome; Humans; Kenya; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Multiple Organ Failure; Treatment Failure | 1999 |
Population pharmacokinetics of mefloquine in patients with acute falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Linear Models; Malaria, Falciparum; Male; Mefloquine; Prospective Studies; Sesquiterpenes; Treatment Outcome | 1999 |
The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand.
Topics: Alleles; Animals; Antigens, Protozoan; Antimalarials; ATP-Binding Cassette Transporters; Codon; DNA, Protozoan; Drug Resistance, Multiple; Gene Dosage; Genetic Markers; Humans; Malaria, Falciparum; Mefloquine; Phenotype; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Reverse Transcriptase Polymerase Chain Reaction; Thailand | 1999 |
Analysis of mefloquine resistance and amplification of pfmdr1 in multidrug-resistant Plasmodium falciparum isolates from Thailand.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Chromosome Mapping; DNA Primers; DNA, Protozoan; Drug Resistance, Multiple; Electrophoresis, Agar Gel; Electrophoresis, Gel, Pulsed-Field; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Quinine; Scintillation Counting; Sequence Analysis, DNA; Thailand | 1999 |
Inoculum effect leads to overestimation of in vitro resistance for artemisinin derivatives and standard antimalarials: a Gambian field study.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Gambia; Hematocrit; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Phenanthrenes; Plasmodium falciparum; Quinine; Scintillation Counting; Sensitivity and Specificity; Sesquiterpenes | 1999 |
Mefloquine-induced psychosis.
Topics: Antimalarials; Child; Humans; Malaria, Falciparum; Male; Mefloquine; Psychoses, Substance-Induced | 2000 |
Serum concentrations of granulocyte-colony stimulating factor in complicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Calcitonin; Calcitonin Gene-Related Peptide; Chemokine CCL4; Child; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Erythropoietin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Macrophage Inflammatory Proteins; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Nitrates; Plasmodium falciparum; Protein Precursors; Reference Values; Sesquiterpenes; Stem Cell Factor | 2000 |
Automated exchange transfusion for life-threatening plasmodium falciparum malaria--lessons relating to prophylaxis and treatment.
Topics: Adult; Exchange Transfusion, Whole Blood; Female; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Travel | 1999 |
The Thai-Burmese border: drug studies of Plasmodium falciparum in pregnancy.
Topics: Antimalarials; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Pregnancy; Pregnancy Complications, Parasitic; Quinine; Sesquiterpenes; Thailand | 1999 |
Gametocytocidal activity of pyronaridine and DNA topoisomerase II inhibitors against multidrug-resistant Plasmodium falciparum in vitro.
Topics: Amsacrine; Animals; Antimalarials; Chloroquine; Drug Resistance, Multiple; Enzyme Inhibitors; Etoposide; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Naphthyridines; Norfloxacin; Nucleic Acid Synthesis Inhibitors; Plasmodium falciparum; Primaquine; Proguanil; Pyrimethamine; Thailand; Topoisomerase II Inhibitors; Triazines | 2000 |
A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Audiometry; Case-Control Studies; Child; Child, Preschool; Drug Resistance, Multiple; Drug Therapy, Combination; Evoked Potentials, Auditory, Brain Stem; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Thailand | 2000 |
Management of a case of chloroquine-resistant falciparum malaria in a pregnant woman with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Topics: Adult; Animals; Antimalarials; Chloroquine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Microbial Sensitivity Tests; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pyrimethamine | 1999 |
Acceptance of short course artesunate plus mefloquine drug combination by malaria patients in rural Myanmar.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Cross-Sectional Studies; Drug Combinations; Female; Health Care Costs; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Patient Compliance; Rural Population; Sesquiterpenes | 1999 |
Prevention and treatment of malaria in UK travellers.
Topics: Age Factors; Antimalarials; Chloroquine; Contraindications; Doxycycline; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Proguanil; Quinine; Risk Factors; Travel | 2000 |
The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin.
Topics: Alleles; Animals; Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Sesquiterpenes; Tetrahydrofolate Dehydrogenase; Tyrosine | 2000 |
The effects of mefloquine treatment in pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Antimalarials; Female; Fetal Death; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Risk Factors; Surveys and Questionnaires; Treatment Outcome | 1999 |
Antimalarial drug combination policy: a caveat.
Topics: Africa; Animals; Antimalarials; Artemisinins; Artesunate; Drug Administration Schedule; Drug Combinations; Drug Resistance; Endemic Diseases; Health Policy; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Thailand | 2000 |
[Malaria imported to Norway 1989-98].
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Chloroquine; Disease Notification; Emigration and Immigration; Female; Humans; Infant; Insect Bites and Stings; Malaria; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Norway; Proguanil; Travel | 2000 |
Mefloquine-resistant strains of Plasmodium falciparum in Madagascar: impact on tourists and public health.
Topics: Animals; Antimalarials; Drug Administration Schedule; Drug Resistance; Endemic Diseases; Humans; Madagascar; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Prospective Studies; Public Health; Travel | 2000 |
[Neuropsychiatric side effects of malarial prophylaxis with mefloquine (Lariam)].
Topics: Adult; Antimalarials; Female; Humans; Malaria, Falciparum; Mefloquine; Psychoses, Substance-Induced | 1999 |
[Malaria in travelers returning to Israel from endemic areas: diagnosis of two patients in a family practice].
Topics: Adult; Animals; Antimalarials; Asia, Eastern; Family Practice; Female; Humans; Israel; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Middle Aged; Travel | 1999 |
Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cohort Studies; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Incidence; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Random Allocation; Sesquiterpenes; Thailand | 2000 |
Treatment of uncomplicated Plasmodium falciparum malaria in Myanmar: a clinical decision analysis.
Topics: Antimalarials; Chloroquine; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Drug Combinations; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2000 |
Malaria, mefloquine and oil-workers.
Topics: Africa South of the Sahara; Antimalarials; Humans; Malaria, Falciparum; Mefloquine; Occupations; Petroleum; Scotland; Travel | 2000 |
Declining chloroquine resistance of Plasmodium falciparum in Lambaréné, Gabon from 1992 to 1998.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Gabon; Humans; In Vitro Techniques; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Practice Guidelines as Topic; Prospective Studies; Quinine | 2001 |
Characterization of specific monoclonal antibodies for detection of mefloquine in body fluids.
Topics: Antibodies, Monoclonal; Antimalarials; Chromatography, High Pressure Liquid; Cross Reactions; Enzyme-Linked Immunosorbent Assay; Humans; Malaria, Falciparum; Mefloquine; Sensitivity and Specificity; Serum Albumin, Bovine; Thailand | 2000 |
Use of the DELI-microtest to determine the drug sensitivity of Plasmodium falciparum in Burkina Faso.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Malaria, Falciparum; Mefloquine; Parasitemia; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Reagent Kits, Diagnostic; Sensitivity and Specificity; Statistics, Nonparametric | 2001 |
Death from malaria following inappropriate chemoprophylaxis.
Topics: Africa; Animals; Antimalarials; Centers for Disease Control and Prevention, U.S.; Chemoprevention; Child; Chloroquine; Drug Resistance; Fatal Outcome; Humans; Malaria, Falciparum; Mefloquine; Middle Aged; Plasmodium falciparum; Proguanil; Travel; United States | 2001 |
Serious adverse events of mefloquine in relation to blood level and gender.
Topics: Adult; Antimalarials; Case-Control Studies; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Regression Analysis; Sex Factors; Travel | 2001 |
Pfmdr1 alleles and response to ultralow-dose mefloquine treatment in Gabonese patients.
Topics: Adolescent; Animals; Antimalarials; ATP-Binding Cassette Transporters; Child; Child, Preschool; Drug Resistance; Gabon; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Point Mutation; Polymorphism, Genetic; Protozoan Proteins | 2002 |
Pulmonary toxicity with mefloquine.
Topics: Antimalarials; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pulmonary Alveoli; Respiratory Distress Syndrome; Tomography, X-Ray Computed | 2001 |
Malaria remains a military medical problem.
Topics: Adult; Animals; Antimalarials; Atovaquone; Chloroquine; Drug Combinations; Global Health; Humans; Kenya; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Military Medicine; Military Personnel; Naphthoquinones; Patient Compliance; Plasmodium falciparum; Plasmodium vivax; Proguanil; Sierra Leone; Treatment Failure; Treatment Outcome; United Kingdom | 2001 |
Community-based program for malaria case management in the Brazilian Amazon.
Topics: Animals; Antigens, Protozoan; Antimalarials; Brazil; Community Health Services; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Preventive Health Services; Program Evaluation | 2001 |
Does mefloquine prophylaxis affect electroencephalographic patterns?
Topics: Adult; Antimalarials; Electroencephalography; Epilepsy; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged | 2002 |
Treatment of imported malaria in an ambulatory setting: prospective study.
Topics: Adolescent; Adult; Africa; Aged; Ambulatory Care; Antimalarials; Follow-Up Studies; Humans; Malaria, Falciparum; Mefloquine; Middle Aged; Outpatient Clinics, Hospital; Prospective Studies; Pyrimethamine; Sulfadoxine; Switzerland; Travel | 2002 |
Resistant malaria in a neonate.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant, Newborn; Malaria, Falciparum; Mefloquine; Quinine; Risk Assessment; Sesquiterpenes; Severity of Illness Index; Treatment Outcome | 2002 |
Sensitivity status of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in a tribal population of District Sundargarh, Orissa.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; India; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1992 |
Severe falciparum malaria: survival with oral therapy.
Topics: Administration, Oral; Child, Preschool; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Mefloquine; Severity of Illness Index | 1992 |
[Treatment of malaria in children in France].
Topics: Antimalarials; Child; Chloroquine; France; Humans; Malaria, Cerebral; Malaria, Falciparum; Mefloquine; Phenanthrenes; Quinine | 1992 |
Mefloquine resistant malaria in Cameroon and correlation with resistance to quinine.
Topics: Animals; Cameroon; Carrier State; Child; Child, Preschool; Drug Resistance; Drug Utilization; Humans; Infant; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Quinine | 1992 |
Treatment of patients with recrudescent falciparum malaria with a sequential combination of artesunate and mefloquine.
Topics: Acute Disease; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Prospective Studies; Recurrence; Sesquiterpenes | 1992 |
Proposals for a new therapeutic strategy for simple Plasmodium falciparum malaria attacks in Cameroon.
Topics: Administration, Oral; Aminoquinolines; Amodiaquine; Animals; Antimalarials; Cameroon; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine | 1992 |
Multi-drug resistant falciparum malaria in Cameroon in 1987-1988. II. Mefloquine resistance confirmed in vivo and in vitro and its correlation with quinine resistance.
Topics: Animals; Cameroon; Child; Child, Preschool; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Quinine | 1992 |
Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon.
Topics: Adult; Animals; Drug Resistance; Humans; Malaria, Cerebral; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum | 1992 |
[Malaria tropica].
Topics: Anti-Bacterial Agents; Antimalarials; Doxycycline; Exchange Transfusion, Whole Blood; Humans; Malaria, Falciparum; Mefloquine; Quinine; Tetracycline | 1992 |
Emergence of multidrug-resistant Plasmodium falciparum in Thailand: in vitro tracking.
Topics: Animals; Antimalarials; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Regression Analysis; Thailand | 1992 |
Susceptibility of Plasmodium falciparum strains to mefloquine in an urban area in Senegal.
Topics: Adolescent; Adult; Aminoquinolines; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Humans; In Vitro Techniques; Infant; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum | 1992 |
Type RI resistance to halofantrine in West Africa.
Topics: Animals; Antimalarials; Biological Availability; Chloroquine; Cote d'Ivoire; Drug Resistance; Follow-Up Studies; France; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Phenanthrenes; Plasmodium falciparum; Quinine; Recurrence; Travel | 1991 |
Mefloquine for multidrug-resistant malaria.
Topics: Animals; Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Psychoses, Substance-Induced; Pyrimethamine; Refugees; Sulfadoxine | 1991 |
[Malaria in the republic of São Tomé and Principe. Epidemiologic evaluation and chemoresistance of P. falciparum].
Topics: Age Factors; Animals; Antimalarials; Atlantic Islands; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Seasons; Sex Factors; Splenomegaly | 1991 |
Breakdown of mefloquine prophylaxis in central Africa.
Topics: Adult; Africa, Central; Drug Resistance; Humans; Malaria, Falciparum; Male; Mefloquine | 1991 |
Severe falciparum malaria (21 cases).
Topics: Adolescent; Adult; Child, Preschool; Chloroquine; Exchange Transfusion, Whole Blood; Female; Humans; Infusions, Intravenous; Intensive Care Units; Malaria, Cerebral; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Quinine; Respiration, Artificial; Retrospective Studies | 1991 |
[Panic attack after therapeutic administration of mefloquine].
Topics: Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Panic Disorder | 1991 |
Malaria prophylaxis.
Topics: Chloroquine; Drug Resistance; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Travel; Zimbabwe | 1991 |
Pharmacokinetics of prophylactic mefloquine.
Topics: Absorption; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Thailand | 1991 |
Mefloquine chemoprophylaxis of soldiers on the Thai-Cambodian border.
Topics: Cambodia; Humans; Incidence; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Military Personnel; Thailand | 1991 |
Pharmacokinetics of mefloquine in treatment failure.
Topics: Absorption; Adolescent; Adult; Diarrhea; Humans; Malaria, Falciparum; Male; Mefloquine; Nausea; Recurrence; Thailand; Vomiting | 1991 |
[Malaria of importation in the child: epidemiological, clinical and therapeutic analysis. Apropos of 70 cases observed in a pediatric hospital in Paris].
Topics: Africa; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Infant; Malaria; Malaria, Falciparum; Mefloquine | 1991 |
Failure of falciparum malaria prophylaxis by mefloquine in travelers from West Africa.
Topics: Adult; Africa, Western; Animals; Child, Preschool; Drug Resistance; Female; France; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Retrospective Studies; Travel | 1991 |
In vivo response of multi-resistant Plasmodium falciparum infections to mefloquine and its combination with sulfadoxine/pyrimethamine in Cambodia.
Topics: Animals; Cambodia; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Recurrence; Sulfadoxine | 1991 |
Halofantrine for the treatment of mefloquine chemoprophylaxis failures in Plasmodium falciparum infections.
Topics: Animals; Antimalarials; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Military Personnel; Phenanthrenes; Plasmodium falciparum; Recurrence; Thailand | 1991 |